The physiological role of peroxiredoxin 2 in human erythrocytes: a  kinetic analysis by Benfeitas, Rui Manuel Vicente
University of Lisbon 
Faculty of Science 
DEPARTMENT OF CHEMISTRY AND BIOCHEMISTRY 
(in association with the Center for Neuroscience and Cell Biology, 
University of Coimbra)
THE PHYSIOLOGICAL ROLE OF 
PEROXIREDOXIN 2 IN HUMAN ERYTHROCYTES: 
A KINETIC ANALYSIS 
 
Rui Manuel Vicente Benfeitas 
Biochemistry Masters 
2011 
University of Lisbon 
Faculty of Science 
DEPARTMENT OF CHEMISTRY AND BIOCHEMISTRY 
(in association with the Center for Neuroscience and Cell Biology, 
University of Coimbra)
THE PHYSIOLOGICAL ROLE OF 
PEROXIREDOXIN 2 IN HUMAN ERYTHROCYTES: 
A KINETIC ANALYSIS 
Advisors 
Armindo Salvador, Ph.D. & Fernando Antunes Ph.D. 
 
1Center for Neuroscience and Cell Biology, University of Coimbra 
2Faculty of Science, University of Lisbon 
Rui Manuel Vicente Benfeitas 
Biochemistry Masters 
2011 
 3 
 
 
To my advisors Dr. Armindo Salvador and Dr. Fernando Antunes, a big thank you for all your 
patience, efforts and very interesting discussions. Thanks for making this so fun! 
 
To my family, friends, lab mates, thank you for pushing me forward. 
 4 
Index 
Index  4 
List of abbreviations  7 
List of values  11 
List of figures  13 
List of tables  15 
1. Summary  17 
 Resumo  19 
2. Introduction  21 
 Reactive Oxygen Species and biological sources of H2O2  22 2.1.
2.1.1. Glutathione autoxidation  23 
2.1.2. Superoxide dismutation  24 
2.1.3. Hemoglobin autoxidation  25 
2.1.4. H2O2 influx from plasma  25 
 Relevance of the main defenses against H2O2 in erythrocytes  28 2.2.
2.2.1. The debate around the relative importance of catalase and GPx1  28 
2.2.2. Evidence of an unknown antioxidant  33 
2.2.3. The relevance of peroxiredoxin  33 
 Peroxiredoxin 2: catalytic cycle and main features in human erythrocytes  38 2.3.
2.3.1. Prx2 structure  38 
2.3.2. Catalytic cycle of Prx2  39 
2.3.3. Prx2 inactivation by H2O2  40 
3. Problem and objective  43 
4. Methods and Technical notes  45 
5. Results ‐ Part I: Study of defenses against H2O2 under steady state conditions  47 
 What is the relative contribution of Peroxiredoxin 2 for hydrogen peroxide consumption?  48 5.1.
5.1.1. Rate constant estimates  48 
 5 
5.1.1.1.  Pseudo‐first order rate constant of GPx1 with respect to H2O2  48 
5.1.1.2.  Pseudo‐first order rate constant of catalase with respect to H2O2  52 
5.1.1.3.  Pseudo‐first order rate constant of Prx2 with respect to H2O2  52 
5.1.2. Relative contribution of the three enzymes under low and high oxidative loads  53 
 What is the maximum rate of H2O2 decomposition by Prx2?  54 5.2.
5.2.1. Parameter estimates and considerations  54 
5.2.1.1.  Dismutase activity of catalase  54 
5.2.1.2.  Peroxidase activity of GPx1  61 
5.2.1.3.  Endogenous H2O2 production and basal intracellular H2O2  64 
5.2.1.4.  Kinetics of H2O2 efflux and consumption by catalase and GPx1  66 
5.2.1.5.  Peroxidase activity and concentration of Prx2  67 
5.2.1.6.  Total concentration of Trx  67 
5.2.1.7.  TrxR concentration  68 
5.2.1.8.  Estimate of the rate constants for H2O2 permeation and endogenous production in the 
experiments of (Low et al., 2007)  68 
5.2.1.9.  Pseudo‐first order rate constant for Trx reduction through TrxR  71 
5.2.1.10.  Estimate of the pseudo‐first order rate constant for formation of PSSP  76 
5.2.2. Maximum rates of H2O2 decomposition by Prx2 at steady state  80 
 At what extracellular H2O2 concentration does Prx2 remain the main H2O2 scavenging process?  81 5.3.
 How does the redox state of Peroxiredoxin 2 vary with Trx or disulfide bond formation rate constants?  86 5.4.
 What is the concentration of each Prx2 form in limit situations and how does it change with system’s 5.5.
parameters?  88 
5.5.1. Fraction of each Prx2 form under low and high oxidative loads  88 
5.5.2. How H2O2 influx and Prx2 reduction affect the redox status of Prx2  91 
 What determines the eH2O2 at which the crossover occurs?  94 5.6.
 Is the sulfinylation of Prx2 physiologically relevant?  96 5.7.
 Is Prx2 essential for plasma H2O2 scavenging by erythrocytes?  100 5.8.
 Could Prx2 be replaced by catalase or GPx1?  104 5.9.
Results ‐ Part II: Analysis of defenses against H2O2 in erythrocytes crossing inflammation sites  110 
 Physiological aspects of human circulatory system and estimates for erythrocytes facing pulses of H2O2 110 5.10.
5.10.1. Human blood contents and blood flow velocities  110 
5.10.2. Frequency of crossing inflammation sites  112 
 6 
5.10.3. Basal intracellular and extracellular values of H2O2  114 
5.10.4. H2O2 production in pathological conditions and cell tolerance to H2O2  115 
 How do different eH2O2 pulses affect the redox state of Prx2?  118 5.11.
 What is the role of catalase in defense against eH2O2 pulses?  120 5.12.
 Could there be accumulation of PSSP due to consecutive crossing of inflammatory sites?  122 5.13.
 Why is Prx2 so abundant in the human erythrocyte?  125 5.14.
6. Discussion  127 
 Prx2 is the main scavenger of low/mild H2O2  128 6.1.
6.1.1. Basal concentration and production of H2O2  129 
6.1.2. Redox status of Prx2 under basal oxidative loads  131 
6.1.3. Prx2 contributes significantly for H2O2 consumption under low/mild loads  132 
 Catalase becomes the main scavenger of iH2O2 under high oxidative stress  135 6.2.
 The contribution of Prx2 for H2O2 consumption is affected by oxidative load and NADPH supply  138 6.3.
 Prx2’s high concentration allows the human erythrocyte to remain protected against H2O2 when crossing 6.4.
inflammation sites  139 
 Prx2 inactivation and reaction between H2O2 and Prx2  141 6.5.
 Improvements and experiments needed  144 6.6.
6.6.1. Basal and pathological oxidative loads  144 
6.6.2. Catalytic cycle of catalase  145 
6.6.3. Frequency of crossing inflammation sites and H2O2 induced by crossing inflammation sites  146 
6.6.4. Peroxidase activity and relevance of Prx2 for H2O2 defense  147 
6.6.5. Effects of NADPH supply on H2O2 defense  149 
 Relevance of the study  150 6.7.
7. Conclusion  152 
8. References  153 
9. Appendix  168 
 Poster presentations  168 9.1.
 Oral communications  172 9.2.
 7 
List of abbreviations 
Latin alphabet 
Abbreviation Meaning 
AS Erythrocyte surface area 
CP Peroxidatic cysteine 
CR Resolving cysteine 
DensityRBC Erythrocyte density 
DeoxyHb Hemoglobin (deoxyhemoglobin, Fe2+ oxidation state) 
Dp H2O2-induced intracellular damage during an H2O2 pulse 
Dr H2O2-induced intracellular damage between H2O2 pulses 
DTNB 5,5'-dithiobis-(2-nitrobenzoic acid) 
eH2O2 Extracellular hydrogen peroxide 
f Order of reaction of glutathione peroxidase 1 with respect to H2O2 
g Order of reaction of glutathione peroxidase 1 with respect to GSH 
G6P Glucose-6-phosphate 
G6PD Glucose-6-phosphate dehydrogenase 
GPx1 Glutathione Peroxidase 1 
GPx1ox Glutathione Peroxidase 1 (oxidized form) 
GPx1red Glutathione Peroxidase 1 (reduced form) 
GPx1-SG Glutathione Peroxidase 1 (associated with glutathione) 
GSH Glutathione 
GSR Glutathione Reductase 
GSSG Glutathione (oxidized form) 
GStot Glutathione (total concentration in the erythrocyte) 
H2O2 Hydrogen peroxide 
Hb Hemoglobin 
i Fraction of total body volume occupied by inflamed tissue 
iH2O2 Intracellular hydrogen peroxide 
kc 
Aggregated pseudo-first order rate constant for hydrogen peroxide consumption by catalase and glutathione 
peroxidase 
kcatalase Pseudo-first order rate constant for hydrogen peroxide consumption by catalase 
kCompoundI Reactivity between Compound I and H2O2 
kCompoundII Pseudo-first order rate constant for reduction of Compound II to Ferricatalase 
kD Proportionality constant for the accumulation of iH2O2-induced damage to the cell 
kefflux Pseudo-first order rate constant for hydrogen peroxide efflux 
kFerricatalase Reactivity between Ferricatalase and H2O2 
kGPx1 Pseudo-first order rate constant for hydrogen peroxide consumption by glutathione peroxidase 1 
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Abbreviation Meaning 
kH Henry’s law constant for the solubility of O2 in water
kIntN Reactivity between Intermediate and NADPH 
kIntN’ Pseudo-first order rate constant for reduction of Intermediate to Ferricatalase, with respect to Intermediate 
kIntRed Pseudo-first order rate constant for reduction of Intermediate to Compound II 
 mK Trx  Michaelis-Menten constant of thioredoxin reductase for thioredoxin 
( )mK NADPH  Michaelis-Menten constant of thioredoxin reductase for NADPH 
kox First-order rate constant for spontaneous glutathione oxidation  
kox,in vivo First-order rate constant for spontaneous glutathione oxidation in vivo, considering physiological pO2 
kox,exp First-order rate constant for spontaneous glutathione oxidation experimentally determined under large pO2 
kspon First-order rate constant for oxidation of glutathione by oxygen 
kp Pseudo-first order rate constant for H2O2 influx across the erythrocyte membrane 
kPrx2 Pseudo-first order rate constant for hydrogen peroxide reduction by peroxiredoxin 2 
kPrxRed Reactivity between peroxiredoxin 2 and hydrogen peroxide 
kPSO2H Second-order rate constant for the sulfinylation of Prx2 
kPSOH First-order rate constant for the formation of disulfide form of Prx2 
kPSSP Reactivity between disulfide peroxiredoxin 2 and reduced thioredoxin 
kR Pseudo-first order rate constant for Prx2 reduction 
kTrxR Pseudo-first order rate constant for thioredoxin reduction by thioredoxin reductase 
MetHb Hemoglobin (methemoglobin, Fe3+ oxidation state) 
MWcatalase Molecular weight of catalase monomer  
MWGPx1 Molecular weight of GPx1 monomer 
MWPrx2 Molecular weight of each monomer of peroxiredoxin 2 
MWTrx Molecular weight of thioredoxin 
MWTrxR Molecular weight of thioredoxin reductase 
NADP+ Nicotinamide adenine dinucleotide phosphate (oxidized form) 
NADPH Nicotinamide adenine dinucleotide phosphate (reduced form) 
OxyHb Hemoglobin (oxyhemoglobin, oxygen-bound state, Fe3+ oxidation state) 
PPP Pentose Phosphate Pathway 
Prx1 Peroxiredoxin 2 (singly-crosslinked monomers) 
Prx2 Peroxiredoxin 2 
Prxtot Total concentration of monomeric peroxiredoxin 2 in human erythrocytes 
PSO2H Peroxiredoxin 2 (sulfinic acid form) 
PSSP Peroxiredoxin 2 (disulfide form) 
Q10 Temperature coefficient 
Srx Sulfiredoxin 
SrxOx Sulfiredoxin (oxidized form) 
SrxRed Sulfiredoxin (reduced form) 
SOD Superoxide Dismutase 
T Period of crossing an inflammation site 
Trx Thioredoxin 
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Abbreviation Meaning 
TrxHolmgren Concentration of thioredoxin in the erythrocyte 
TrxOx Thioredoxin (oxidized form) 
TrxR Thioredoxin reductase 
TrxRed Thioredoxin (reduced form) 
Trxtot Total concentration of thioredoxin 
TSA Thiol-specific antioxidant 
Vbathed Volume of human body that is bathed with blood 
Vblood cells Total volume of human blood cells 
vCompoundI Rate of Compound I-mediated H2O2 dismutation 
vdecay Rate of decay of Compound I to Intermediate 
Ve Erythrocyte cell volume 
Vew Volume of erythrocyte water 
vH2O2 Total rate of H2O2 consumption by catalase, peroxiredoxin 2 and glutathione peroxidase 1 
vinflux Rate of H2O2 influx 
Vinterstitial Volume of interstitial fluids 
vIntRed Rate of reduction of Intermediate to Compound II 
 appmax OxV Trx  Apparent maximal rate of reduction of thioredoxin by thioredoxin reductase 
PPP
maxV  Maximum rate of NADPH production by the pentose phosphate pathway 
2Prx
maxV  Maximum rate of hydrogen peroxide consumption by peroxiredoxin 2 
Red
m axV  Maximum rate of Prx2 reduction 
TrxR
maxV  Maximum rate of activity of thioredoxin reductase 
vNADPHcons Rate of NADPH-mediated reduction of Intermediate to Ferricatalase 
Vo Extracellular volume 
vcatalase Rate of H2O2 consumption by catalase 
vPrx2 Rate of H2O2 consumption by peroxiredoxin 2 
vPSSP Rate of Prx2 reduction 
Vskeleton Average skeleton volume 
Vtotal Average total body volume 
vTrxR Rate of activity of thioredoxin reductase 
WaterContentRBC Average erythrocyte water volume 
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Greek alphabet 
Abbreviation Meaning 
εcatalase Fold increase in catalase concentration in order to compensate for the absence of Prx2 or GPx1 
εGPx1 Fold increase in GPx1 concentration in order to compensate for the absence of catalase or Prx2 
εPrx2 Fold increase in Prx2 concentration in order to compensate for the absence of catalase or GPx1 
κ Hydrogen peroxide diffusion constant across the erythrocyte membrane 
φ Rate of H2O2 influx across the erythrocyte membrane 
ϕ Endogenous production of hydrogen peroxide 
ϕ1 Reciprocal rate constant for net forward reaction of Glutathione Peroxidase 1 with hydrogen peroxide 
ϕ2 Reciprocal rate constant for net forward reaction of Glutathione Peroxidase 1 with glutathione 
 Hydrogen peroxide production in the experiments of (Low et al., 2007) 
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List of values 
Abbreviation Value Reference 
AS 1.3510-5 dm2 (Evans and Fung, 1972) 
DensityRBC 1.094 Kg erythrocytes/L packed erythrocytes (Raftos et al., 1999) 
GPx1 0.97×10-6 M Estimated, Section 5.1.1.1  
GStot 3.2×10-3 M (Thorburn and Kuchel, 1987) 
Hb 
340 g Hb/dm3 packed erythrocytes 
486 g Hb/dm3 erythrocyte water 
(Beutler, 1984) 
Estimated, considering Vew by (Savitz et al., 1964) 
kc 258 s-1 Estimated, Section 5.2.1.4 
kcatalase 218 s-1 (Mueller et al., 1997a) 
kCompoundI 1.6×107 M-1 s-1 (Chance et al., 1952) 
kCompoundII 8×10-6 s-1 (Kirkman et al., 1999) 
kefflux 12 s-1 Estimated, Section 5.2.1.4 
kFerricatalase 0.6×107 M-1 s-1 (Chance et al., 1952) 
kGPx1 40 s-1 Estimated, Section 5.1.1.1 
kH 1.3×10-3 M/atm (Wilhelm et al., 1977) 
 mK Trx  1.83×10-6 M (Turanov et al., 2006) 
( )mK NADPH  6×10-6 M (Urig et al., 2006) 
kspon 0.1 M-1s-1 (Scarpa et al., 1996) 
kp 8 s-1 Estimated, Section 5.2.1.2 
kPrx2 3.7×104 s-1 Estimated, Section 5.1.1.3 
kPrxRed 108 M-1 s-1 (Manta et al., 2009) 
kPSO2H 0.23 M-1 s-1 Estimated, Section 5.7 
kPSOH 0.26 s-1 Estimated, Section 5.2.1.10 
kPSSP 2.1105 M-1s-1 (Manta et al., 2009) 
kR 1.7 s-1  Estimated, Section 5.7 
kTrxR 0.5 s-1 Estimated, Section 5.2.1.9 
MWcatalase 25 600 Da (Bonaventura et al., 1972) 
MWGPx1 23 000 Da (Awasthi et al., 1975) 
MWPrx2 22 000 Da (Moore and Shriver, 1994; Schroder et al., 2000) 
MWTrx 12 000 Da (Cha and Kim, 1995) 
MWTrxR 116 000 Da (Tsang and Weatherbee, 1981) 
Prxtot 3.7×10-4 M Estimated, Section 5.1.1.3 
TrxHolmgren 3.710-2 g/Kg erythrocyte (Holmgren and Luthman, 1978) 
TrxR 30×10-9 M Estimated, Section 5.2.1.7 
Trxtot 4.8×10-6 M For bovine erythrocytes. Estimated, Section 5.2.1.6 
Vbathed 48 dm3 Estimated, Section 5.10.2  
Vblood cells 2.3 dm3 Estimated, Section 5.10.2 
Ve 10-13 dm3 (Evans and Fung, 1972) 
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Abbreviation Value Reference 
Vew 710-14 dm3 Estimated, Section 5.2.1.4 
Vinterstitial 14 dm3 Estimated, Section 5.10.2 
PPP
maxV  1.9×10-6 M/s (Albrecht et al., 1971; Gaetani et al., 1974) 
Red
m axV  2.4×10-4 M/s Estimated, Section 5.2.2 
TrxR
maxV  0.77×10-6 M/s Estimated, Section 5.2.1.9 
Vskeleton 5.5 dm3 Estimated, Section 5.10.2 
Vtotal 70 dm3 Section 5.10.2 
WaterContentRBC 0.7 dm3 water/dm3 erythrocytes (Savitz et al., 1964) 
κ 610-5 dm/s (Nicholls, 1965) 
ϕ1 2.410-8 Ms (Takebe et al., 2002) 
ϕ2 4.310-6 Ms (Takebe et al., 2002) 
 0.6910-9 M/s Estimated, Section 5.2.1.6 
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1. Summary 
Peroxiredoxin 2 (Prx2) is a hydrogen peroxide reducing protein abundant in human erythrocytes. 
Due to its large concentration (3.7×10-4 M) and high reactivity with hydrogen peroxide        
(k~108 M-1s-1) it is a potentially very relevant antioxidant for the defense of erythrocytes against 
hydrogen peroxide. However, its contribution for H2O2 defense is not clear. The antioxidant 
activity of Prx2 is affected by the limited capacity that erythrocytes have for reducing Prx2 to its 
active form after it is oxidized by hydrogen peroxide. Further, human erythrocytes also possess 
catalase, an H2O2 scavenger whose antioxidant activity entails minimal NADPH consumption. In 
contrast, Prx2-mediated H2O2 reduction is stoichiometrically coupled to NADPH oxidation. Why 
do then erythrocytes need Prx2? Why do they not rely only on catalase, the H2O2 scavenger 
whose activity requires less NADPH? Is Prx2 redundant for H2O2 defense in human 
erythrocytes? 
We used kinetic analyses and mathematical modeling to clarify these issues. We considered the 
main processes protecting human erythrocytes against H2O2: glutathione peroxidase (GPx1), 
catalase and Prx2. The analysis of the dynamic behavior of the Prx2 system under various 
oxidative conditions indicates the following. 
Basal oxidative conditions, assuming a sustained extracellular H2O2 (eH2O2) concentration     
<10-7 M or intracellular H2O2 (iH2O2) concentration <2×10-11 M allow Prx2 to remain fully 
reduced. Prx2 then consumes more than 99% of the iH2O2. On the other hand, catalase becomes 
the main defense against H2O2 in erythrocytes facing sustained exposure to loads that fully 
oxidize Prx2 (eH2O2> 1.4×10-6 M). Catalase and GPx1 then contribute for 84% and 16% of the 
H2O2 consumption, respectively. Even when Prx2 is fully oxidized, eH2O2 consumption by 
erythrocytes is limited by membrane permeation. Thus, although erythrocytes are quite likely the 
main sink of plasma H2O2, Prx2 is dispensable for this role. 
Despite the slow Prx2 regeneration under strong oxidative loads, our analyses also suggest that 
erythrocytes could not rely solely on catalase and Gpx1 for defense against H2O2. To fully 
replace Prx2, maintaining the same H2O2 concentration and response time as in normal 
erythrocytes, ~11×10-12 g catalase (6×10-12 g GPx1) would be required. This would amount to 
32% (18 %) of the hemoglobin in human erythrocytes. Such a solution could therefore impair 
 18 
oxygen transport either by making erythrocytes bigger, and thus less able to cross capillaries, or 
by reducing the space available for hemoglobin. On the other hand, a <1 % increase in Prx2 
concentration would suffice to compensate for the effect of catalase elimination on H2O2 
concentration and response time at basal oxidative loads. These differences are due to the much 
higher specific activity of Prx2. 
Our analyses also suggest that crossing of inflammation sites may lead to substantial but brief 
Prx2 oxidation. The residence time of a circulating erythrocyte in an inflammation site is 
determined by the time (~2 s) to cross the capillaries, where these cells are in most intimate 
contact with the vasculature walls and circulate most slowly. Full Prx2 oxidation occurs if those 
inflammation foci lead to > 25×10-6 M H2O2 in the plasma, which is in the scale of the strongest 
loads experimentally determined for inflammatory foci in other organisms. 
Once all Prx2 is oxidized, erythrocytes can regenerate the reduced form in minutes if the 
oxidative load returns to basal values. However, a stepwise increase in Prx2 oxidation through 
repeated crossing of inflammation sites is very unlikely. This because such crossings are 
expected to occur many hours in between, time enough for Prx2 to be fully reduced.  
Altogether, our results show that Prx2 is the main defense of human erythrocytes against H2O2 
under most physiological circumstances. Extensive Prx2 oxidation may be attained in 
inflammation sites, affecting its contribution for H2O2 consumption. Yet, this does not impair the 
erythrocytes’ ability to scavenge plasma H2O2 because they can still rely on catalase for the 
defense against H2O2. Our results have important implications for the study of antioxidant 
protection and reactive oxygen species-associated diseases in mammalian cells, where Prx2 and 
catalase are found. 
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Resumo 
A Peroxirredoxina 2 (Prx2) é uma proteína que reduz peróxido de hidrogénio e uma das mais 
abundantes em eritrócitos humanos. Nestas células a Prx2 representa uma defesa potencialmente 
importante contra o peróxido dada a sua concentração (3.7×10-4 M) e reactividade com o 
peróxido de hidrogénio (k~108 M-1s-1). No entanto, a sua contribuição para a protecção contra 
H2O2 não é clara. A actividade antioxidante da Prx2 é condicionada pela capacidade limitada de 
redução da Prx2 à sua forma activa após ter reagido com o H2O2. Para além disso, os eritrócitos 
humanos possuem também catalase, um enzima cuja actividade antioxidante acarreta apenas um 
consumo mínimo de NADPH. Por outro lado, a redução de H2O2 pela Prx2 está 
estequiometricamente associada à oxidação de NADPH. Se assim é, porque é que os eritrócitos 
precisam de Prx2? Porque é que a defesa destas células contra o peróxido de hidrogénio não é 
constituída apenas pelo catalase, visto que a sua actividade requere menos NADPH? Será a Prx2 
uma defesa contra o H2O2 redundante nos eritrócitos humanos? 
Com o intuito de responder a estas questões utilizámos análises cinéticas e modelação 
matemática. Considerámos os principais mecanismos de protecção contra o H2O2 presentes nos 
eritrócitos humanos: peroxidase de glutationo 1 (GPx1), catalase e Prx2. A análise do 
comportamento do sistema da Prx2 sob várias condições oxidativas indica o seguinte. 
Em condições oxidativas basais, assumindo exposição constante a peróxido extracelular (eH2O2) 
<10-7 M ou intracelular (iH2O2) <2×10-11 M, a Prx2 permanece na forma reduzida. Isto permite 
que mais de 99% do iH2O2 seja consumido pela Prx2. Por outro lado, o catalase torna-se a 
principal defesa contra H2O2 quando a carga oxidativa a que os eritrócitos são sujeitos leva à 
oxidação completa da Prx2 (eH2O2> 1.4×10-6 M). Nessas condições, a catalase e a GPx1 
contribuem respectivamente para 84% e 16% do consumo de H2O2. No entanto, o consumo de 
eH2O2 pelos eritrócitos é limitado pela permeação membranar mesmo quando a Prx2 está 
completamente oxidada. Portanto, ainda que os eritrócitos sejam provavelmente o principal 
sumidouro de H2O2 no plasma, a Prx2 não é necessária para tal. 
A regeneração da Prx2 é lenta quando o eritrócito é exposto a elevadas cargas oxidativas. No 
entanto, os nossos resultados sugerem que esta célula não poderia utilizar catalase ou GPx1 
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como as suas únicas defesas contra o H2O2. Seriam necessário ~11×10-12 pg catalase (6×10-12 g 
GPx1) para substituir completamente a Prx2, mantendo o mesmo iH2O2 e tempo de resposta que 
num eritrócito normal. Isto totalizaria 32% (18%) da hemoglobina presente na célula. No entanto 
isto afectaria o transporte de oxigénio por esta célula pois ou seria necessário uma célula maior 
(impossibilitando portanto a sua capacidade para atravessar capilares), ou limitaria o espaço 
intracelular disponível para a hemoglobina. Por outro lado, um mero aumento de <1 % na 
concentração total de Prx2 seria suficiente para compensar a ausência de catalase, mantendo a 
mesma concentração de iH2O2 e tempo de resposta encontrados em cargas oxidativas basais. 
Estas diferenças são devidas à actividade específica da Prx2, muito maior do que as actividades 
específicas do catalase ou GPx1. 
Os nossos resultados sugerem também que exposição a focos de inflamação poderá levar à 
oxidação substancial, ainda que transiente, da Prx2. A duração da exposição a um foco 
inflamatório é determinada pelo tempo (~2 s) que o eritrócito demora a atravessar um capilar, o 
local onde esta célula está em mais íntimo contacto com o endotélio e onde a velocidade do fluxo 
sanguíneo é menor. A oxidação completa da Prx2 dá-se nesses locais se o eH2O2> 25×10-6. Este 
eH2O2 está na escala das cargas oxidativas mais elevadas detectadas experimentalmente, em 
focos inflamatórios noutros organismos. 
Quando completamente oxidada a Prx2 é regenerada em minutos se a carga oxidativa regressar a 
condições basais. No entanto, a oxidação cumulativa da Prx2 devido à exposição a focos 
inflamatórios sucessivos é muito pouco provável dado que são necessárias várias horas para um 
eritrócito ser exposto a dois focos sucessivos. Isto permite que haja tempo suficiente para a Prx2 
ser completamente reduzida. 
Estas evidências mostram que a Prx2 é a principal defesa dos eritrócitos humanos contra H2O2, 
na maioria das condições fisiológicas. A oxidação substancial da Prx2 pode dar-se em focos 
inflamatórios, afectando a capacidade deste antioxidante para consumir H2O2. No entanto não 
condiciona a capacidade dos eritrócitos para consumir H2O2 do plasma, dado que estas células 
possuem ainda catalase para se defenderem contra H2O2. Estes resultados têm implicações 
importantes para o estudo da protecção antioxidante e de doenças associadas a espécies reactivas 
de oxigénio em células de mamíferos onde a Prx2 e catalase estejam presentes. 
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2. Introduction 
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Erythrocytes are often exposed to hydrogen peroxide (H2O2), one type of Reactive Oxygen 
Species (ROS) that may have toxic effects in these cells. The role of antioxidant enzymes such as 
Glutathione Peroxidase or Catalase in the protection of human erythrocytes against H2O2 has 
been studied for long (Cohen and Hochstein, 1963; Flohé et al., 1972; Gaetani et al., 1989; 
Johnson et al., 2000; Johnson et al., 2010). More recently, (Peskin et al., 2007) found that these 
cells also contain very large quantities of Peroxiredoxin 2, a peroxidase. But despite the very 
high reactivity [108 M-1 s-1 (Manta et al., 2009)] of Prx2 with H2O2, (Low et al., 2007) observed 
that erythrocytes have a very limited capacity for regenerating Prx2 once it is oxidized to its 
disulfide form by H2O2. Therefore, the role and relevance of Prx2 for antioxidant protection in 
human erythrocytes is currently a matter of debate. The present work uses a set of mathematical 
models and kinetic analyses of H2O2 metabolism in human erythrocytes to analyze relevant 
aspects of Prx2 action in vivo and to clarify its physiological role.  
 Reactive Oxygen Species and biological sources of H2O2 2.1.
Reactive Oxygen Species (ROS) are oxygen-containing molecules highly reactive in redox 
reactions. They regulate several processes such as cell growth and survival (Davies et al., 1995), 
transcription (Liu et al., 2005), and have important effects in wound healing (Broughton et al., 
2006). However, these molecules also have toxic effects in the cell, such as oxidation of proteins 
and nucleic acids or lipid peroxidation (Sarsour et al., 2009; Watson and Jones, 2003). ROS were 
also related with the development of some diseases like cancer, diabetes, fibrosis, 
neurodegenerative diseases, cellular aging (Sarsour et al., 2009), atherosclerosis (Lusis, 2000; 
Rose and Afanasyeva, 2003), and Parkinson’s disease (Lotharius and Brundin, 2002).  
Hydrogen Peroxide (H2O2) is one of the most investigated ROS and was related with many of 
these processes. Like other ROS, it can be found in many different cell types in the human body 
(Halliwell et al., 2000). It permeates cellular membranes (Chance et al., 1979) and is produced 
endogenously in the mitochondrial respiratory chain, or via the dismutation of superoxide, 
among others (Chance et al., 1979; Gonzalez-Flecha and Demple, 1995; Messner and Imlay, 
1999). 
In the human erythrocyte (the target cell of our study), some of the endogenous sources of H2O2 
are glutathione autoxidation, hemoglobin autoxidation, and dismutation of superoxide. However, 
 23 
this cell is also exposed to exogenous H2O2 while in circulation. We will now discuss evidence 
that points out the oxidative stress caused by H2O2 to these cells. Except where otherwise stated, 
all the evidence here reported pertains to analyses done in human erythrocytes. 
2.1.1. Glutathione autoxidation 
Glutathione (GSH) autoxidation may have a significant contribution for the H2O2 produced 
endogenously as we now show. (Thorburn and Kuchel, 1985) assessed the rate of GSH 
autoxidation in human erythrocytes. The authors observed a first-order decay of GSH to its 
oxidized form (GSSG) with rate constant kox = 7.4×10-5 s-1 for the spontaneous oxidation of 
glutathione. 
 GSH  0.5 GSSG  Reaction 2.1 
This rate constant was determined from erythrocytes from venous blood (hematocrit 60%), with 
no added glucose, incubated at 37ºC under a humidified stream of gas (O2:CO2 = 19:1, which 
corresponds to a pO2 ≈ 720 torr if we consider the total gas pressure of 760 torr). Under these 
conditions it corresponds to a continuous GSH oxidation of ≈2×10-7 M GSH/s considering a 
GSH concentration1 of 3.2×10-3 M in the erythrocyte (Thorburn and Kuchel, 1985). 
However, these experiments were performed under an oxygen pressure much higher than what is 
found in vivo. Considering a pO2 = 90 torr [as reported by (Scarpa et al., 1984) for venous blood], 
and assuming that O2 freely diffuses across the erythrocyte membrane, we may find an upper 
estimate for the value of kox, and the corresponding rate of GSH oxidation. To adjust the value of 
kox for the O2 partial pressure found in vivo consider Equation 2.1 
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   Equation 2.1 
Where kox,in vivo is the adjusted rate constant, kox,exp = 7.4 × 10-5 s-1 was the rate constant observed 
by (Thorburn and Kuchel, 1985), and pO2,corrected and pO2,exp are the in vivo (pO2 = 90 torr) and 
experimental (pO2 = 720 torr) partial oxygen pressures considered. Replacing these values into 
                                                 
 
1 From this point on, all concentrations are referred to as moles per liter of erythrocyte water. 
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Equation 2.1 gives kox,in vivo ≈ 9.3 × 10-6 s-1. This would lead to a constant oxidation of GSH of   
≈29×10-9 M/s, again assuming a GSH concentration of 3.2×10-3 M in the erythrocyte (Thorburn 
and Kuchel, 1985). 
Oxygen oxidizes GSH enzymatically (Winterbourn et al., 2002) and non-enzymatically (Scarpa 
et al., 1996), with overall reaction 
 2 2 22 GSH + O GSSG + H O Reaction 2.2 
(Scarpa et al., 1996) used the rate of GSH oxidation and determined the rate constant for the 
reaction above, finding kspon = 0.1 M-1s-1, as determined from the rate of GSH oxidation. 
How does this rate constant compare with the experiments by (Thorburn and Kuchel, 1985)? 
Considering a kH = 1.3×10-3 M O2/atm ≈ 1.7×10-6 M O2/torr (Wilhelm et al., 1977) for Henry’s 
law constant of O2 dilution in water, and assuming that the experiments of (Thorburn and Kuchel, 
1985) were done at pO2 = 720 torr, this kspon would correspond to an apparent kox≈ 1.2×10-4 s-1. 
This value is not very far from what was obtained by (Thorburn and Kuchel, 1985), which 
further adds confidence to these estimates. 
But how does this rate of GSH oxidation compare with kox found in vivo? And what would be the 
corresponding rate of H2O2 production due to GSH oxidation (Reaction 2.2)? Considering        
kspon = 0.1 M-1s-1, we obtain a kox = 1.5×10-5 s-1 for the O2 partial pressure in venous blood      
(pO2 = 90 torr, kH = 1.7×10-6 M/torr). This value would thus correspond to a maximal rate of             
48×10-9 M H2O2/s produced, considering that all of the glutathione contents in the cell                  
[GStot = 3.2×10-3 M, (Thorburn and Kuchel, 1985)] is in reduced form. Because part of the GSH 
contents may be oxidized, this value represents an upper estimate for the rate of H2O2 produced 
due to GSH oxidation. Nevertheless, it shows that GSH autoxidation may potentially be a source 
of oxidative stress in the human erythrocyte. 
2.1.2. Superoxide dismutation 
Hydrogen peroxide may also be produced due to the dismutation of superoxide. Hemoglobin 
autoxidation produces superoxide that may then be dismutated to H2O2, in a reaction catalyzed 
by superoxide dismutase (SOD): 
 SOD-2 2 2 22 O  + 2H H O  + O
  Reaction 2.3 
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The rate of production of superoxide was determined by (Scarpa et al., 1984) in hemolysates, at 
various oxygen pressures. Considering the oxygen pressure in arterial blood                        
(≈90 torr ≈ 0.12 atm) the authors obtained a rate of superoxide production of ≈ 15×10-9 M/s. If 
all of the superoxide produced is dismutated by superoxide dismutase this would correspond to 
7.5×10-9 M H2O2/s, assuming that superoxide production limits the activity of SOD. 
However, (Scarpa et al., 1996) refer that only a small fraction (≈1.6%) of the H2O2 produced due 
to glutathione autoxidation results from superoxide dismutation. Considering 48×10-9 M H2O2/s 
from the glutathione autoxidation by (Thorburn and Kuchel, 1985) at 90 torr, superoxide 
dismutation cannot account for more than ≈7.7×10-10 M superoxide/s. Therefore, another process 
must be contributing for the larger superoxide produced as determined by (Scarpa et al., 1996). 
2.1.3. Hemoglobin autoxidation 
Hemoglobin (Hb) autoxidation has been referred as one of the main sources of superoxide in the 
erythrocyte (Misra and Fridovich, 1972; Wever et al., 1973), which is then dismutated to H2O2. 
H2O2 dismutation occurs at a rate of 2-3% of the total hemoglobin contents per day (Bunn and 
Forget, 1986), which would correspond to ≈9.7×10-9 M/s considering 7×10-3 M Hb (Gerber et al., 
1973) and that superoxide is produced per monomer of Hb. This rate of superoxide production is 
in the same order of magnitude as the 15×10-9 M superoxide/s reported by (Scarpa et al., 1984), 
and the differences may be explained by the hemolysate dilution in the latter work. However, 
because the dilution is not clearly referred by (Scarpa et al., 1984) we cannot estimate an 
approximate rate of superoxide production in vivo from those experiments. 
If all of the superoxide is dismutated to H2O2, the 9.7×10-9 M superoxide/s corresponds to a rate 
of H2O2 production of ≈4.9×10-9 M/s. Yet, this value is also lower than the estimates of H2O2 
produced from glutathione autoxidation or superoxide dismutation found above. Although this 
does not rule out the potentially relevant contribution of Hb autoxidation for endogenous H2O2 
production, it does not support the claim that Hb autoxidation is the main source of ROS in the 
human erythrocyte (Giulivi et al., 1994; Johnson et al., 2005; Low et al., 2007). 
2.1.4. H2O2 influx from plasma 
Various processes may expose erythrocytes to extracellular H2O2. In localized infection foci 
there is recruitment of leukocytes that produce H2O2 at various rates (Iyer et al., 1961; Kazura et 
al., 1981; Nakagawara et al., 1981; Reiss and Roos, 1978). Leukocyte recruitment occurs in 
 26 
wounds, tumors (Dvorak, 1986; Szatrowski and Nathan, 1991) and atherosclerotic lesions 
(Faggiotto et al., 1984; Gerrity et al., 1979; Watson et al., 1997), therefore increasing the H2O2 
concentration near those locations. 
Blood plasma possesses antioxidants to scavenge H2O2: glutathione peroxidase (Avissar et al., 
1989; Maddipati and Marnett, 1987), peroxiredoxins (Schwertassek et al., 2007), low-molecular 
weight antioxidants (Jones et al., 1995; Jones et al., 2002), among others (Frei et al., 1988). This 
decreases the oxidative load that erythrocytes face2. Yet, erythrocytes may be exposed to strong 
oxidative stress while passing by inflammatory foci. These cells are actually regarded as the 
main H2O2 sinks in the human blood (Manta et al., 2009; Winterbourn and Stern, 1987). But 
does H2O2 permeation across the erythrocyte membrane allow a rapid diffusion of H2O2 across 
the cell membrane? 
(Nicholls, 1965) determined the H2O2 diffusion constant across the membrane of horse 
erythrocytes. Using the catalase activity in hemolysates and intact cells, the authors determined 
an H2O2 diffusion constant κ≈6×10-4 cm/s. We may use this constant to estimate a pseudo-first 
order rate constant for H2O2 permeation across the membrane (kp) from Equation 2.2. 
 S
p
ew
Ak
V
   Equation 2.2 
where AS is the erythrocyte surface area [=1.35×10-8 dm2 (Evans and Fung, 1972)], and Vew is the 
erythrocyte water volume [=7×10-14 dm3/cell, obtained by considering 0.7 dm3 water/dm3 cells 
(Savitz et al., 1964) and erythrocyte volume of 10-13 dm3 (Evans and Fung, 1972)]. Considering 
these values we obtain a kp ≈ 8 s-1. 
(Mueller et al., 1997b) also used the dismutase activity of catalase to determine the H2O2 influx 
rate constant. To do so they determined the breakdown of H2O2 using spectrophotometric 
methods. Prx2’s contribution for H2O2 scavenging is very likely negligible given the very diluted 
hemolysate considered [0.086 g Hb/dm3, corresponding to ≈0.2 % if 329 g Hb/dm3 erythrocytes 
                                                 
 
2 Oxidative load refers to the total iH2O2 production, both from endogenous processes and H2O2 influx. If the rate of 
endogenous production is small and fixed, the oxidative load is approximately proportional to eH2O2. 
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(Thorburn and Kuchel, 1985)] and high H2O2 concentrations (10-5 M) repetitively added to the 
mixture, which likely allows Prx2 to accumulate in oxidized form and become inactivated. 
(Mueller et al., 1997b) obtained a pseudo-first order rate constant for the activity of catalase             
kcatalase = 0.5 s-1·g Hb-1·dm3 (expressed per dm3 of solvent). This corresponds to kcatalase = 235 s-1 
considering 329 g Hb/dm3 erythrocytes (Thorburn and Kuchel, 1985) and 0.7 dm3 water/dm3 
erythrocytes. Assuming that catalase is the main H2O2 scavenger in the conditions of the 
experiment we may consider the reaction scheme 
 
2 2 2 2
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Where kp is the pseudo-first order rate constant for H2O2 permeation across the erythrocyte 
membrane. One may describe mathematically the reactions above according to Model 2.1. 
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Model 2.1 
When iH2O2 is in steady state and taking Model 2.1 into consideration we get 
 2 2
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 
 Equation 2.3 
Which, considering that hemolysates present only 5.8% of the catalase activity of intact cells as 
found by (Mueller et al., 1997b) gives 
 1 0.0581 1 catalase
p catalase
k
k k
 

 
Equation 2.4 
Replacing kcatalase = 235 s-1 as found by (Mueller et al., 1997b) into the equation above we obtain 
a kp ≈ 13.6 s-1. This value is slightly higher than kp = 8s-1 obtained from the permeability constant 
of (Nicholls, 1965) but is still in agreement with the latter. 
These two independent experiments determined the pseudo-first order rate constants for H2O2 
permeation across the erythrocyte membrane. The values obtained (kp = 8 – 14 s-1) show that the 
kinetics of H2O2 diffusion across the erythrocyte membrane may occur at fast rates if the plasma 
 28 
H2O2 is relatively high. Because erythrocytes may be exposed to H2O2 concentrations up to the 
micromolar range in pathological conditions (Lacy et al., 1998; Niethammer et al., 2009; Varma 
and Devamanoharan, 1991), extracellular H2O2 represents a potential source of oxidative stress 
for this cell. 
 Relevance of the main defenses against H2O2 in erythrocytes 2.2.
The accumulation of H2O2 may have various deleterious effects for the erythrocyte. Exposure to 
high H2O2 loads leads to the formation of echinocytes, increases membrane rigidity, and leads to 
phagocytosis of erythrocytes by monocytes (Snyder et al., 1985). H2O2 leads to lipid 
peroxidation (Bunyan et al., 1960), oxidizes hemoglobin leading to larger ROS production (Fox 
et al., 1974; Giulivi and Davies, 1990; King and Winfield, 1963; Svistunenko et al., 1997; 
Winterbourn, 1985). H2O2 may also cause hemoglobin denaturation and induce hemolysis 
(Davies and Goldberg, 1987; Younkin et al., 1971), thus affecting oxygen transport. Because 
erythrocytes may be exposed to H2O2 from various sources (Sections 2.1.1 to 2.1.4) and H2O2 is 
potentially toxic for the cell, defenses against H2O2 are very important for these cells.  
In this section we review relevant properties of the three main defenses against H2O2 in human 
erythrocytes: Glutathione Peroxidase 1 (GPx1), catalase, and Peroxiredoxin 2 (Prx2). Although 
we focus on human cells, some of the evidence that led to the current knowledge in H2O2 defense 
was obtained from studies done in other organisms. These studies will be referred to show how 
the current picture of H2O2 defense in human erythrocytes came to involve GPx1, catalase and 
Prx2. 
2.2.1. The debate around the relative importance of catalase and GPx1 
Catalase was discovered in the beginning of the twentieth century and was the first enzyme 
described with H2O2 scavenging ability (Loew, 1900). Due to its antioxidant properties it was 
since considered the intracellular defense against H2O2. In the erythrocyte, only fifty years later 
was another H2O2 defense found: (Mills, 1957) found in rat erythrocytes that this antioxidant, 
together with glutathione, was able to protect hemoglobin from oxidative breakdown. The 
authors had discovered GPx1. As we will see, GPx1 was then considered the main defense of 
human erythrocytes cells against H2O2. Further studies done later then set catalase as a more 
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relevant defense against H2O2. The peroxidase activity of Prx2 was only acknowledged in the 
2000s. 
The human erythrocyte GPx1 is responsible for reducing H2O2 and lipid peroxides. The 
experiments of (Mills, 1957, 1959) with rat erythrocytes put in question the role of catalase as 
the intracellular hydrogen peroxide scavenger. This issue was addressed by (Cohen and 
Hochstein, 1963) who demonstrated the presence of GPx1 in human erythrocytes.  
GPx1-catalized H2O2 reduction is coupled with the oxidation of glutathione (GSH). Oxidized 
glutathione (GSSG) is then regenerated back to GSH by glutathione reductase (GSR) at the 
expense of NADPH (Figure 2.1). The pentose phosphate pathway (PPP) is the main source of 
NADPH in the human erythrocyte (Kirkman et al., 1986). 
 
Figure 2.1 – H2O2 reduction by GPx1 and coupled oxidation of GSH. GSR reduces GSSG at the expense of NADPH, 
whose main source is the PPP. Adapted from (Cohen and Hochstein, 1963). 
(Cohen and Hochstein, 1963) assessed the redox status of hemoglobin as a means to determine 
the intracellular H2O2 in the cytoplasm. They also quantified the amount of reduced glutathione 
(GSH) present in cells (GPx1 oxidizes GSH when reducing H2O2). They observed that 
erythrocytes subjected to H2O2 exhibited less GSH, accumulated methemoglobin (MetHb, an 
oxidized form of hemoglobin) and presented higher hemolysis than control (untreated) 
erythrocytes. 
On the other hand, erythrocytes supplemented with glucose show practically no accumulation of 
MetHb, a low hemolysis and high GSH concentrations. These observations may be explained by 
a larger NADPH supply due to the glucose provided. Glucose-6-phosphate is used by the PPP as 
a substrate to produce NADPH. Reducing equivalents from NADPH are then used by GSR to 
regenerate glutathione (Worthington and Rosemeyer, 1976). If the NADPH supply is not limiting 
GSR’s activity, GSH is regenerated and the H2O2 scavenging activity of GPx1 is not limited by 
GSH availability. Under those conditions, GPx1 is able to prevent the accumulation of H2O2 and 
MetHb. Further, even erythrocytes exposed to sozium azide (a catalase inhibitor), glucose and 
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H2O2 exhibited similar GSH levels to those found in untreated erythrocytes, showing that GPx1 
is an efficient H2O2 scavenger under those conditions. 
The evidence above led (Cohen and Hochstein, 1963) to conclude that GPx1 was the main line 
of defense against H2O2 in the human erythrocyte, only then followed by catalase. These 
conclusions were accepted for several years (Awasthi et al., 1975; Beutler, 1977; Little et al., 
1970; Luzzatto and Testa, 1978). Further supporting them was the observation that a low 
NADPH supply leads to higher oxidative stress (Gaetani et al., 1974). If GPx1 was the main 
defense against H2O2, and because its activity is stoichiometrically coupled with NADPH 
oxidation, a deficient NADPH supply would affect the antioxidant activity of GPx1. This would 
explain why glucose-6-phosphate dehydrogenase (G6PD) deficient erythrocytes are particularly 
prone to suffer with oxidative stress, thus accumulating GSSG and presenting low 
NADPH/NADP+ ratios (Gaetani et al., 1974; Kirkman et al., 1975). 
The findings that catalase tightly binds NADPH (Kirkman and Gaetani, 1984) and that this 
NADPH prevents catalase inactivation (Kirkman et al., 1987) prompted a reassessment of the 
contribution of catalase and GPx1 for the defense of the human erythrocyte against H2O2.  
The PPP is not only the main source of NADPH in the human erythrocyte (Kirkman and Gaetani, 
1986), it is also the main source of CO2 in this cell (Brin and Yonemoto, 1958). H2O2 reduction 
is stoichiometrically coupled to NADPH production by the PPP as                       
1Glucose-6-phosphate:2NADPH:1CO2:4GSH:2H2O2. This means that oxidation of each 
glucose-6-phosphate (G6P) molecule to ribulose-5-phosphate by the PPP generates 2 NADPH 
and 1 CO2 molecules. In turn, for every NADPH molecule used by GSR, 2 GSSG are 
regenerated to GSH. Because GPx1 consumes 2 GSH per H2O2 reduced, each G6P molecule 
consumed by the PPP allows the regeneration of two H2O2 molecules by GPx1. This verifies if 
GSR used all of the NADPH produced by the PPP. 
(Gaetani et al., 1989) determined the rate of NADPH production by providing radioactively-
labeled (14C) glucose to erythrocytes and quantifying the amount of 14CO2 as a proxy for the PPP 
activity. (Gaetani et al., 1989) compared the rate of 14CO2 production to the rate of H2O2 
consumed, by considering the stoichiometry of G6P oxidation/H2O2 consumed above.  
According to (Gaetani et al., 1989), if GPx1/GSR was the main H2O2 defense, the rate of 14CO2 
formed would be about half of the rate of H2O2 added. The study of (Gaetani et al., 1989) further 
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differed from what had been previously done by (Cohen and Hochstein, 1963) because the 
authors were now able to expose erythrocytes to a constant and controlled rate of formation of 
H2O2 (through addition of glucose oxidase to the medium). This allowed the authors to directly 
compare the rates of NADPH produced (through 14CO2 formed) with the rate of H2O2 formed in 
normal and acatalasemic human erythrocytes. According to the stoichiometry above, for every 
mole of H2O2 produced half a mole of 14CO2 would be formed. 
(Gaetani et al., 1989) observed that acatalasemic erythrocytes had larger rates of 14CO2 formed 
than normal erythrocytes when exposed to H2O2. This suggested that those erythrocytes had to 
produce more NADPH for GPx1/GSR to scavenge H2O2, thus compensating for the absence of 
catalase. Based on the rate of 14CO2 formed, the authors referred that about 90% of the H2O2 was 
consumed by GPx1 in acatalasemic erythrocytes. However, in normal erythrocytes GPx1 would 
only account for 20 – 40% of the H2O2 consumed. These results would go against what had been 
previously thought: catalase seemed to have a larger contribution for H2O2 scavenging than what 
was found from the studies of (Cohen and Hochstein, 1963). 
The following later observations (Gaetani et al., 1994) further reinforced this conclusion. Instead 
of using acatalasemic erythrocytes, (Gaetani et al., 1994) now inhibited catalase (with 3-amino-
l:2:4-triazole) to compare the relevance of GPx1 and catalase for defense of human erythrocytes 
against H2O2. Similarly to (Gaetani et al., 1989), they also determined the rate of NADPH 
formed by determining the rate of formation of 14CO2. (Gaetani et al., 1994) found that 
erythrocytes exposed to aminotriazole supplemented with glucose did not exhibit accumulation 
of methemoglobin, depletion of GSH or extensive hemolysis, unlike what was observed by 
(Cohen and Hochstein, 1963) in catalase-inhibited erythrocytes. This suggested that a sufficient 
NADPH supply allows erythrocytes to remain protected against H2O2. (Gaetani et al., 1994) 
attributed this ability to GPx1/GSR. These results, in agreement with (Cohen and Hochstein, 
1963), suggest that GPx1/GSR was able to protect human erythrocytes as long as the NADPH 
supply was sufficient to cope with the oxidative load. 
With this in mind, the authors then aimed to determine the fraction of catalase inactivated under 
which the NADPH supply would increase, thus showing that GPx1 had the highest contribution 
for H2O2 consumption. This would allow them to find the fraction of catalase inactivation 
required for erythrocytes to rely mainly on GPx1/GSR for their H2O2 defense. They observed 
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that only >98% catalase inactivation would increase the rate of NADPH production, suggesting a 
very different contribution for the two antioxidants in defense against H2O2. These results 
support a more important role of catalase for H2O2 defense than previously thought.  
Adding further support to this conclusion, (Gaetani et al., 1996) studied a cell-free system that 
consisted of a mixture of catalase and GPx1 and coupled cycles (GSH/GSR, NADPH production 
by G6PD). This allowed the concentration of individual components of the system to be changed, 
providing a better insight into the role of each defense in H2O2 removal than what could be 
gained using intact cells. The authors aimed to mimic the intracellular conditions found in vivo: 
catalase, GPx1 and Hb were purified and their concentrations were proportional to the ones 
found in vivo; oxidative conditions similar to the ones found in the cell (GSH and NADPH-wise). 
Excess G6PD and GSR were added to the reaction mixture, as well as a low and constant flow of 
≈88×10-9 M H2O2/s. (Gaetani et al., 1996) used the rate of formation of 6-phosphogluconate to 
determine the rate at which H2O2 was being removed by the GPx1/GSR system. 
They found that in this cell-free system GPx1 consumes only ≈15% of the H2O2, the rest being 
consumed by catalase. These observations now imply that GPx1 contributes very little for 
defense against H2O2 comparatively to catalase. This conclusion was further supported by the 
experiments of (Mueller et al., 1997a) where the authors used both purified enzymes and 
hemolysates to determine catalase and GPx1 activity. The authors concluded that GPx1 
consumes H2O2 at a rate that is at most 8% of that achieved by catalase. In agreement with these 
findings, (Johnson et al., 2000) addressed the contribution of GPx1 for the protection of mice 
erythrocytes. The authors disrupted the GPx1-encoding gene in mice and found that erythrocytes 
from GPx1-mutant mice did not exhibit larger accumulation of MetHb than wild type 
erythrocytes. 
The observations of (Gaetani et al., 1996), (Mueller et al., 1997a) and (Johnson et al., 2000) 
showed that GPx1 has a small contribution for the defense of erythrocytes against H2O2. But if 
catalase is the main defense against H2O2 in human erythrocytes, why do these cells need GPx1? 
(Gaetani et al., 1996) hypothesized that GPx1 is required for defending these cells against 
organic peroxides. The importance of GPx1 for defense of erythrocytes from organic peroxides 
had been previously suggested by (Flohe, 1978). As showed by (Johnson et al., 2002), GPx1-
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deficient mice erythrocytes exhibited larger concentrations of MetHb when exposed to cumene 
peroxide than wild type cells. 
2.2.2. Evidence of an unknown antioxidant 
The experiments of (Gaetani et al., 1996) went further to compare the rate of 6-
phosphogluconate generated in their in vitro assay to that found in intact cells, relatively to 
catalase activity. They observe that the rate of generation of 6-phosphogluconate decreases with 
catalase activity, which is consistent with a decreasing relevance of GPx1/GSR for H2O2 
decomposition with increasing catalase activity. Interestingly, they observed that the rate of 6-
phosphogluconate generation decreases more steeply with increasing catalase activity in their 
cell-free experiments (no added Hb) than in the experiments done with whole cells (Gaetani et al., 
1994). This difference suggests that another process besides GPx1/GSR is spending NADPH to 
consume H2O2. 
While the NADPH-dependent prevention of catalase inactivation may account for part of the 
NADPH consumed, the rate at which catalase oxidizes NADPH is only ≈7% of its rate of H2O2 
dismutation (Kirkman et al., 1987). Therefore, another process must account for the difference in 
rates of generation of 6-phosphogluconate between the experiments of (Gaetani et al., 1996) and 
(Gaetani et al., 1994). (Gaetani et al., 1996) hypothesize that the peroxidase activity of 
hemoglobin (Gunzler et al., 1974) may account for part of the differences found: when they 
added Hb to the reaction mixture there was a slight increase in the rate of 6-phosphogluconate 
produced. Yet, the peroxidase activity of Hb alone cannot account for the differences in 6-
phosphogluconate produced between their experiments and the experiments of (Gaetani et al., 
1994). This suggests that still another process may be oxidizing NADPH while consuming H2O2.  
Further, as per studies done in mice, it was shown that certain acatalasemic tissues retain more 
than half of their H2O2-consumption activity comparatively to wild-type cells (Ho et al., 2004). 
Yet, this is unlikely due to GPx1 activity: the disruption of the GPx1-encoding gene does not 
change catalase activity or affect the survival in various mice tissues (Ho et al., 1997).  
2.2.3. The relevance of peroxiredoxin 
Thiol-specific antioxidant (TSA), a peroxidase that had recently been discovered in yeast was a 
plausible candidate for explaining such observations for the following three reasons. First, TSA 
homologues were found in human cells (Chae et al., 1994b), which prompted addressing whether 
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they would be contributing for H2O2 scavenging in human erythrocytes. Second, TSA had an 
important contribution for the defense against oxidative stress in various organisms (Chae et al., 
1993; Kim et al., 1989). It could have a similar relevance for the defense of human erythrocytes 
against H2O2 if found in these cells. Third, its antioxidant activity was coupled with NADPH 
oxidation (Chae et al., 1994a). This could explain the differences in the rates of NADPH 
consumption observed in the experiments of (Ho et al., 1997) and (Ho et al., 2004). 
TSA was first discovered by (Kim et al., 1985) in Saccharomyces cerevisiae. Although its 
importance for defense against H2O2 was not known at the time, its potential as an antioxidant 
was readily acknowledged. The authors observed that glutamine synthetase was inactivated in 
thiol-containing buffers but retained their activity in crude extracts containing the same thiols. 
This suggested the existence of a thiol protective protein. 
The same group went on to study this enzyme (Kim et al., 1989; Kim et al., 1988). (Kim et al., 
1989) compared the concentrations of TSA in Saccharomyces cerevisiae cultured in normal 
aerobic conditions (1atm, ≈21% O2, ≈78% N2), with those of cells either shifted to hyperaerobic 
conditions (1atm, 95% O2, 5% CO2) or anaerobic conditions (1atm, 95% N2, 5% CO2). The 
authors observed a ≈1.7 fold increase TSA concentration 4 hours after cells had been shifted to 
hyperaerobic conditions. On the other hand, cells shifted to anaerobic conditions exhibited a 65% 
decrease in TSA concentration. (Chae et al., 1993) then assessed the effects of TSA-deficiency 
on cell survival by constructing yeasts whose TSA-encoding gene had been knocked-out. The 
mutant cells exhibited similar growth rates to the wild-type cells when grown in anaerobic 
conditions but significant slower growth rates when cultured under aerobic conditions or when 
exposed to ROS (H2O2, superoxide or hydroxyl). 
The studies of (Kim et al., 1989) and (Chae et al., 1993) suggested that TSA was an important 
antioxidant defense in yeast cells. TSA homologues were found in various organisms including 
humans, rodents, bacteria, fungi and plants (Chae et al., 1994b). This family of peroxidases was 
later renamed as peroxiredoxins. Peroxi comes from their ability to reduce peroxides and redoxin 
from the various types of electron donors they use. These donors may be thioredoxin [as found in 
S. cerevisiae (Chae et al., 1994a)], thioredoxin homologues [as found in Salmonella typhimurium 
(Jacobson et al., 1989)], or even glutaredoxin [as found in Populus trichocarpa (Rouhier et al., 
2001)]. Their peroxide reducing activity relies in highly conserved cysteines (Chae et al., 1994a). 
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The discovery of peroxiredoxins in the human brain (Chae et al., 1994b; Lim et al., 1994a) 
prompted studies to determine if human erythrocytes also possessed such peroxidases. Indeed, a 
TSA homologue later called peroxiredoxin 2 was found to be the third most abundant protein in 
the human erythrocyte (Moore et al., 1991).  
Initial studies of erythrocyte peroxiredoxin 2 showed that it was able to prevent peroxidation of 
the cell membrane (Lim et al., 1994b). This finding prompted further studies about its role as an 
antioxidant in this cell. (Lee et al., 2003) carried out one of the first studies to assess the 
relevance of Prx2 in vivo. They found that although the Prx2-knockout mice were healthy in 
appearance and fertile, exhibited hemolytic anemia and a series of pathologies in their 
erythrocytes: they formed Heinz bodies (accumulation of denatured Hb), accumulated ROS and 
MetHb, and were morphologically abnormal. The hematocrit of Prx2-deficient mice was also 
significantly decreased, although higher rates of erythropoiesis were found. This showed that 
although Prx2 was not essential for mice survival, it had an important role in redox physiology of 
the human erythrocyte. 
(Johnson et al., 2005) went further to determine whether the H2O2 scavenging activity of Prx2 
was indeed contributing for the protection of erythrocytes from H2O2. (Johnson et al., 2005) 
aimed to determine the rates of Hb autoxidation and endogenous generation of H2O2. They did so 
through experimental and modeling methods. First they quantified the amount of MetHb in mice 
erythrocytes and determined the rate of catalase inactivation. They used GPx1-deficient mice so 
that GPx1 would not compete with Prx2 for H2O2, thus assessing just the role of catalase and 
Prx2. 
The rate of catalase inactivation was used for determining the H2O2 produced endogenously as 
we now explain. As ferricatalase reduces H2O2 there is accumulation of Compound I (a redox 
form of catalase), which may then be reduced back to ferricatalase through reaction with H2O2 
again. 
 Ferricatalase(Fe3+) + H2O2 → Compound I(Fe4=O) + H2O Reaction 2.4 
 Compound I(Fe4=O) + H2O2 → Ferricatalase(Fe3+) + H2O + O2 Reaction 2.5 
The catalase inhibitor 3-Amino-1,2,4-Triazole competes with H2O2 for Compound I, irreversibly 
forming a product that cannot be converted to Ferricatalase: 
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 Compound I + 3-Amino-1,2,4-Triazole → Inactive Compound Reaction 2.6 
Thus, for 3-Amino-1,2,4-Triazole concentrations that are high enough to strongly outcompete 
H2O2 for Compound I the rate of catalase inactivation is proportional to H2O2 concentration. 
Using this approach, (Johnson et al., 2005) observed that catalase inactivation is very slow 
(≈3.5% catalase inhibition/hour), which indicates a low intracellular concentration of H2O2. This 
was observed both in GPx1-deficient and wild type erythrocytes, not exposed to exogenous H2O2. 
With the aim of understanding if Prx2 was contributing for the defense against H2O2 in GPx1 
deficient cells (Johnson et al., 2005) built a kinetic model. This model considered the H2O2-
scavenging activity of Prx2 and catalase; interaction between superoxide and Hb; dismutation of 
superoxide by superoxide dismutase; and hemoglobin autoxidation and reduction. Using this 
model they observed that only the inclusion of Prx2 would permit fitting the predicted 
inactivation of catalase to the experimental data. With this model they also obtained similar 
MetHb levels as those found experimentally. This shows that the H2O2 scavenging activity of 
Prx2 is indeed necessary for explaining the low intracellular H2O2 found experimentally in 
erythrocytes. 
The role of Prx2 in protecting human erythrocytes from endogenously generated H2O2 was 
further supported by the studies of (Low et al., 2007). The authors assessed the redox status of 
Prx2 when human erythrocytes (≈0.05% hematocrit) were exposed to 0 - 2×10-4 M H2O2 boluses. 
They observed that Prx2 was very sensitive to H2O2 oxidation: more than 60% of the Prx2 
contents were oxidized when cells were exposed to 5×10-7 M H2O2. These results are further 
supported by the high reactivity of Prx2 with H2O2, of 107 M-1 s-1 (Peskin et al., 2007). However, 
because oxidized Prx2 does not reduce H2O2, accumulation of oxidized Prx2 affects the 
contribution of Prx2 for H2O2 scavenging. (Low et al., 2007) thus refer that Prx2 contributes for 
the protection of the human erythrocyte only against low H2O2 loads.  
The importance of Prx2 for H2O2 consumption was later addressed by (Johnson et al., 2010). The 
authors compared the contributions of these three antioxidants using four gene knockout mice: 
catalase knockouts; GPx1 knockouts; catalase and GPx1 double knockouts; and Prx2 knockouts. 
They then assessed the redox status of erythrocytes from those knockouts by determining MetHb 
accumulation and the rate of accumulation of intracellular H2O2 [using similar methods to the 
 37 
ones used by (Johnson et al., 2005)]. This was addressed by exposing the erythrocytes (5% 
hematocrit) to 0 – 5×10-4 M H2O2 boluses. 
In agreement with previous studies, they found that catalase knockout or double knockout 
erythrocytes accumulated MetHb. This accumulation was more extensive when cells were faced 
with higher H2O2 loads. GPx1 knockouts did not show substantial MetHb accumulation. On the 
other hand, Prx2 knockouts accumulate intracellular H2O2 when no exogenous H2O2 is added. 
Given that GPx1 contributes little for the defense against H2O2, this suggests that catalase is able 
to protect the erythrocyte under basal oxidative conditions. It also suggests that Prx2 activity is 
important for controlling the rate at which H2O2 accumulates due to endogenous production. 
Using a model similar to the one built by (Johnson et al., 2005) the authors again assessed the 
rate of catalase inactivation in wild type and Prx2-deficient mice erythrocytes, obtaining a very 
good fitting to their experimental data. Using this model they estimate the intracellular H2O2 
found in each of the knock-outs, under basal conditions. They estimate a ≈388% increase in 
intracellular H2O2 in the absence of Prx2, and only ≈23% and 4% in the absence of GPx1 and 
catalase, respectively. 
These results suggest that Prx2 and catalase have very distinct roles in the defense of the human 
erythrocyte against H2O2. Catalase is the main defense against high H2O2 loads, thus protecting 
the cell from extracellular H2O2. On the other hand Prx2 plays an important role in the defense 
against low H2O2, thus being the main defense against endogenously generated H2O2.  
However, if Prx2 is one of the most abundant proteins in the human erythrocyte and has a very 
high reactivity with H2O2 [107 – 108 M-1s-1, (Manta et al., 2009; Peskin et al., 2007)] what limits 
Prx2 activity? As previously suggested by (Chae et al., 1994a) in their studies from TSA in yeast, 
and later by the studies of (Low et al., 2007) in human erythrocytes, H2O2 consumption by Prx2 
is affected by the regeneration of Prx2. Prx2 regeneration is in turn dependent on the ability of 
the Thioredoxin/Thioredoxin Reductase cycle to maintain a high rate of Prx2 reduction. 
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 Peroxiredoxin 2: catalytic cycle and main features                  2.3.
in human erythrocytes 
As we will show in this section, Prx2 activity is highly dependent on the ability of the 
Thioredoxin/Thioredoxin Reductase to regenerate Prx2. Before further expanding this issue we 
will characterize several features of Prx2 in human erythrocytes. 
Although human cells have various peroxiredoxins (Wood et al., 2003b), Prx2 is the most 
abundant peroxiredoxin in human erythrocytes. Other than its peroxidase activity, various reports 
showed that Prx2 is important for other processes: activates the Gardos channel for K+ efflux 
(Moore et al., 1991; Moore et al., 1990), and acts as a chaperone against heat-shock (Jang et al., 
2004; Moon et al., 2005). In human erythrocytes, Prx2 is the third most abundant protein after 
hemoglobin and carbonic anhydrase (Moore et al., 1991). 
2.3.1. Prx2 structure 
Prx2 is a pentamer of dimers (Figure 2.2) with a monomeric weight of 22 kDa (Moore and 
Shriver, 1994; Schroder et al., 2000). 
 
Figure 2.2– Quaternary structure of Prx2 adapted from (Schroder et al., 2000), deposited at the Protein Data Bank 
(Bernstein et al., 1977) with accession number 1QMV. The bars separate each dimer. Each monomer is marked with a 
different color. 
There are various types of peroxiredoxins, classified based on their catalytic cycles. However, all 
of them rely on highly conserved cysteines to scavenge H2O2 (Chae et al., 1994b). Prx2 is a 
“typical 2-Cysteine” peroxiredoxin, meaning it relies on two cysteines per monomer to catalyze 
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H2O2 reduction: Cys51 and Cys172. In each dimer, the two monomers are arranged in an anti-
parallel way. Figure 2.3 shows this anti-parallel disposition and highlights the two cysteines. 
        A  B  
Figure 2.3 – Antiparallel structure of two monomers (cyan and yellow) in each dimer of Prx2. A – Ribbon diagram of a 
dimer showing the location of Cys172 (red residues) and a Cys51 (black residues); taken from PDB (Bernstein et al., 1977) 
entry 1QMV. B – Representation of the antiparallel disposition of the two monomers, showing the peroxidatic (CP) and 
resolving (CR) cysteines in each monomer. 
Cys51 and Cys172 are respectively called peroxidatic (CP) and resolving (CR) cysteine due to their 
role in the catalysis of H2O2 reduction. The antiparallel arrangement of the two monomers in a 
dimer permits that CP of a monomer interacts with a CR of the subsequent monomer during the 
catalytic cycle of Prx2 described below. 
2.3.2. Catalytic cycle of Prx2 
During the catalytic cycle of Prx2 (Figure 2.4), H2O2 oxidizes the peroxidatic cysteine (CP-SH) 
to a sulfenic acid (CP-SOH). This residue then condenses with the resolving cysteine from the 
other monomer (CR-SH) to form a disulfide bond. (Cha and Kim, 1995) showed that these 
cysteines are then reduced to sulfidryl through the oxidation of thioredoxin (Trx). The oxidized 
Trx (TrxOx) is then reduced back (TrxRed) by thioredoxin reductase (TrxR) at the expense of 
NADPH. The sulfenic acids may be further oxidized to sulfinic acid, inactivating the protein 
(Schroder et al., 2000). This reaction is often referred as “overoxidation” or “sulfinylation” of 
Prx2. (Biteau et al., 2003) showed that cysteines in sulfinic form may be reduced through 
sulfiredoxin (Srx) oxidation, coupled to ATP hydrolysis. In vitro experiments showed that Trx 
and GSH may both act as electron donors to regenerate Srx to its reduced form (Chang et al., 
2004). 
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Figure 2.4 - Catalytic cycle of Prx2 showing the redox status of the peroxidatic (CP) and resolving (CR) cysteines. The 
dashed lines represent disulfide bonds. TrxRed – Reduced thioredoxin; TrxOx– Oxidized thioredoxin; TrxR – Thioredoxin 
reductase; SrxRed – Reduced sulfiredoxin; SrxOx – Oxidized sulfiredoxin. 
Figure 2.4 represents a simplification of the catalytic cycle of Prx2, thought to involve unfolding 
of the active site and interaction with other conserved residues besides cysteines (Wood et al., 
2003a). From this point on we will refer to the various redox forms of Prx2 as follows: reduced 
(PrxRed), sulfenic-acid (PSOH), disulfide (PSSP), sulfinic-acid (PSO2H). 
2.3.3. Prx2 inactivation by H2O2 
Prx2 may be inactivated by H2O2 if it accumulates either in PSO2H or PSSP forms. The 
inactivation of Prx2 due to accumulation of PSSP was studied by (Low et al., 2007). The authors 
showed that Prx2 is very sensitive to oxidation: ≈60 % of the total Prx2 contents are in PSSP 
form when erythrocytes (hematocrit ≈ 0.05%) are exposed to 5×10-7 M H2O2 boluses. Higher 
oxidative loads lead to more extensive accumulation of PSSP. 
Why does Prx2 accumulate in PSSP form? Various factors contribute to this. First, Prx2 has a 
very high reactivity with H2O2 [k≈ 107 – 108 M-1s-1 (Manta et al., 2009; Peskin et al., 2007)]. 
This allows Prx2 to be quickly oxidized by H2O2. Second, (Low et al., 2007) observed that Prx2 
regeneration occurs slowly (takes about 20 minutes to fully reduce Prx2 that had accumulated in 
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PSSP form). (Low et al., 2007) found that TrxR has a slow rate of activity, as assessed by the 
rate of DTNB reduction, a TrxR substrate commonly used for assessment of TrxR activity. A 
slow TrxR activity leads to PSSP and TrxOx accumulation, hence limiting the TrxRed available to 
reduce Prx2. However, it is not clear whether TrxR activity is limited by NADPH supply, total 
Trx, or low TrxR activity. 
Prx2 may also be inactivated due to accumulation in PSO2H form. This type of inactivation was 
found in peroxiredoxins from other human cells (Mitsumoto et al., 2001; Yang et al., 2002) and 
regeneration of PSO2H occurs very slowly and consumes ATP (Biteau et al., 2003). It was 
proposed that this process allows Prx2 to act as a floodgate (Wood et al., 2003a). According to 
this hypothesis, Prx2 protects cells against low concentrations of H2O2. However, because Prx2 
is inactivated by formation of PSO2H when the oxidative load is too intense, the “floodgate 
opens” and H2O2 accumulates. This permits H2O2 to develop its signaling functions. The 
sulfinylation of Prx2 also allows this protein to aggregate into high molecular weight oligomers 
(such as decamers or dodecamers), switching on the chaperone activity of Prx2 (Jang et al., 
2004; Moon et al., 2005). It also stimulates the association of Prx2 with membranes (Cha et al., 
2000; Moore et al., 1991). 
But the accumulation of PSO2H affects the contribution of Prx2 for defense against H2O2. (Low 
et al., 2007) addressed whether Prx2 would accumulate in PSO2H form in the human erythrocyte 
by exposing cells (≈0.05% hematocrit) to a 5×10-6 - 2×10-4 M H2O2 boluses for 10 minutes. The 
authors observed that PSO2H accumulation does not occur in human erythrocytes, regardless of 
the H2O2 which the cells are exposed to. They explain the absence of PSO2H with the slow rate 
of Prx2 regeneration: the accumulation of PSSP limits the formation of PSOH, thus affecting the 
accumulation of PSO2H. 
Another study also addressed the issue of PSO2H accumulation (Cho et al., 2010). The authors 
detected PSO2H in erythrocytes (50% hematocrit) 3 hours after exposed to a steady flux of 
75×10-9 M H2O2/s. However, no PSO2H was detected in absence of added H2O2 even when 
catalase had been inhibited by sozium azide or 3-Amino-1,2,4-Triazole. These results suggest 
that although the Srx activity is sufficient to keep PSO2H below detection limits under basal 
H2O2 conditions, exposure to extracellular H2O2 leads to accumulation of PSO2H. This may be 
attributable to the importance of Prx2 in scavenging low H2O2: because Prx2 is important for 
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protecting the erythrocyte from the endogenously generated H2O2, Srx activity must cope with 
the rate at which Prx2 is being sulfinylated under basal oxidative loads. For this reason, 
inhibiting catalase does not lead to accumulation of PSO2H under basal oxidative loads. 
The results of (Cho et al., 2010) seem in disagreement with what had been observed by (Low et 
al., 2007). However, as we now explain both results may be explained by the hypothesis raised 
by (Low et al., 2007) for absence of PSO2H. Note that as per the conditions of their experiments, 
(Low et al., 2007) exposed erythrocytes to much larger oxidative stress than (Cho et al., 2010). 
(Cho et al., 2010) addressed the redox status of Prx2 after having exposed erythrocytes to a 
constant flux of H2O2 that had generated 6×10-3 M extracellular H2O2 by the time of the 
assessment, as per experimental quantification. On the other hand (Low et al., 2007) exposed 
erythrocytes to a bolus of <2×10-4 M H2O2 and assessed the redox status of Prx2 only after 10 
minutes of reaction. Yet, (Low et al., 2007) considered a very diluted hematocrit (≈1000-fold 
lower than the hematocrit considered by (Cho et al., 2010)). Therefore, the erythrocytes were 
subjected to much lower oxidative stress in the experiments of (Cho et al., 2010) than in the 
experiments of (Low et al., 2007).  
A low oxidative stress may have allowed Prx2 regeneration to prevent accumulation of PSSP in 
the experiments of (Cho et al., 2010), thus allowing the accumulation of PSO2H. Supporting this 
explanation is the observation that most of the Prx2 contents in the experiments of (Cho et al., 
2010) are in reduced form at time of assessment, whereas most Prx2 is in PSSP form in the 
experiments of (Low et al., 2007). Altogether, these results suggest that Prx2 sulfinylation 
depends on the H2O2 load which erythrocytes are exposed to. 
Nevertheless, we may hypothesize about the relative contribution of each defense in erythrocytes 
facing various H2O2 loads. Under basal oxidative conditions, Prx2 is the main scavenger of H2O2 
due to its high abundance and reactivity with H2O2. On the other hand, H2O2 loads that lead to 
Prx2 inactivation may occur either if TrxR activity is insufficient to cope with the demand for 
TrxRed or if Prx2 accumulates in sulfinylated form. Under such conditions, catalase becomes the 
main H2O2 scavenger. 
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3. Problem and objective 
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The observations above bring us to the objective of this work: to understand what is the 
physiological role of Prx2. 
Prx2 is one of the most abundant proteins in the human erythrocyte, and has a very high 
reactivity with H2O2. For this reason, it is a potentially very relevant defense of human 
erythrocytes against H2O2. However, its role in the defense of this cell against peroxide is not 
clear. Prx2 regeneration is limited in erythrocytes facing strong oxidative stress, thus affecting 
the contribution of Prx2 for H2O2 scavenging. Furthermore, human erythrocytes also possess 
catalase, an H2O2 scavenger whose activity is sub-stoichiometrically coupled with NADPH 
oxidation. On the other hand, Prx2-mediated H2O2 consumption is stoichiometrically coupled 
with NADPH oxidation. Then why do human erythrocytes need Prx2? Why do they not rely only 
on catalase, the antioxidant whose activity requires much less NADPH? Is Prx2 a redundant 
antioxidant in the defense against H2O2? Why is such a high concentration of Prx2 needed? 
With this work we aimed to address these questions, in order to clarify what is the relevance of 
Prx2 in the defense of human erythrocytes against H2O2. We analyzed these issues bearing in 
mind the physiological and pathological oxidative conditions that human erythrocytes face while 
in circulation. 
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4. Methods and Technical notes 
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The study of the redox behavior of the Prx2/Trx/TrxR system was fully done in silico with the 
help of Wolfram MathematicaTM 7 (Wolfram Research, 2008). This was a step-by-step study 
where we addressed various questions related with the redox behavior of the Prx2/Trx/TrxR 
system. We started with very simplified models and considerations to gain cleared understanding 
of the behavior of the system. As we would gain more insight, the complexity of the models was 
increased as required. 
We tried to obtain analytical expressions whenever possible. Numerical analyses were used 
when the expressions obtained were too complex to be interpreted intuitively or when numerical 
results were relevant. For every computation, the results obtained were rounded by considering 
the significant figures and round-to-even rules. All the equations are presented in the most 
simplified form obtained through arithmetic simplification. 
The following table is a list of some of the functions we used the most in Mathematica. 
Table 4.1 – List of some of the most used Mathematica functions. 
Function Meaning 
DSolve Solves the differential equations 
FindFit Finds numerical values for parameters in order to give the best fit to a list of data 
FindRoot Searches for a numerical root of an expression 
Fit Finds a least-squares fit to a list of data 
FullSimplify Simplifies an expression to the simplest form it finds 
Integrate Finds the integral of an expression 
Limit Finds the limiting value of an expression 
ListPlot Plots a list of values 
NDSolve Find a numerical solution for the list of ordinary differential equations  
Plot Plots a graph 
ReplaceAll Applies a rule or list of rules in order to transform each subpart of an expression 
Solve Solve the system of equations for the specified variables 
In the next sections all of the italic abbreviations represent the value of the respective parameter 
or variable. For instance, Prxtot represents the value of the total concentration of Prx2. A 
description of the values or abbreviations is present at the beginning of this report. All the 
intracellular concentrations are expressed with respect to volume of erythrocyte water. 
In our results we have numbered every equation, figure, model, reaction and table according to 
the section of the results where it was first introduced. 
 47 
5. Results - Part I 
Study of defenses against H2O2 under steady state 
conditions 
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We start by addressing the kinetics of H2O2 consumption by the various defenses against H2O2 
when erythrocytes are subjected to sustained exposure to H2O2. This analysis is relevant for 
sepsis, anaphylactic shock or diabetes, pathological conditions characterized by systemic 
inflammation. With this in mind, we analyzed the response of Prx2, catalase and GPx1 to 
different H2O2 loads, under steady state conditions 
These three antioxidants were the only defenses against H2O2 considered in this work because 
they are currently thought to be the main defenses of human erythrocytes against H2O2. Because 
the Prx2 cycle is coupled with the oxidation of Trx, we also examine the kinetics of the Trx 
redox cycle and how it affects the antioxidant properties of Prx2, the antioxidant in focus. 
In these analyses we considered a wide range of oxidative conditions because oxidative loads 
depend on organism, its immune response, infection state and other conditions. The highest 
oxidative loads correspond to hydrogen peroxide concentrations in blood plasma characteristic of 
systemic inflammation of the organism. On the other hand, basal oxidative loads correspond to 
hydrogen peroxide concentrations in blood plasma in absence of inflammation or other 
pathological sources of oxidative stress. 
 What is the relative contribution of Peroxiredoxin 2 for 5.1.
hydrogen peroxide consumption? 
Seeking to find the process that potentially contributes the most for H2O2 consumption, we 
compared the pseudo-first order rate constants of Prx2, GPx1 and catalase, with respect to H2O2. 
Coupled reactions to each of these antioxidant enzymes are therefore not considered as limiting 
steps, a plausible assumption under basal oxidative loads. Before presenting and discussing the 
main results we will explain how the estimates of these rate constants were done. 
5.1.1. Rate constant estimates 
5.1.1.1.Pseudo-first order rate constant of GPx1 with respect to H2O2 
Glutathione Peroxidase 1 has ping-pong kinetics (Flohé et al., 1972): its reaction cycle includes 
successive steps of oxidation and reduction, and a stepwise association with its two substrates, 
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H2O2 and glutathione (Reaction 5.1 to Reaction 5.3). In order to decompose H2O2, this enzyme is 
first oxidized by H2O2 and then reduced by GSH (Flohé et al., 1972): 
GPx1
1
GPx1
-1
k
red 2 2 ox 2
k
GPx1 + H O  GPx1 + H O  Reaction 5.1 
GPx1
2
GPx1
-2
k
ox 2
k
GPx1 +GSH  GPx1- SG+H O  Reaction 5.2
GPx1
3
GPx1
-3
k
redk
GPx1-SG+GSH  GPx1 +GSSG  Reaction 5.3 
We use the rate equation that describes H2O2 reduction through the three reactions above 
[Equation 5.1, (Flohé et al., 1972)] to compute the pseudo-first order rate constant for GPx1 
catalysis. 
 
1 2
GPx1
2 2
GPx1v
H O GSH
   Equation 5.1 
In the above equation, ϕ1 is the reciprocal rate constant for the net forward Reaction 5.1 
( 1 1
1
1
GPxk
  ); ϕ2 is the reciprocal rate for the net reactions of GPx1 with glutathione in Reaction 
5.2 and Reaction 5.3 (giving
 
2 1 1
2 3
1 1
GPx GPxk k
   ). For the human erythrocyte enzyme, ϕ1 and ϕ2 
have values of 2.410-8 Ms and 4.310-6 Ms (Takebe et al., 2002) respectively. 
We determined the pseudo-first order rate constant for H2O2 reduction by GPx1, with respect to 
H2O2, through Equation 5.1. Because we want to know if GPx1 is the main defense of the human 
erythrocyte against H2O2, we seek to find the highest possible value of this rate constant, 
irrespective of GSH reduction. Thus we assumed that all the glutathione is kept reduced. A 
constant value of 3.2×10-3 M GSH was used, corresponding to the total glutathione concentration 
(GStot) determined by (Thorburn and Kuchel, 1987). This high value of GSH only pertains to 
conditions in which glutathione reduction does not limit GPx1-mediated H2O2 reduction (i.e. low 
oxidative conditions), allowing glutathione to remain mostly reduced (Thornalley et al., 1996). 
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Therefore, the pseudo-first order rate constant obtained represents an upper limit and is smaller 
at higher H2O2. 
To find the value of this pseudo-first order rate constant order we had to find the concentration of 
GPx1 in the cell. We estimate a value of 9.7×10-7 M GPx1 from the experiments of (Mueller et 
al., 1997a) as follows. (Mueller et al., 1997a) determined the GPx1 activity in human 
hemolysates [0.094 g Hb/dm3 erythrocytes, which corresponds to ≈ 0.03% hematocrit, if we 
consider 340 g Hb per liter of packed cells (Beutler, 1984)]. Using 1×10-4 M H2O2 and 2×10-3 M 
GSH as initial values, the authors obtained the following figure. 
 
Figure 5.1 – H2O2 consumption by Glutathione Peroxidase (0.094 g Hb/dm3, 2 mM GSH), from Figure 5 of (Mueller et al., 
1997a). Initial concentration of H2O2 was 1×10-4 M. Catalase was inhibited with 1×10-3 M NaN3. 
We aimed to obtain values of ϕ1, ϕ2 and GPx1 for Equation 5.1 that could reproduce the time 
course of H2O2 consumption by GPx1 from the figure above. Using Equation 5.1 and 
considering that 2 molecules of GSH are consumed per molecule of H2O2 reduced (as Reaction 
5.1 to Reaction 5.3 show) we obtain Model 5.1. 
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H O GSH
d GSH GPx
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
  

 Model 5.1 
Using the above model and considering the initial values of H2O2 (1×10-4 M) and GSH               
(2×10-3 M) used in the experiment of (Mueller et al., 1997a) we computed the set of values of ϕ1, 
ϕ2 and GPx1 that minimize the error function 
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where 1 2( 1, , , )comp iy GPx t   stands for the computed value of 2 2iH O  at time it as per Equation 5.1, 
exp ( )iy t stands for the experimental value of 2 2iH O  at time it from Figure 5.1, and N stands for 
the number of points. Time points were sampled as shown in Figure 5.2. The best-fit values for 
ϕ1, ϕ2 and GPx1 were 2.0×10-8 Ms, 4.7×10-8 Ms and 9.7×10-7 M, respectively. The values for ϕ1 
and ϕ2 are close to those obtained in dedicated experiments by (Takebe et al., 2002), at different 
experimental conditions, which adds confidence on the estimated value of GPx1. 
 
Figure 5.2 - Best-fit time course of H2O2 consumption to the data sampled (dots) from Figure 5 of (Mueller et al., 1997a). 
The above estimate allowed us to obtain the parameters of Equation 5.1 expressed in Table 5.1. 
Table 5.1 - Parameters used to compute the pseudo-first order rate constant for H2O2 consumption through GPx1. 
Parameter Value Reference 
GPx1 9.7×10-7 M Estimated. See main text 
GStot 3.2×10-3 M (Thorburn and Kuchel, 1987) 
ϕ1 2.410-8 Ms (Takebe et al., 2002) 
ϕ2	 4.310-6 Ms (Takebe et al., 2002) 
Replacing these parameters into Equation 5.1 and considering GSH = GStot we get 
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K H O H O
   Equation 5.3 
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With appmK (H2O2) = 18×10
-6 M and appmaxV =7.110-4 M/s, which led to a pseudo-first order rate 
constant of 
2 2
40
( )
app
max
GPx1 app
m
Vk
K H O
   s-1. The value obtained for appmK  (H2O2) indicates that H2O2 
consumption by GPx1 is well approximated by a pseudo-first-order kinetics up to                 
iH2O2 ≈ 2×10-6 M, provided that nearly all the GSH remains in reduced form. Because 
physiological values of iH2O2 under basal to moderate oxidative loads are expected to be much 
lower [as per observations of (Giulivi et al., 1994)], we can confidently assume that under these 
conditions the kinetics of H2O2 consumption by GPx1 is well approximated by a pseudo-first-
order rate expression. 
5.1.1.2.Pseudo-first order rate constant of catalase with respect to H2O2 
We considered the value of 218 s-1 for this pseudo-first order rate constant, as determined by 
(Mueller et al., 1997a). In their experiments the authors did not account for the contribution of 
Prx2 for H2O2 consumption. However, the following three reasons indicate that this omission did 
not substantially influence the estimate. First, given its reactivity with H2O2 [108 M-1s-1, (Manta 
et al., 2009)], Prx2 should be quickly and quantitatively converted to the inactive PSSP form 
under the conditions of the experiment. Namely, an initial 10-5 M H2O2 and a very dilute 
hemolyzate. Second, the progression curve for H2O2 consumption in these hemolysates in 
absence of added GSH is very well fitted by a single exponential. Third, addition of the catalase 
inhibitor NaN3 under these conditions fully abolished H2O2 consumption. 
5.1.1.3.Pseudo-first order rate constant of Prx2 with respect to H2O2 
We estimated the concentration of monomeric Prx2 (Prxtot = 3.7×10-4 M) from Equation 5.4: 
 Moore
RBC Monomer
Prx2Prxtot
WaterContent ×MW
 Equation 5.4 
In which Prx2Moore represents the concentration of Prx2 found by (Moore et al., 1991) (5.6g 
Prx2/L Packed Erythrocytes), WaterContentRBC is the average erythrocyte water volume [0.7 L 
water/L erythrocytes (Savitz et al., 1964)] and MWPrx2 is the molecular weight of Prx2 monomers 
[≈22 000 Da (Moore and Shriver, 1994; Schroder et al., 2000)]. Replacing these values into 
Equation 5.4 yields a concentration of 3.7×10-4 M Prx2 monomer. Because in each monomer 
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only one cysteine reacts with H2O2 this monomeric concentration also corresponds to the 
concentration of reactive cysteines. 
Using the concentration estimated above and 108 M-1s-1 for the reactivity of reduced Prx2 with 
H2O2 (Manta et al., 2009) we obtain a value of 3.7ൈ104 s-1 for the pseudo-first order rate constant 
of H2O2 reduction by Prx2. 
5.1.2. Relative contribution of the three enzymes under low and                     
high oxidative loads 
Through the estimates above we obtain the following pseudo-first order rate constants for H2O2 
consumption. 
Table 5.2 - Pseudo-first order rate constants for H2O2 scavenging by GPx1 (kGPx1), catalase (kcatalase) and Prx2 (kPrx2). 
Pseudo-first order rate constant Value (s-1) 
kGPx1 40 
kcatalase 218 
kPrx2 37 000 
The rate constants of GPx1 and Prx2 represent upper limits because glutathione and Prx2 were 
considered fully reduced. Yet, these constants serve as a comparison for the potential of H2O2 
consumption by each of the proteins, and should be representative of the in vivo situation under 
basal oxidative loads. The rate constant for Prx2 is approximately 1000 fold higher than the rate 
constant of GPx1. Likewise, the rate constant estimated in here for the activity of catalase is 
about 180-fold smaller than the rate constant for Prx2.  
Knowledge of these rate constants allows us to analyze the contribution of each protein under 
various oxidative loads as follows. The relative contribution of Prx2 for H2O2 reduction may be 
computed from the values of the rate constants obtained in Table 5.2: 
 0.99Prx2
Prx2 catalase GPx1
k
k + k + k
  Equation 5.5 
The above equation shows that when the oxidative load is low (i.e. loads that allow Trx and Prx2 
to remain mostly reduced), Prx2 contributes to practically all of the H2O2 reduction (≈99%). 
Conversely, the relative contributions of GPx1 and catalase for H2O2 scavenging are respectively 
≈0.1% and ≈0.6% under those conditions. Where the oxidative load is high enough for Prx2 to 
accumulate in the PSSP form, kPrx2 is practically null, giving 
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 0.84catalase catalase
Prx2 catalase GPx1 catalase GPx1
k k
k + k + k k + k
   Equation 5.6 
This means that when the concentration of cytoplasmic H2O2 leads to accumulation of oxidized 
Trx and Prx2, catalase is responsible for about 84% of the H2O2 consumption, and GPx1 is 
responsible for about 16% of H2O2 consumption. In the next section, we will discuss the basis for 
claiming that kPrx2 is practically null in conditions in which there is accumulation of oxidized Trx 
and Prx2. 
Altogether, this further supports the notion that catalase, GPx1 and Prx2 have different relevance 
for H2O2 scavenging in the human erythrocyte. Prx2 is potentially the antioxidant that 
contributes the most for H2O2 reduction, under H2O2 loads that allow Prx2 to remain active. If 
the contribution of Prx2 for H2O2 scavenging is disregarded, catalase becomes the main H2O2 
scavenger in the human erythrocyte. 
 What is the maximum rate of H2O2 decomposition by Prx2? 5.2.
The rate at which Prx2 decomposes H2O2 ( Prx2v ) depends on the oxidative load. If the latter is 
large, there is accumulation of PSSP and TrxOx (i.e. PSSP=Prxtot and TrxOx=Trxtot, with Prxtot 
and Trxtot as the total concentration of Prx2 and Trx in the erythrocyte, respectively). This 
allows the rate of TrxOx reduction to approach its maximum ( TrxRmaxV ), hence limiting the maximum 
rate of H2O2 decomposition by Prx2 ( 2PrxmaxV ). In order to estimate 
2Prx
maxV  at steady state we had to 
estimate several parameters. We discuss these estimates in the subsequent subsections. 
5.2.1. Parameter estimates and considerations 
5.2.1.1.Dismutase activity of catalase 
We considered that catalase exhibits pseudo-first order kinetics with respect to H2O2 [218 s-1, 
(Mueller et al., 1997b)]. This assumes that catalase is not inactivated. We now discuss the 
conditions in which catalase may be inactivated. 
Four catalase forms are considered in its catalytic cycle, based on observations by (Chance et al., 
1952),(Gaetani et al., 1989) and (Kirkman et al., 1999): Ferricatalase, Compound I, Compound II 
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and an Intermediate state. The Intermediate is an unstable state between Compound I and II, and 
may either be reduced to Ferricatalase at the expense of NADPH or to Compound II due to the 
presence of other electron donor (Hillar et al., 1994; Kirkman et al., 1999). NADPH is used to 
prevent accumulation of Compound II, an inactivate form of catalase (Kirkman et al., 1999; 
Kirkman et al., 1987). The formation and consumption of Compound II occurs by reduction, 
hence requiring the presence of electron donors. These donors may either be small molecules 
(e.g. ferrocyanide) or a poorly known endogenous donor found in catalase itself (Hillar and 
Nicholls, 1992; Hillar et al., 1994). The following figure is a simplified catalytic cycle of 
catalase that includes the four states and shows the reactions in which intracellular H2O2 and 
NADPH participate. 
 
Figure 5.3 – Simplified representation of the catalytic cycle of catalase based on observations by (Chance et al., 1952; 
Gaetani et al., 1989; Kirkman et al., 1999). The rate constants of all reactions are represented as ki.  
Some values of the rate constants in Figure 5.3 are found in Table 5.3. 
Table 5.3 – Values of parameters in Figure 5.3. 
Parameter Value Reference 
kCompoundI 1.6×107 M-1 s-1 (Chance et al., 1952) 
kCompoundII 8×10-6 s-1 (Kirkman et al., 1999) 
kdecay 1.1×10-2 s-1 (Nicholls, 1964)
kFerricatalase 0.6×107 M-1 s-1 (Chance et al., 1952) 
Catalase has still another inactive form, Compound III, but this appears to be very minor even 
when NADPH is absent in the experiments of (Kirkman et al., 1999). The formation of 
Compound II is still not completely understood. We will now discuss the conditions under which 
the accumulation of Compound II may occur, leading to inactivation of catalase. 
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(Kirkman et al., 1999) assessed the relative abundance of each catalase form in vitro in a reaction 
mixture where there was constant H2O2 production (1×10-7 to 2×10-7 M H2O2/s). The authors 
observed that catalase was found as Ferricatalase, Compound I and II even in the absence of 
NADPH. When there was no NADPH in the mixture most of catalase was found in Ferricatalase 
state (40 – 55% total catalase), but there was also accumulation of Compound II (7 – 20% total 
catalase). On the other hand, there was practically no Compound II present when NADPH    
(2×10-6 M) was added to the mixture. Again, most of catalase is in Ferricatalase form under such 
conditions. So under which conditions is NADPH able to protect catalase from inactivation? To 
assess this we built a kinetic model of the reactions depicted in Figure 5.3: 
( )
 
(
IntN CompoundII 2 2 CompoundI Ferricatalase
Ferricatalase 2 2 CompoundI 2 2 de
d Ferricatalase
= k NADPH Intermediate k CompoundII H O k CompoundI k Ferricatalase
dt
d CompoundI
k H O Ferricatalase CompoundI k H O k
dt
        
      
Re
)
 
( )
cay
decay IntN Int d
d Intermediate
k CompoundI Intermediate k NADPH k
dt
CatalaseT = Ferricatalase +CompoundI +CompoundII + Intermediate
     
 Model 5.2 
We used Model 5.2 to compare the rates of H2O2 consumption through Compound I (vCompoundI) 
with the decay of Compound I to Intermediate (vdecay) and NADPH consumption (vNADPHcons). 
These rates are respectively represented in Equation 5.7 to Equation 5.9: 
 CompoundI 2 2CompoundIk H O CompoundIv     Equation 5.7 
 decay decayv k CompoundI   Equation 5.8 
 NADPHcons IntNv k Intermediate NADPH    Equation 5.9 
The total rate of H2O2 dismutation by catalase is given by 
  H2O2cons 2 2 Ferricatalase CompoundIH O k Ferricatalase k CompoundIv       Equation 5.10 
The formation of Intermediate may compete for Compound I with the reaction in which the latter 
is used for H2O2 dismutation. When this occurs catalase then accumulates in its inactive form. 
The following ratio allows us to compare the flux of Compound I decay to Intermediate with the 
flux in which Compound I is used for H2O2 dismutation. 
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2 2CompoundI CompoundI
decay decay
v k H O
v k
  Equation 5.11 
Considering the values of parameters in Table 5.3, Equation 5.11 then becomes 
9
2 21.5 10
CompoundI
decay
v
H O
v
    Equation 5.12 
Equation 5.12 shows that for H2O2 < 1×10-9 M the decay of catalase competes for Compound I 
with Compound I-mediated H2O2 dismutation (i.e. vCompoundI ≈ vdecay). For higher H2O2 the rate of 
reduction of Compound I to Ferricatalase is much larger than the decay of Compound I to 
Intermediate. This occurs because the pseudo-first order rate constant for reduction of 
Compound I to Ferricatalase with respect to Compound I (given by kCompoundI × H2O2) will be 
much larger than kdecay (i.e. vCompoundI » vdecay). 
There may still be accumulation of Compound II if the reduction of Intermediate to Ferricatalase 
is limited by NADPH availability. But as we now show, Model 5.2 and the parameter estimates 
above also imply that NADPH is oxidized at much lower rates than those of H2O2 dismutation by 
catalase. Under steady state conditions, solving Model 5.2 in order to the dependent variables 
and replacing them into Equation 5.9 and Equation 5.10 gives 
    
'
'
2 22
decay IntNNADPHcons
H2O2cons CompoundI decay IntRed IntN
k kv
v k H O k k k
       Equation 5.13 
where kIntN’ is the pseudo-first order rate constant for Intermediate reduction to Ferricatalase 
(=kIntN×NADPH). If the NADPH concentration is high enough to make kIntN’ » kIntRed Equation 
5.13 then becomes 
 
2 22
decayNADPHcons
H2O2cons CompoundI decay
kv
v k H O k
     
Equation 5.14 
It would be useful to know how high would the NADPH concentration have to be for this 
approximation be accurate (i.e. for kIntN’ » kIntRed to be verified). However, we have not found any 
reports in the literature for the values of kIntRed or kIntN. Nevertheless, we can find a lower estimate 
for the kIntN’ that allows kIntN’ > kIntRed as follows. Consider that kIntRed must be higher than or 
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equal to kdecay if accumulation of Intermediate in the absence of NADPH is to be avoided. 
Making kIntRed = kdecay, and considering the parameters in Table 5.3, we get kIntN’ > 0.011 s-1. 
From this pseudo-first order rate constant we may also obtain a rough estimate of kIntN. The total 
concentration of bound plus unbound NADP is about 40×10-6 M (Wagner and Scott, 1994), of 
which a large fraction is bound to proteins. About 16×10-6 M NADPH is catalase-bound 
(Kirkman et al., 1986) and exchanges with unbound NADPH very slowly (Kirkman and Gaetani, 
1984). As per determination by (Wagner and Scott, 1994), unbound NADP comprises about 
≈28×10-6 M in the human erythrocyte. Considering NADPH = 28×10-6 M and kIntN’ = 0.011 s-1 
we get kIntN ≈ 390 M-1s-1. However, we would like to note that this kIntN represents a lower 
estimate, and further studies are required to determine a more accurate value for this rate 
constant. 
Considering the values in Table 5.3, Equation 5.14 gives 
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     
Equation 5.15 
Equation 5.15 shows that for H2O2 « 10-10 M the oxidation of NADPH and the total rate of H2O2 
dismutation occur at comparable rates (i.e. vNADPHcons ≈ vcatalase). This means that under such 
oxidative loads the rate at which catalase oxidizes NADPH is limited by H2O2 availability. On 
the other hand, for values much higher than 10-10 M H2O2 the ratio above becomes practically 
null. This means that when H2O2 increases above 10-10 M the rate of NADPH consumption by 
catalase becomes negligible compared to the rate of H2O2 dismutation. Therefore, higher 
oxidative loads will lead to much higher increase in the rate of H2O2 dismutation by catalase than 
in the rate of NADPH oxidation by catalase. Although NADPH is needed to prevent 
accumulation of inactive catalase, at high oxidative loads catalase likely consumes very little 
NADPH compared to the antioxidant activity it exerts. This conclusion is in accordance with the 
experimental observations by (Kirkman et al., 1999). These authors show that 2×10-6 M of 
catalase consumes ≈13×10-6 M H2O2/s while oxidizing only ≈0.006×10-6 M NADPH/s, 
maintaining a steady state H2O2 of ≈3×10-9 M. It would be interesting to find if H2O2 <10-10 M 
allows NADPH oxidation to be limited by H2O2 availability. Also supporting the assertion that 
catalase oxidizes NADPH at low rates compared to H2O2 consumption is the observation that 
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catalase oxidizes one NADPH molecule for every 4 to 14 molecules dismutated (Kirkman et al., 
1987), the exact ratio depending on the concentrations of superoxide, H2O2 and other 
intracellular reductants. The authors obtained these values in an in vitro experiment where H2O2 
was being generated at 8×10-9 to 10-7 M H2O2/s (2×10-6 M catalase, 0.1 M glucose, 0.2×10-6 M 
glucose-6-phosphate dehydrogenase, 4×10-6 M NADP). As the rate of H2O2 generated increased 
so did the rate of NADPH consumed. 
An important issue that we would like to point out is that NADPH availability may on the other 
hand affect the dismutase activity of catalase. If catalase accumulates mostly in inactive form 
there is less enzyme available to dismutate H2O2. This occurs if kIntN’ < kIntRed, making vNADPHcons 
smaller than the flux of conversion of Intermediate to Compound II (vIntRed, Equation 5.16). 
 IntRed IntRedv k Intermediate   Equation 5.16 
The estimates that led to Equation 5.15 were done by assuming that NADPH does not limit the 
reduction of Intermediate to Ferricatalase. (Kirkman et al., 1987) observed that                        
<0.1×10-6 M NADPH prevents the accumulation of Compound II when 2×10-6 M bovine 
catalase is exposed to ≈ 3×10-8 M H2O2/s. However, it could still be interesting to determine the 
NADPH concentration that prevents accumulation of Compound II for higher oxidative 
conditions. Again the issue of having just a lower estimate of kIntN and kIntRed prevent us from 
finding such concentration. Yet, from our estimates above we find that a kIntN’ > 0.011 s-1 allows 
vNADPH > vIntRed. This value represents a lower estimate for the value of kIntN’ required to prevent 
accumulation of Compound II. 
More experiments are required in order to improve these estimates and to analyze under what 
conditions is the dismutase activity of catalase limited by NADPH. Such experiments could be 
done in vitro to analyze various issues. For instance, some could assess the kinetics of NADPH 
oxidation by catalase in reaction mixtures where H2O2 is being produced at various fluxes. By 
analyzing such rates one would be able to obtain rate constants for such reactions. Other 
experiments could determine the kinetics of Intermediate formation and disappearance, in the 
absence of NADPH. While this is a technically difficult issue given the instability of the 
Intermediate, some experiments using spectroscopic techniques were already used to identify the 
presence of this Intermediate in Proteus mirabilis and bovine catalases (Ivancich et al., 1996; 
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Ivancich et al., 1997). Obtaining more insight onto the formation and consumption of the 
Intermediate would allow us to have more accurate estimates of which conditions lead to catalase 
inactivation. 
The issues above prevent a precise estimate of the conditions in which NADPH prevents the 
accumulation of inactive catalase. However, given the important role of catalase in the defense of 
erythrocytes against H2O2 (Gaetani et al., 1996; Johnson et al., 2010; Scott et al., 1991) it is 
unlikely that a large fraction of catalase is inactivated even in erythrocytes facing strong 
oxidative loads. This is further supported by the experiments of (Johnson et al., 2010), who 
showed that catalase is not significantly inactivated even under strong oxidative conditions. The 
authors assessed the intracellular redox state of mice erythrocytes by assaying the redox state of 
hemoglobin. The authors used erythrocytes collected from Prx2- and GPx1-knockout mice. 
Those erythrocytes were then exposed to various H2O2 boluses and the fraction of oxidized 
hemoglobin (methemoglobin) was quantified. In the absence of Prx2 and GPx1 the main defense 
against H2O2 was catalase. Due to the higher catalase activity required to compensate for the 
absence of Prx2/GPx1 it could occur that a larger fraction of catalase would be inactivated. 
However, these authors show that even in Prx2-mutant erythrocytes exposed to boluses up to 
500×10-6 M H2O2 there is not a significant accumulation of methemoglobin (oxidized form of 
hemoglobin) in comparison to the wild-type erythrocytes. If there was an increase in 
methemoglobin levels it could be due to the accumulation of intracellular H2O2, as a result of 
catalase inactivation. If NADPH availability was not preventing catalase inactivation there would 
be a much larger accumulation of methemoglobin in the mutant erythrocytes. Also, the 
methemoglobin concentration is similar in wild type erythrocytes subjected to 50×10-6 and 
500×10-6 M H2O2 boluses. This suggests that erythrocytes subjected to both oxidative loads have 
similar abilities to scavenge H2O2, hence preventing accumulation of oxidized hemoglobin. 
These results suggest that catalase is able to scavenge H2O2 even in the absence of Prx2 or GPx1 
(Johnson et al., 2010). Yet, one should regard these results carefully as they could easily be 
influenced by the conditions of the experiment. In the experiments of (Johnson et al., 2010) the 
ability of Prx2- and GPx1-mutant erythrocytes to scavenge H2O2 may be only temporary: the 
NADPH pool may only be able to protect catalase from inactivation for a short period of time, 
surpassing the erythrocyte’s capacity to produce NADPH and maintain catalase active. Also, 
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despite the similar ability that wild type and Prx2-mutant erythrocytes have to maintain the redox 
state of hemoglobin, Prx2-mutant erythrocytes exhibit only ≈80 % catalase activity relatively to 
the wild types. However, it is not clear if this is due to slower catalytic activity, lower catalase 
concentration or accumulation of inactive enzyme. 
Though these results suggest that catalase alone is able to defend the erythrocyte from H2O2, 
more experiments are needed to study catalase inactivation and how this process affects its 
antioxidant activity. Such experiments would provide values under which the dismutase activity 
of catalase is effectively a first-order process with respect to H2O2. 
In our work we started by considering that catalase activity is not limited by NADPH availability 
hence disregarding the accumulation of inactive catalase. This was done because we first want to 
compare the relevance of Prx2, GPx1 and catalase for H2O2 scavenging. We want to understand 
which of these three antioxidants could represent the main H2O2 scavenging process where the 
supply reducing equivalents are not rate limiting. 
5.2.1.2.Peroxidase activity of GPx1 
GPx1 oxidizes two GSH molecules per H2O2 molecule reduced (Reaction 5.1 to Reaction 5.3). 
In our analyses we considered a pseudo-first order rate constant of 40 s-1 (Section 5.1.1.1) for 
GPx1 activity, with respect to iH2O2.  
However, under high oxidative loads GSH availability limits the rate of H2O2 reduction by GPx1. 
Glutathione Reductase (GSR) is the enzyme responsible for GSSG reduction, consuming 
NADPH in this process. In Section 5.1.1.1 we showed that GPx1 has a 2 2( )
app
mK H O  18×10-6 M, 
a value that exceeds plausible iH2O2 [which should be <3×10-9 M iH2O2 under basal oxidative 
conditions, and up to ≈10-7 M iH2O2 in pathological conditions, as per the experiments of 
(Giulivi et al., 1994; Kirkman et al., 1999)], provided that all of the GSH contents are in reduced 
form. Under which oxidative loads does GPx1 exhibit first-order kinetics with respect to H2O2?  
To address this question we started by estimating the iH2O2 that yields a kinetic order of 0.5 for 
the reaction of with respect to H2O2, as a function of the fraction of GSSG. Consider that GPx1 
reduces H2O2 with overall reaction 
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 2 2 2 2 2iH O GSH H O GSSG   Reaction 5.4 
With overall conservation relationship 
 GSH + 2GSSG = GStot Equation 5.17 
The kinetic order for Reaction 5.4 with respect to iH2O2 (f) is 
 Log[ ]
Log[ ]
GPx1
2 2
d vf
d iH O
  Equation 5.18 
where vGPx1 is the rate of H2O2 reduction by GPx1 (Equation 5.1, Section 5.1.1.1). Taking into 
consideration Equation 5.17 and Equation 5.18 we get 
 
2 2 2
1
1
1
1 2
f iH O
GSSGGStot
GStot


       
 
Equation 5.19 
We compute the iH2O2 required for vGPx1 to be half saturated with H2O2 (i.e. f = 0.5) from 
Equation 5.19 giving 
 
1
2 2
2
1 2 GSSGGStot
GStotiH O


       
Equation 5.20 
Under which conditions is GPx1 half saturated with H2O2 and half of the erythrocyte’s NADPH 
production capacity is used towards GPx1-mediated H2O2 reduction? To assess this we 
considered parameters from Table 5.1 (Section5.1.1.1), vGPx1 from Equation 5.1 (Section 5.1.1.1), 
the conservation relationship in Equation 5.17, and iH2O2 from Equation 5.20. Taking all this 
into account, we estimated the fraction of GSSG under which vGPx1 = 2
PPP
maxV  where PPPmaxV  is the 
maximum rate of NADPH production by the PPP [=1.9×10-6 M/s, as determined using 
methylene blue as NADPH oxidant (Albrecht et al., 1971; Gaetani et al., 1974)]. Under these 
conditions we find that >99% of GStot is oxidized, and would correspond to                       
≈4.7×10-8 M iH2O2 as estimated through Equation 5.20. 
Under such an oxidative load, Prx2 would consume H2O2 at a rate vPrx2 = kPrx2×iH2O2                       
≈ 1.7×10-3 M/s (considering kPrx2 = 37 000 s-1, Section 5.1.1.3). This rate largely surpasses the 
erythrocyte’s capacity to produce NADPH [=1.9×10-6 M/s, (Albrecht et al., 1971; Gaetani et al., 
1974)]. Therefore, Prx2’s activity is limited by NADPH supply under these conditions and the 
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contribution of this protein for H2O2 consumption is negligible (Section 5.1.2). Most of iH2O2 is 
consumed by catalase, as per our analysis in Section 5.1.2. 
The steady state eH2O2 that would achieve such an oxidative load (4.7×10-8 M iH2O2) may be 
computed as follows. Considering only GPx1 and catalase consume iH2O2 we get 
 influx catalase GPx1v v v   Equation 5.21 
where  
 2 2influx pv k eH O   Equation 5.22 
 
catalase catalase 2 2v k iH O   Equation 5.23 
 
2
PPP
max
GPx1
Vv   
Equation 5.24 
The parameters of Equation 5.22 to Equation 5.24 are found in Table 5.4. 
Table 5.4 – Parameters considered to compute the eH2O2 under which GPx1 is not saturated with iH2O2. 
Parameter Value Notes/Reference 
kcatalase 218 s-1 Pseudo-first order rate constant for H2O2 consumption by catalase (Section 5.1.1.2) 
kp 8 s-1 
Estimated after considering kp= S
e
A
V   where κ is the H2O2 permeability constant [=6×10
-5 dm/s 
(Nicholls, 1965)]; AS is the erythrocyte surface area [=1.35×10-8 dm2(Evans and Fung, 1972)]; and 
Ve is the erythrocyte volume [10-13 dm3  (Evans and Fung, 1972)] 
PPP
maxV  1.9×10
-6 M/s Maximum rate of NADPH production by the PPP (Albrecht et al., 1971; Gaetani et al., 1974) 
After considering parameters from Table 5.4 we estimate that ≈1.9×10-6 M eH2O2 would be 
enough to maintain a steady state 4.7×10-8 M iH2O2, and would correspond                        
to vinflux ≈ 1.1×10-5 M/s. 
These conditions thus represent the load under which GPx1 is not saturated with iH2O2. In the 
analyses below we considered that GPx1 exhibits first-order kinetics with respect to iH2O2 and 
zeroth-order kinetics with respect to GSH. This would pertain to low oxidative loads     
(≈1.3×10-6 M eH2O2 and 4.7×10-8 M iH2O2), where 2 GSSG GSH  is low (Cohen and Hochstein, 
1963).  
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5.2.1.3.Endogenous H2O2 production and basal intracellular H2O2  
A few studies addressed what are the basal levels of H2O2 in the erythrocyte cytoplasm. In the 
studies of (Kirkman et al., 1999) and (Giulivi et al., 1994) the authors found values between 
2×10-10 and 3×10-9 M iH2O2. However, we believe that these values may overestimate those in 
vivo for the reasons we discuss below. 
First, we cannot disregard the possibility that the H2O2 found in both studies represents the 
detection limit of the methods used, which are not sensitive to sub-nanomolar concentrations. 
Second, both studies use indirect methodologies to quantify H2O2 which may be associated with 
methodological imprecision. Third, the contribution of Prx2 (and other antioxidants) for H2O2 
scavenging was not accounted for. We will now discuss these issues. 
(Giulivi et al., 1994) determined the rate of H2O2 dismutation by catalase in bovine erythrocyte 
(5% hematocrit). Catalase dismutates H2O2 according to Reaction 5.5 and Reaction 5.6 
 Ferricatalase + H2O2 → Compound I + H2O Reaction 5.5 
 Compound I + H2O2 → Ferricatalase + H2O + O2 Reaction 5.6 
The authors determined the rate of catalase inactivation by 3-amino-1,2,4-triazole to determine 
the rate at which catalase is consuming H2O2: a higher rate of H2O2 dismutation by catalase leads 
to higher flux of formation of Compound I. Because aminotriazole binds to Compound I and 
inactivates catalase (Reaction 5.7), a higher rate of catalase inactivation corresponds to a higher 
rate of H2O2 consumption by catalase. 
 Compound I + 3-Amino-1,2,4-Triazole → Inactive Compound Reaction 5.7 
The authors observed a constant decrease in catalase activity after 4 hours of incubation, which 
they attributed to a steady state of H2O2 (estimated as ≈2×10-10 M iH2O2). They also determined 
an endogenous production of ≈4×10-10 M iH2O2/s. We will now discuss the reliability of these 
determinations.  
(Giulivi et al., 1994) determined the rate of H2O2 produced endogenously as per the method of 
(Aebi, 1984): using the absorbance of H2O2 at 240nm, they determined the pseudo-first order 
rate constant for H2O2 dismutation by catalase. Larger iH2O2 thus corresponds to higher catalase 
activity, which leads to higher catalase inactivation by aminotriazole. As catalase is 
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progressively inactivated by aminotriazole, H2O2 accumulates if catalase is the main H2O2 
scavenger. GPx1 and Prx2 have a minor contribution for H2O2 consumption because NADPH 
production was prevented by adding no glucose to the incubation medium in their experiments, 
and iodoacetamide was added. Iodoacetamide is an inhibitor used to prevent formation of 
disulfide bonds, thus inhibiting Prx2 and GPx1. 
Using Equation 5.25 we estimate the steady state iH2O2 that would be attained under basal loads, 
consideringthe rate of H2O2 production  determined by the authors (ࢶ= 4×10-10 M H2O2/s). 
Consider Prx2 the main H2O2 scavenger (Section 5.1.2) with kPrx2 = 37 000 s-1 (Section 5.1.1.3). 
 2 2 02 2 Prx2
d H O H O k
dt
     Equation 5.25 
 142 2 10 MH O
   
This suggests that if we consider the peroxidase activity of Prx2 we would obtain a much lower 
iH2O2. 
On the other hand, the authors also estimated the steady state H2O2 that would correspond to the 
above catalase activity (=4×10-10 M/s). Considering catalase as the only H2O2 scavenger they 
determined 2×10-10 M H2O2 under steady state basal oxidative loads. However, a few issues 
prevent us from considering this as the steady state H2O2 found under basal oxidative conditions 
as we now discuss. 
Considering that Prx2 consumes practically all of the iH2O2 under basal loads (Section 5.1.2), a 
very high endogenous production of H2O2 would be required to maintain a steady state 2×10-10 
iH2O2. Considering 2×10-10 M iH2O2 and kPrx2 = 37 000 s-1 (Section 5.1.1.3), the rate of H2O2 
production in the erythrocyte (ࢶ) in steady state conditions is 7.4×10-6 M H2O2/s. 
H2O2 dismutation by Prx2 is stoichiometrically coupled with NADPH oxidation through the 
Trx/TrxR cycles. So the NADPH supply must cope with such rate of H2O2 reduction. However, a 
ࢶൌ7.4ൈ10‐6	 M	 H2O2/s surpasses the erythrocyte’s capacity to produce NADPH via the Pentose 
Phosphate Pathway [=1.9×10-6 M NADPH/s (Albrecht et al., 1971)]. Thus, part of the rate of 
H2O2 production determined likely is produced by the medium. These issues prevent us from 
taking into consideration the above steady state iH2O2. 
(Kirkman et al., 1999) on the other hand, determined a 3×10-9 M H2O2 through an in vitro assay 
which tried to reproduce the conditions found in human erythrocytes (such as enzyme 
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concentrations, pH, temperature, etc.). The authors quantified H2O2 by following the 
disappearance of catalase fluorescence by spectrophotometric methods at 240 nm. They also 
used bovine catalase as an antioxidant, disregarding the contributions of Prx2 or GPx1 for H2O2 
consumption. Considering 3×10-9 M H2O2 and kPrx2 = 37 000 s-1 we obtain                        
ࢶ = 10-4 M H2O2/s through Equation 5.25. This value is again implausibly high under 
physiological conditions because it also largely surpasses the erythrocyte’s capacity to produce 
NADPH. 
With the above in mind we considered the basal iH2O2 as 10-12 M. This value would correspond 
to a basal endogenous production of 3.7×10-8 M H2O2/s considering kPrx2 = 37 000 s-1 and 
Equation 5.25. Assuming that Prx2 consumes all of the iH2O2 under basal oxidative loads, 
NADPH would have to be produced at a rate of 3.7×10-8 M NADPH/s in order to regenerate 
Prx2. This value is ≈50 fold smaller than the erythrocyte’s maximal rate of NADPH production 
by the PPP [=1.9×10-6 M NADPH/s (Albrecht et al., 1971)]. Considering 3.7×10-8 M/s as the rate 
of H2O2 reduction by Prx2 and kp = 8s-1 (Section 5.2.1.2), a steady state iH2O2 = 10-12 M would 
be achieved if eH2O2 < 5×10-9 M. 
Thus, Prx2 activity is not limited by NADPH supply under sustained eH2O2 < 5×10-9 M and 
3.7×10-8 M H2O2/s, considered the basal oxidative conditions in agreement with NADPH supply. 
5.2.1.4.Kinetics of H2O2 efflux and consumption by catalase and GPx1 
Even for high oxidative loads, in which Prx2 is mostly oxidized, the pseudo-first order rate 
constant for H2O2 consumption through catalase and GPx1 (kc=kcatalase+kGPx1=258 s-1, Table 5.2, 
Section 5.1.2) is much higher than the first order rate constant for H2O2 efflux (kefflux): 
 112 ssefflux
ew
Ak
V
     Equation 5.26 
With κ as the H2O2 permeability constant [6×10-5 dm/s (Nicholls, 1965)], AS as the erythrocyte 
surface area [1.35×10-8 dm2 (Evans and Fung, 1972)] and Vew as the erythrocyte water volume 
[7×10-14 dm3 water/cell, obtained by multiplying the erythrocyte water content WaterContentRBC 
= 0.7 dm3 water/dm3 cells (Savitz et al., 1964) with the erythrocyte volume of ≈10-13 dm3 (Evans 
and Fung, 1972)]. 
 67 
The comparison of the value of kc and kefflux shows that antioxidant-mediated decomposition of 
intracellular H2O2 is much higher than H2O2 efflux. Further, if Prx2 is also contributing for H2O2 
scavenging, the difference between the rate constants for intracellular H2O2 decomposition by 
antioxidants and membrane efflux will be even larger. So, we neglected the contribution of H2O2 
efflux for H2O2 clearance from the erythrocyte. 
5.2.1.5.Peroxidase activity and concentration of Prx2 
Regarding the antioxidant action of Prx2, we considered the following reactions: 
 Prxred + H2O2 PrxRed
k  PSSP + H2O Reaction 5.8 
 PSSP + TrxRed PSSP
k  Prxred + TrxOx Reaction 5.9 
In these reactions we assume that Prx2 oxidation leads directly to the formation of disulfide 
bonds, whose reduction is coupled with the oxidation of Trx. We also consider that each of the 
above reactions occurs simultaneously in all monomers. 
Although the formation of the inactive sulfinylated form of Prx2 may occur under high oxidative 
loads, it is negligible in human erythrocytes (Low et al., 2007). Therefore we neglected Prx2 
sulfinylation. In a later part of this work we address the sulfinylation of Prx2 and its influence on 
the catalytic cycle of Prx2 (Section 5.7). 
(Manta et al., 2009) reported a value of 108 M
-1s-1 for the rate constant of H2O2 reduction by 
Prxred (kPrxRed). At this stage we have considered that Reaction 5.8 happens in a single step. PSSP 
is then reduced by TrxRed (Reaction 5.9), with a second order rate constant kPSSP = 2.1×105 M-1s-1 
(Manta et al., 2009). 
Because only two oxidation states of Prx2 will be considered initially (PrxRed and PSSP), the 
following conservation relationship is obtained: 
 Prxtot = Prxred + PSSP Equation 5.27 
The total concentration of Prx2 used (Prxtot= 3.7×10-4 M) was estimated in Section 5.1.1.3. 
5.2.1.6.Total concentration of Trx 
Two oxidized states of Trx are considered: a reduced state (TrxRed) and an oxidized state (TrxOx). 
Accordingly, the following conservation relationship is obtained 
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 Trxtot = TrxRed + TrxOx Equation 5.28 
Because the total concentration of Trx in human erythrocytes (Trxtot) is unknown, we used a 
value obtained for bovine erythrocytes. The following equation was used to estimate the 
concentration of Trx: 
 Holmgren
RBC Trx RBC
Trx
Trxtot
WaterContent MW Density
   Equation 5.29 
In which TrxHolmgren is the concentration of Trx [37×10-3 g Trx/Kg erythrocyte wet weight 
(Holmgren and Luthman, 1978)]; MWTrx is the molecular weight of Trx [12 kDa (Cha and Kim, 
1995)]; DensityRBC is the erythrocyte density [1.094 Kg/L (Raftos et al., 1999)] and 
WaterContentRBC as the erythrocyte water content [0.7 dm3 water/dm3 erythrocytes (Savitz et al., 
1964)]. Replacing these values into Equation 5.29 yields a Trx concentration of ≈4.8×10-6 M. 
5.2.1.7.TrxR concentration 
We estimated the concentration of TrxR as follows: 
 
Méplan
TrxR
TrxR
TrxR
MW
  Equation 5.30 
with TrxRMéplan as the concentration of TrxR 1 in human erythrocytes [3.5×10-3 g TrxR/dm3 
erythrocyte lysate (Méplan et al., 2007)] and with MWTrxR as the molecular weight of the same 
enzyme [116 kDa (Tsang and Weatherbee, 1981)]. Replacing these values into the above 
equation yields a concentration of ≈30×10-9 M TrxR. 
5.2.1.8.Estimate of the rate constants for H2O2 permeation and endogenous 
production in the experiments of (Low et al., 2007) 
To determine the value of kTrxR we considered the experiments of (Low et al., 2007). But before 
we could estimate the value of that rate constant we had to estimate the values of kp and the 
endogenous production of H2O2 in those experiments. 
The authors assessed the time course of H2O2 consumption after exposing                       
5×109 erythrocytes/dm3 to 5×10-6 M H2O2 boluses [Figure 4B of (Low et al., 2007)]. To frame 
our problem we studied the time course of H2O2 consumption, represented in Figure 5.4. 
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Figure 5.4 – Time course of H2O2 consumption by 5×106 erythrocytes/ml after a 5×10-6 M H2O2 bolus. Taken from Figure 
4B of (Low et al., 2007). 
The hydrogen peroxide concentration decreases quickly in the first 10 minutes of the experiment 
and then settles to a steady value of about 10-7 M. This steady state suggests that H2O2 is 
constantly being produced by the medium (or by the cellular membrane of erythrocytes)3. We 
estimated this production () and the first-order rate constant for hydrogen peroxide permeation 
through erythrocytes (kp) by fitting Equation 5.31 to the time course of H2O2 consumption in 
Figure 5.4. 
  2 2
p 2 2
d eH O k eH O
dt
   Equation 5.31 
We computed the values of   and pk  that minimize the error function 
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

       , where ( , , )comp p iy k t  stands for the computed value of 2 2eH O  
at time it as per Equation 5.31, exp ( )iy t stands for the experimental value of 2 2eH O  at time it
from Figure 5.4, and N stands for the number of points. The values that allowed the best fit were 
pk  4.210-3 s-1,    69×10-11 M/s (Figure 5.5). This value of  is low enough to be a 
plausible estimate of the spontaneous H2O2 generation in an experimental preparation exposed to 
                                                 
 
3 However, the possibility that the apparent steady state is an artifact due to the attainment of the detection limit of the 
method used by (Low et al., 2007) to determine H2O2 cannot be discarded. 
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O2 at atmospheric pressure, was not subject to treatments to remove transition metals and may 
contain a few activated phagocytes. 
 
Figure 5.5 – Best-fit time course of H2O2 consumption of the experimental data (dots) from Figure 4B of (Low et al., 2007). 
(Low et al., 2007) claim that the settling observed 10 minutes after the H2O2 bolus is not a steady 
state but the detection limit of the experiment. If this is what is occurring there would be a 
steeper decrease in the H2O2 concentration and possibly the value of kp would be higher. 
To reinforce our confidence in the obtained value of kp, we compare this value with the kp 
computed through Equation 5.32. 
 s
p
o e
n Ak
V n V
     
Equation 5.32 
The parameters of this equation are found in Table 5.5. 
Table 5.5 - Parameters used for computing the pseudo-first order rate constant for H2O2 permeation across erythrocytes 
membranes, for the experiments of (Low et al., 2007). 
Parameter Value Notes/Reference 
κ 6×10-5 dm/s H2O2 permeability constant (Nicholls, 1965) 
AS 1.35×10-8 dm2 Erythrocyte surface area (Evans and Fung, 1972) 
n 5×109 cells/dm3 Number of erythrocytes per volume unit under the experimental conditions of (Low et al., 2007) 
Ve 10-13dm3 Erythrocyte volume (Evans and Fung, 1972) 
Vo  10-3 dm3 Extracellular volume. Experimental conditions of (Low et al., 2007) 
Because the hematocrit used by the authors was very low (i.e. e on V V  ), Equation 5.32 
becomes 
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Equation 5.33 
Replacing the values of Table 5.5 into Equation 5.33 we get kp ≈ 4.010-3 s-1. With this approach 
we further reinforce our confidence in the value of kp we obtained.  
If the constant H2O2 concentration found by (Low et al., 2007) towards the end of their 
experiment is not due to the detection limit of the techniques used, it could only be explained by 
additional H2O2 production. If we neglect H2O2 production by the medium the time-course of 
H2O2 depletion in Figure 5.4 could only be explained by a very high rate of H2O2 production 
from the erythrocytes. We now show our estimate of the rate of endogenous H2O2 production (ϕ) 
that allows H2O2 to remain constant. In order to maintain eH2O2 = 10-7 M (as observed towards 
the end time of the experiment in Figure 5.4), even for an implausibly high steady state value of 
iH2O2 = 10-6 M, ϕ would have to be very high: 
 
62 10  M/s
2 2 p 2 2 GPx1 catalase peH O k iH O (k + k + k )
 
   
   Equation 5.34 
The above ϕ was determined by considering parameters from Table 5.2 (Section 5.1.2) and      
kp= 4.210-3 s-1 (as estimated above), and not including Prx2 as an antioxidant. If the latter was 
included, an even higher ϕ would be required to maintain an H2O2 efflux rate able to cope with 
the H2O2 influx rate. As per comparison to the experiments of (Giulivi et al., 1994) this ϕ is 
implausibly high to be achieved by human erythrocytes in physiological conditions. This shows 
that the settling observed in Figure 5.4 is not due to endogenous production of H2O2 by the 
erythrocytes but is either due to an additional production of H2O2 by the medium or due to the 
detection limit of the methods. 
In the next section we estimate the value of kTrxR from the experiments of (Low et al., 2007) by 
considering kp = 4.210-3 s-1 and  = 69×10-11 M/s. 
5.2.1.9.Pseudo-first order rate constant for Trx reduction through TrxR 
TrxR reduces oxidized Trx (TrxOx) at the expense of NADPH. We considered that the reduction 
of Trx (Reaction 5.10) was not limited by NADPH: 
 
Ox Red
TrxRkTrx Trx Reaction 5.10 
 72 
The rate constant of Trx reduction through TrxR (kTrxR) was estimated from the experiments of 
(Low et al., 2007). This was done by using Figure 4A, where the authors assess the redox state of 
Prx2 through immunoblotting at different time points, after exposing 5×106 erythrocytes/dm3 to 
a bolus of 5×10-6 M H2O2: 
 
Figure 5.6 – Immunoblot of Prx2, for 5×106 erythrocytes/dm3 exposed to 5×10-6 M H2O2, taken from Figure 4A of (Low et 
al., 2007). D – Dimerized (disulfide form) Prx2; M – Monomeric (reduced) Prx2. 
We sought to find a value of kTrxR that yields a fraction of reduced Prx2 similar to the one 
exhibited twenty minutes after the H2O2 bolus. We estimated this fraction by comparing Figures 
2A and B from (Low et al., 2007) (reproduced in Figure 5.7 below) to the immunoblot in     
Figure 5.6, proceeding as follows. The intensity of reduced Prx2 (Monomer) in the latter 
immunoblot is intermediate between those found in Figure 5.7B, which (Low et al., 2007) 
determined to correspond to 3% and 21% of Prx2 in reduced form. Thus, the mean of these two 
values, 12%, seems a reasonable estimate for the fraction of Prx2 in reduced form twenty 
minutes after the H2O2 bolus in the immunoblot in Figure 5.6. 
 
Figure 5.7 – Oxidation of Prx2 in 5×106 erythrocytes/ml exposed to different peroxide boluses. A. Immunoblot of the 
redox state of Prx2, determined 20 minutes after a 5 μM H2O2 bolus [Figure 4A of (Low et al., 2007)]; B. Quantification of 
oxidized Prx2 (left) determined from immunoblots against oxidized state of Prx2 (right), determined 10 minutes after 2 
and 5 μM H2O2 boluses [Figure 2A and B from (Low et al., 2007)]. D – Dimerized (disulfide form) Prx2; M – Monomeric 
(reduced) Prx2. 
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Note that the experiment does not distinguish singly from doubly-crosslinked Prx2 in Figure 5.6. 
Therefore, to estimate the value of kTrxR we consider a reaction scheme which takes into account 
three oxidized states of Prx2: reduced Prx2 (PrxRed), singly-crosslinked (Prx1) and doubly-
crosslinked (PSSP) Peroxiredoxin 2. 
 
Figure 5.8 – Reactions considered to estimate kTrxR from the data of (Low et al., 2007). 
Model 5.3 was built from the scheme above and allows us to estimate the rate constant of Trx 
reduction. 
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 Model 5.3 
The meaning of each parameter of the above model is found in Table 5.6. 
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Table 5.6 – Parameters used to estimate kTrxR through Model 5.3. 
Parameter Value Meaning/Reference 
AS 1.35×10-8 dm2 Erythrocyte surface area (Evans and Fung, 1972) 
kc 258 s-1 Aggregate pseudo-first-order rate constant of catalase and GPx, obtained through the 
sum of kcatalase and kGPx1 (Section 5.1.2) 
kp 4.210-3 s-1 First-order rate constant for hydrogen peroxide consumption by erythrocytes. 
Estimated in Section 5.2.1.8 
kPrxRed 108 M-1s-1 Reactivity between reduced Prx2 and H2O2 (Manta et al., 2009) 
kPSSP  2.1×105 M-1s-1 Reactivity between reduced Trx and PSSP (Manta et al., 2009) 
kTrxR To be estimated Pseudo-first order rate constant for Trx reduction through TrxR 
n 5×109 cells/dm3 Concentration of erythrocytes in the experiments of (Low et al., 2007) 
Prxtot 3.7×10-4 M Total concentration of Prx2 monomers. Estimated in Section 5.1.1.3 
Trxtot 4.8×10-6 M Total Trx concentration (from bovine erythrocytes). Estimated in Section 5.2.1.6 
Ve 1×10-13 dm3 Erythrocyte volume (Evans and Fung, 1972) 
Vew 7×10-14 dm3 water/cell Erythrocyte water volume. Obtained by multiplying 0.7 dm3 water/dm3 cells (Savitz 
et al., 1964) with the erythrocyte volume of 10-13 dm3 (Evans and Fung, 1972) 
Vo 1×10-3 dm3 Extracellular volume. Experimental conditions of (Low et al., 2007) 
κ 6×10-5 dm/s H2O2 permeability constant (Nicholls, 1965) 
 69×10-11 M/s Hydrogen peroxide production, estimated in Section 5.2.1.8 
In this model we neglect the intracellular production of hydrogen peroxide. kPrxRed was used as 
the rate constant for the oxidation of a peroxidatic cysteine in both singly-crosslinked and 
reduced Prx2; kPSSP was the rate constant for doubly-crosslinked and singly-crosslinked Prx2. We 
acknowledge the possibility that the reactivity between peroxidatic cysteines and H2O2 differs in 
singly- and doubly-crosslinked monomers, due to conformational changes or allosteric 
regulation. The same may also occur during Prx2 reduction. However, we did not find any 
reports confirming or denying such events. We treated thioredoxin reduction as a first-order 
process. However, because the thioredoxin concentration exceeds the KM(Trx) of thioredoxin 
reductase [1.83×10-6 M (Turanov et al., 2006)], this assumption is reasonable only at low 
oxidative loads where a small fraction of the thioredoxin is in oxidized form. 
Seeking to find the value of kTrxR, we started by computing the steady state expressions for all the 
dependent variables in Model 5.3. The obtained expressions were then used as the initial values 
for the numerical integration of Model 5.3 with exception for eH2O2 which had initial value of 
5×10-6 M. This was done by considering parameters from Table 5.6, leaving kTrxR as the only 
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unknown parameter. In each trial, we sought to find a kTrxR that yielded 12% of reduced Prx2 20 
minutes after a H2O2 bolus, and found kTrxR ≈ 0.5 s-1. 
In turn, we also estimated the kTrxR from the data of (Turanov et al., 2006) through Equation 5.35. 
TrxR follows ping-pong kinetics to reduce TrxOx, oxidizing NADPH in the process (Arscott et al., 
1997; Williams, 1995), and has the following rate equation  
 
( ) ( )1
TrxR
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m m
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Equation 5.35 
This equation may be rearranged algebraically giving 
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The value of TrxRmaxV  may be computed by the product of the total concentration of enzyme found 
(TrxR = 30×10-9 M, Section 5.2.1.7) with the catalytic constant [kcat = 25.8 s-1, (Turanov et al., 
2006)]. This gives TrxRmaxV  ≈ 77×10-9 M/s. (Turanov et al., 2006) found a Km(Trx) = 1.83×10-6 M 
for the human Trx. Using the values of TrxRmaxV  and Km(Trx) one may estimate the pseudo-first 
order rate constant for Trx reduction through Equation 5.37 
  
  0.45
app
max Ox
TrxR app
m Ox
V Trx
k
K Trx
  s-1 Equation 5.37 
This value is close to the 0.5 s-1 obtained through the fitting of Model 5.3, but because the 
experimental conditions in (Turanov et al., 2006) are not completely clear we considered        
kTrxR = 0.5 s-1 in our next analyses. 
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5.2.1.10.Estimate of the pseudo-first order rate constant for formation of PSSP 
We consider three oxidized states of Prx2: reduced (PrxRed), sulfenic acid form (PSOH) and 
disulfide form (PSSP). Hydrogen peroxide first oxidizes each peroxidatic cysteine to a sulfenic 
acid (-SOH) which then reacts with a resolving cysteine to form disulfide bonds. The reduction 
of these disulfide bonds is accomplished through the oxidation of Trx (Reaction 5.9, Section 
5.2.1.5). Thus, we have replaced Reaction 5.8 (Section 5.2.1.5) by the following reactions: 
 
Red 2 2 2
PrxRedkPrx + H O PSOH + H O Reaction 5.11 
 PSOHkPSOH PSSP
 
Reaction 5.12 
kPrxRed and kPSOH are the rate constants for each of the reactions. The total concentration of Prx2 
is therefore given by the sum of PrxRed, PSOH and PSSP. Note that we assume that any of the 
above reactions (including Reaction 5.9, Section 5.2.1.5) occurs equivalently in every monomer 
of the protein. This should approximate what happens in vivo unless Prx2 presents cooperativity 
among its monomers. However, we have not found any evidence in the literature for 
cooperativity in mammalian peroxiredoxins. 
We have estimated kPSOH from the study of (Manta et al., 2009). These authors evaluated the 
overoxidation (sulfinylation) of Prx2, obtaining the results in Figure 5.9. 
 
Figure 5.9 – Overoxidation of Prx2. Oxidation of NADPH monitored at 340 nm, as determined by (Manta et al., 2009). 
Reaction mixture contained 200×10-6 M NADPH, 10-6 M human TrxR, 8×10-6 M human Trx1, 5×10-7 M Prx2 and was 
assayed for the peroxidase activity at the indicated H2O2 concentrations in 100×10-3 M phosphate buffer, pH 7.4,        
1×10-3 M DTPA, at 25 ºC. Taken from Figure 5A of (Manta et al., 2009). 
These authors assessed NADPH oxidation as a means to determine the overoxidation of Prx2 in 
an in vitro assay. We used the plot corresponding to the lower H2O2 because it shows almost no 
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overoxidation, as noted by the constant rate of NADPH decrease. If the rate of PSSP formation is 
the limiting step of the system, it will be possible to determine the value of the rate constant of 
this reaction (kPSOH) from the kinetics of NADPH oxidation above. The reaction scheme of this 
experiment is the following 
 
Figure 5.10 – Reaction scheme for the experiment of (Manta et al., 2009). 
The initial concentrations of each of the variables in the experiment are represented in Table 5.7. 
Table 5.7– Initial conditions of the experiment of (Manta et al., 2009). 
Variable Initial value (×10-6 M) 
NADPH 200 
TrxR 1 
Trxtot 8 
Prxtot 0.5 
H2O2 250 
We now show how we determined which is the limiting step of the experiment. Notice that 
NADPH is oxidized at a constant rate, which means that the concentrations of the various Prx2 
and Trx forms are at steady state. 
In order to know if TrxOx has accumulated, we first determined if NADPH consumption is 
occurring at the maximal rate of TrxR. We used the plot with the lower H2O2 in Figure 5.9 after 
converting absorbance to NADPH concentration. This was done by first computing a scaling 
factor (sf) from Equation 5.38. 
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Equation 5.38 
whereWhere 0tNADPH  is the initial NADPH concentration considered in the experiments 
(200×10-6 M) and 0tabs   is the mean of absorbances registered for the three plots in Figure 5.9 
when t=0 (0.951). The data was then normalized by multiplying each registered absorbance by sf. 
A least-squares fit of these experimental results yields the following best-fit line: 
 NADPH [t] ≈ 0.11×10-6 × t + 200×10-6 Equation 5.39 
  
Figure 5.11 – NADPH consumption by hTrxR obtained through the experiment of (Manta et al., 2009) – dots – and fitting 
to the experimental data through the Method of Linear Least Squares – line. 
As Figure 5.11 shows, Equation 5.39 provides an excellent fit (R2 ≈ 0.99) to the data by (Manta 
et al., 2009). The slope of the line indicates that NADPH is oxidized at 11×10-6 M/s. Because in 
the experimental setup designed by the authors only TrxR is oxidizing NADPH, this rate also 
corresponds to the activity of TrxR (vTrxR, Equation 5.35, Section 5.2.1.9). Note that these 
authors initially had NADPH = 2×10-4 M, a concentration well above the Km of TrxR for this 
substrate [Km,TrxR(NADPH)= 6×10-6 M, (Urig et al., 2006)]. Because NADPH » Km(NADPH), the 
rate of TrxR activity (Equation 5.35, Section 5.2.1.9) then becomes 
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Vv K TrxOx
Trx
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Equation 5.40 
If the TrxR activity was limited by Trx there would be accumulation of oxidized Trx. This would 
make TrxOx = Trxtot = 8×10-6 M (Table 5.7), leading to vTrxR = 11×10-8 M/s. However, replacing 
the values of TrxOx = 8×10-6 M, TrxRmaxV  = 77×10
-8 M/s (Section 5.2.1.9) and Km(TrxOx) = 1.83×10-6 
Experimental 
Fitting 
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M (Turanov et al., 2006) in Equation 5.35 gives vTrxR ≈ 6×10-7 M/s. Because this rate is much 
higher than the rate of NADPH oxidation observed by the authors, it is not Trx reduction that is 
the limiting step. Indeed if we consider vTrxR = 11×10-8 M/s, TrxRmaxV  = 77×10
-8 M/s and Km(TrxOx) 
= 1.83×10-6 M (Turanov et al., 2006), we get TrxOx ≈ 3×10-6 M (about 4% of the total Trx 
contents considered in the experiments). Therefore we can assume that Trx is mostly reduced in 
the experiments of (Manta et al., 2009). 
On the other hand, Prx2 reduction may be the limiting step. (Manta et al., 2009) determined a 
kPSSP = 2.1×105 M-1s-1 in their experiments. Taking this value and the concentrations in Table 5.7 
into consideration and assuming that all the Prx2 is in PSSP form, the rate of Prx2 reduction 
vPSSP is 
 884 10  M/s
PSSP PSSP
PSSP
v k Trxtot Prxtot
v 
  
    
Equation 5.41 
Yet, the reaction rate obtained through Equation 5.41 is much higher than the 0.11 μM NADPH/s 
oxidized (Figure 5.11), indicating that Prx2 reduction is not the limiting step either. 
These authors also estimated the reactivity between Prx2 and H2O2 and found kPrxRed = 108 M-1s-1. 
Using this value, we find that the pseudo-first order rate constant for PrxRed oxidation under the 
conditions of the experiment is extremely high (k = kPrxRed × H2O2 ≈ 2.5×104 s-1 with H2O2 from 
Table 5.7). Note that this pseudo-first order rate constant is much higher than the pseudo-first 
order rate constant for Prx2 reduction obtained above (kPSSP×Trxtot ≈ 1.7 s-1). Therefore, the 
limiting step may only be the formation of PSSP. 
Because the system is at steady state and Trx is mostly reduced, we get 
 
PSSP PSSP Redv k Trx PSSP    
Equation 5.42 
 
966 10  M
PSSP PSSPv k Trxtot PSSP
PSSP 
   
  
Equation 5.43 
with vPSSP = 11×10-6 M/s, Trxtot = 8×10-6 M, kPSSP = 2.1×105 M-1s-1. Because PrxRed oxidation is 
extremely fast (k ≈ 2.5×104 s-1), the concentration of PrxRed is negligible. Therefore, 
PrxtotPSOH+PSSP, yielding 43×10-8 M PSOH if Prxtot = 5×10-7 M (Table 5.7) and PSSP= 
66×10-9 M. 
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Under these conditions, we get 
 
PSSP PSOH PSOHv v k PSOH    Equation 5.44 
from which the value of kPSOH = 0.26 s-1 is obtained by considering PSOH = 43×10-8 M and     
vPSSP = 11×10-8 M/s. 
5.2.2. Maximum rates of H2O2 decomposition by Prx2 at steady state 
The maximum rate of H2O2 reduction achieved by Prx2 depends on the redox status of the 
erythrocyte, not only in terms of iH2O2 but also in terms of NADPH supply and Trx oxidation. If 
either NADPH or Trx supply is limiting Prx2 reduction, the maximum rate achieved by Prx2 is 
equal to the rate of supply under steady state conditions.  
If Trx reduction is limiting the peroxidase activity of Prx2, one may use the maximum rate of 
Trx reduction to estimate the maximum rate of Prx2 reduction ( RedmaxV ). Taking this into 
consideration, Prx2v  reaches its maximum value (
2Prx
maxV ) when 
 2Prx TrxRPrx2 max maxv V V   Equation 5.45 
 with TrxRmax TrxRV k Trxtot   Equation 5.46 
Considering Equation 5.46, kTrxR = 0.5 s-1 (Section 5.2.1.9) and TrxOx = Trxtot = 4.8×10-6 M 
(Section 5.2.1.6) gives RedmaxV  ≈ 2.4×10-6 M/s. This rate is comparable to the maximum rate of 
NADPH production by the hexose monophosphate shunt under stimulation by methylene blue 
[1.9×10-6 to 2.4×10-6 M/s (Albrecht et al., 1971; Gaetani et al., 1974)]. This suggests that 
NADPH supply and not Trx availability or TrxR activity limit Prx2 reduction. 
Other evidence also points this as a likely possibility. The TrxR activity in human erythrocytes 
determined by (Low et al., 2007) using DTNB as substrate is 7.9×10-6 M/s (at 37ºC). The 
enzyme has a catk 33.3 s-1 for DTNB at 25ºC (Urig et al., 2006), which tentatively considering a 
Q10 of 1.2 would translate into a kcat = 48 s-1 at 37ºC. On the other hand, using the data by 
(Turanov et al., 2006) we obtain that kcat (Trx) ≈ 0.77 kcat (DTNB), which would correspond to 
an activity of 0.777.9×10-6 M/s = 6.1×10-6 M/s. This high TrxRmaxV  is 2.5 to 4.7 fold higher than 
the erythrocyte’s capacity for NADPH production [1.9×10-6 to 2.4×10-6 M/s (Albrecht et al., 
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1971; Gaetani et al., 1974)]. This again suggests that NADPH supply may limit Trx (and Prx2) 
reduction hence affecting the antioxidant activity of Prx2 under high oxidative loads. 
However, the estimates above are pinned on some uncertainties. Namely, the value of Trxtot in 
human erythrocytes, doubts about the interpretation of the progression curve in Figure 5.5 
(Section 5.2.1.8), the imprecise estimate of the fractions of Prx2 in reduced form in Figure 5.6 
(Section 5.2.1.9), unclear experimental conditions in the experiments of (Turanov et al., 2006) 
and doubts about the precise kinetics of Prx2 oxidation and reduction. Clearly, the issue of what 
limits Prx2 reduction in human erythrocytes requires further experimental investigation with 
more sensitive and precise methods. 
 At what extracellular H2O2 concentration does Prx2 remain 5.3.
the main H2O2 scavenging process? 
As the above sections show, when Prx2 is mostly reduced catalase and GPx1 have negligible 
contributions for H2O2 scavenging as noted by their rate constants (Table 5.2, Section 5.1.2). 
However, because Trx reduction limits the peroxidase activity of Prx2 under high oxidative loads, 
it would be interesting to estimate the maximal sustained oxidative load tolerated by the 
Prx2/Trx cycles. 
However, such estimate is associated with a couple problems, some of which were already 
discussed in Section 5.2.2. Also, NADPH may become scarce at high eH2O2, and we have not 
assessed yet how TrxR and GSR compete for NADPH when the latter is scarce. For these 
reasons we will instead determine the oxidative load under which the Prx2/Trx cycles are not 
saturated with H2O2, remaining the main H2O2 scavenging process in the erythrocyte. 
Using Figure 4A of (Low et al., 2007) partially represented in Figure 5.6 (Section 5.2.1.9), we 
estimated the rate of Prx2 reduction as we now explain. As shown in that figure, the band of 
reduced Prx2 is much less intense than the band of dimerized Prx2 20 minutes after the 
erythrocytes were exposed to a 5×10-6 M H2O2 bolus. 30 minutes after the exposure to the H2O2 
bolus, the bands of reduced and dimerized Prx2 were about the same intensity. 
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Tentatively assuming that about 12% and 50% of Prx2 is in reduced form respectively 20 and 30 
minutes after the bolus as per the immunoblot in Figure 5.6 (Section 5.2.1.9), we computed the 
concentrations of Prx2 in each reduced fraction by considering Prxtot = 3.7×10-4 M (Section 
5.2.1.2). The values corresponding to each concentration are present in Table 5.8. 
Table 5.8 – Approximated fractions of reduced Prx2 in the experiments of (Low et al., 2007), and corresponding 
concentration of reduced Prx2. Refer to Figure 5.7 (Section 5.2.1.9) and to the text above for more detail on the 
experiments of (Low et al., 2007). 
 20 minutes 30 minutes 
PrxRed (% of total) 12 50 
Corresponding PrxRed (×10-6 M) 44 185 
In ten minutes (185 – 44)×10-6 ≈ 1.4×10-4 M Prx2 was reduced. This gives a rate of Prx2 
reduction of ≈2.3×10-7 M/s. To achieve half of this flux the H2O2 influx rate (vinflux) would have 
to be 
 7
72.3 10 1.2 10  M/s
2influx
v

    
 
where 
 
2 2influx pv k eH O   Equation 5.47 
Considering kp = 8 s-1 (Section 5.2.1.2) we get eH2O2 ≈ 2×10-8 M. This value represents the 
oxidative load that may be sustained by a human erythrocyte without leading to saturation of its 
Prx2/Trx systems. 
In Equation 5.47 we are assuming that most of Prx2 is in reduced form, thereby representing the 
main H2O2 scavenger in the cell4. This would occur when Prx2 reduction is limited by H2O2 
availability. The iH2O2 that would correspond to such a vinflux, considering kp = 8 s-1,             
eH2O2 = 1.5×10-8 M and kPrx2 = 3.7×104 s-1 (Section 5.1.1.3), would be 
 influx Prx2v v   
 2 2p Prx2 2 2k eH O k ×iH O   Equation 5.48 
                                                 
 
4 In Section 5.1.2 we compared the contributions of Prx2 with those of GPx1 and catalase for H2O2 scavenging by 
considering that each process has pseudo-first order kinetics with respect to H2O2. 
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This value corresponds to the oxidative load under which we may safely assume that the 
erythrocyte’s Prx2/Trx cycles are not saturated with H2O2. It may be higher if catalase/GPx1 or 
other processes are contributing substantially for H2O2 scavenging; or if part of the oxidized Prx2 
in Figure 5.6 (Section 5.2.1.9) is due to unaccounted oxidation of Prx2 during sample preparation. 
To support this estimate we have also computed the load supported by the Prx2/Trx cycles by 
considering that TrxR activity (and Prx2 reduction) is limited by NADPH supply. We have 
already presented evidence that suggests that TrxR is likely limited by NADPH, and not by Trx 
availability, under high oxidative loads (Section 5.2.2). Bearing this in mind, consider that iH2O2 
scavenging by Prx2 is occurring at half the maximal rate of NADPH production by the 
erythrocyte. Under such conditions, Prx2 activity is limited by iH2O2 availability and not by 
NADPH supply. The eH2O2 that would correspond to such rate, considering again kp = 8 s-1 and 
PPP
maxV  = 1.9×10-6 M/s would be 
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Equation 5.49 
Considering again Equation 5.48 and taking eH2O2 = 10-7 M, we find that this would correspond 
to iH2O2 ≈ 2×10-11 M. This value could represent the 2 2( )appmK iH O  of Prx2 if all of the NADPH 
produced in the cell was consumed by TrxR at high eH2O2. Though, because NADPH may be 
distributed between TrxR and GSR under such loads, we cannot assume that 2 2( )
app
mK iH O  of 
Prx2 is 2×10-11 M. 
If these values are the basal iH2O2 found in the erythrocyte they thus represent the oxidative load 
under which Prx2 remains mostly reduced. We now proceed to estimate the fractions of PrxRed 
and TrxRed that would correspond to the iH2O2 estimated above. To do so we considered the 
reaction scheme in Figure 5.12. 
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Figure 5.12 – Representation of reactions used to study the fraction of PrxRed under various iH2O2. 
These reactions led to Model 5.4, whose parameters were estimated in Section 5.2.1: 
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Model 5.4 
In this model, we are disregarding NADPH supply as a possible limiting step for TrxR activity in 
erythrocytes facing higher oxidative loads. However, NADPH might limit Trx reduction, thus 
affecting Prx2 activity. Therefore, this model pertains only to oxidative loads in which the 
NADPH supply can keep up with the demand for reducing equivalents by TrxR and other 
processes. 
Consider kp = 8 s-1 (Section 5.2.1.2Erro! A origem da referência não foi encontrada.), kTrxR = 
0.5 s-1 (Section 5.2.1.9), kPSOH = 0.26 s-1 (Section 5.2.1.10) and other values from Table 5.6 
(Section 5.2.1.9). In steady state conditions, solving Model 5.4 in order to every dependent 
variable allows us to estimate the fractions of PrxRed and TrxRed under various iH2O2. In Table 5.9 
we show the eH2O2 and fractions of PrxRed and TrxRed that would correspond to the basal iH2O2 
estimated above. We also compare them to the iH2O2 estimated by (Giulivi et al., 1994) and 
(Kirkman et al., 1999). These authors respectively estimated 2×10-11 and 3×10-9 M iH2O2 under 
basal oxidative loads, as discussed in Section 5.2.1.3. 
 85 
Table 5.9 – eH2O2 and fractions of PrxRed and TrxRed that would correspond to the basal iH2O2 estimated by us from 
PPP
maxV  
and from the experiments (Low et al., 2007), and iH2O2 estimated by (Giulivi et al., 1994) and (Kirkman et al., 1999). 
eH2O2 computed through Equation 5.48; fractions of PrxRed and TrxRed computed through Model 5.4. Consider Prx2 as the 
main H2O2 scavenger in the erythrocyte; kp = 8 s-1; kPrx2 = 3.7×104 s-1. 
Source iH2O2 (×10-9 M) eH2O2 (×10-6 M) PrxRed (% Prxtot) TrxRed (% Trxtot) 
Estimate using experiments by (Low et al., 2007)  0.003 0.02 >99.8 95.4 
Estimate using 
PPP
maxV  
0.02 0.1 98.9 70 
Estimate by (Giulivi et al., 1994) 0.2 0.9 32 0.97 
Estimate by (Kirkman et al., 1999) 3 10 2 0.67 
According to our estimates, an eH2O2 ≈ 10-7 M (and iH2O2 ≈ 2×10-11 M) is sustained by the 
Prx2/Trx cycles, much lower than the basal loads found by (Giulivi et al., 1994; Kirkman et al., 
1999). We also found that the basal iH2O2 estimated by us allow most of the Prx2 contents to 
completely reduced, unlike what would be obtained if one considered the basal iH2O2 estimated 
by (Giulivi et al., 1994; Kirkman et al., 1999).We also see that the iH2O2 estimated by (Giulivi et 
al., 1994) and (Kirkman et al., 1999) would lead to most of the Trx contents in the erythrocyte to 
be in oxidized form. TrxR would then be constantly consuming NADPH in order to reduce such 
a high (>99% TrxOx) fraction of oxidized Trx. On the other hand, TrxR would achieve a much 
lower rate of NADPH consumption if we considered the iH2O2 we estimated                       
(2×10-11 M or 3×10-11 M). 
Yet, we found that TrxRed would account for 70% of the total Trx contents considering          
iH2O2 = 2×10-11 M as basal oxidative load. Having TrxOx = 30% of the total Trx concentration 
would correspond to a constant NADPH consumption by TrxR of 7.2×10-7 M/s by considering 
kTrxR = 0.5 s-1 (Section 5.2.1.9) and Trxtot = 4.8×10-6 M (Section 5.2.1.6). Although this rate is 
lower than the maximal rate of NADPH supply by the PPP [1.9×10-6 M/s, (Albrecht et al., 
1971)], TrxR would still account for a very significant NADPH consumption. Therefore, the 
basal iH2O2 must be lower than 2×10-11 M. 
Our next analyses will be done by considering steady state conditions. We analyzed not only 
pathological conditions (such as systemic inflammation) but also low H2O2 (iH2O2 « 3×10-12 M 
and eH2O2 « 2×10-8 M) from basal oxidative loads (<9.5×10-7 M iH2O2/s).  
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 How does the redox state of Peroxiredoxin 2 vary with Trx or 5.4.
disulfide bond formation rate constants? 
In the sections above we estimated and discussed the load sustained by the Prx2/Trx cycles, 
assuming that NADPH supply may or may not limit Prx2 reduction (Sections 5.2.2 and 5.3). 
Because Prx2 reduction is affected by the redox status of Trx, it is important to address how the 
Trx cycle affects the redox status of Prx2. Because we had to estimate the rate constant for the 
formation of disulfide Prx2, we will now analyze how this rate constant affects the redox state of 
Prx2. Because we estimated the Trx concentration using data from bovine erythrocytes (Section 
5.2.1.6), in this section we also analyze how Trxtot affects the redox state of Prx2. 
We consider again intracellular H2O2 as an independent variable. As we saw in Section 5.1.2, 
catalase and GPx1 have negligible contributions for H2O2 reduction provided that Prx2 is mostly 
reduced. This simplification is reasonable for eH2O2 < 3×10-12 M as per our estimates in Section 
5.3. With these simplifications we were able to obtain simpler analytical expressions of the 
steady-state of each dependent variable in Figure 5.12 (Section 5.3). 
Considering steady state conditions, we solved Model 5.4 (Section 5.3) in order to every 
dependent variable and obtained their respective steady state values. We considered               
kPSOH = 0.26 s-1 (Section 5.2.1.10), and parameters in Table 5.6 (Section 5.2.1.9). We then 
plotted the fraction of each Prx2 form against various Trx concentrations (Figure 5.13) under 
basal iH2O2 (= 10-12 M, Section 5.2.1.3) 
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Figure 5.13 – Log-log plots of the steady state fraction of PrxRed (red), PSOH (blue) and PSSP (green) for various Trxtot 
(iH2O2 = 10-12 M). The dashed line represents the in vivo concentration ≈ 4.8×10-6 M Trxtot (Section 5.2.1.6). See text above 
for more details. 
The above figure shows that for low Trxtot, practically all Prx2 is in the PSSP form. This is 
expected to happen when the oxidative load is above the capacity of the Trx/TrxR cycle to keep 
reducing Prx2 (i.e. there is not enough Trx to keep reducing Prx2). On the other hand, a larger 
Trxtot allows these cycles to endure larger oxidative loads, leading to the accumulation of 
reduced Prx2. The shift from a “high capacity” system (i.e. PrxRed accumulates) to a “low 
capacity” system (i.e. PSSP accumulates) depends on the oxidative load (iH2O2) and on Trxtot. If 
iH2O2 is very large PSSP accumulates. If Trxtot increases, the maximal oxidative load supported 
by the Prx2/Trx cycles increase as well, allowing a larger TrxRmaxV . 
In Figure 5.14 we plot how PSOH and PrxRed change with Trxtot. This figure shows that, up until 
a certain breakpoint value of Trxtot (which we refer as “crossover” from now on), PSOH and 
PrxRed increase with Trxtot. After the crossover, further increasing Trxtot does not significantly 
change PSOH nor PrxRed. Notice however that PSOH represents <0.1% of the total Prx2 contents, 
a value obtained for larger Trxtot. 
Because the estimate of kPSOH was done by considering a series of assumptions we also analyzed 
how this parameter affects the redox state of Prx2. As Figure 5.14 shows, neither the fractions of 
PrxRed or PSSP are affected by kPSOH. In that figure we plotted the steady state value of the 
fractions of PSSP, PrxRed and PSOH, against various Trxtot and kPSOH. We again considered 
kPSOH = 0.26 s-1 (Section 5.2.1.10), and parameters in Table 5.6 (Section 5.2.1.9). 
PrxRed 
 
 
PSSP 
 
PSOH 
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Figure 5.14 – Log-log plot of the steady state fraction of PSSP and PrxRed (left) or PSOH (right) with Trxtot.                    
kPSOH = 0.026 s-1 (Red), or 0. 26 s-1 (Blue). The dashed line represents the assumed in vivo concentration ≈ 4.8×10-6 M 
Trxtot (Section 5.2.1.6). See text above for more details. 
The figure above shows that decreasing the value of kPSOH does not significantly change the 
fraction of PrxRed nor PSSP (note that the plots for the same Prxi are superimposed for both 
kPSOH). However, decreasing kPSOH increases the fraction of PSOH due to the slower formation of 
disulfide bonds. These results show that Trxtot controls the fraction of oxidized Prx2 for a given 
oxidative load. The fraction of PSOH, but not PrxRed nor PSSP, is affected by kPSOH. 
 What is the concentration of each Prx2 form in limit 5.5.
situations and how does it change with system’s parameters? 
In this section we estimated the fraction of each redox form of Prx2 under low and high 
oxidative loads. We also estimated how each redox form changes with the parameters from the 
model. In this section we describe these estimates. 
5.5.1. Fraction of each Prx2 form under low and high oxidative loads 
Using Model 5.4 (Section 5.3) we computed the fraction of PrxRed, PSOH and PSSP when Trxtot 
tends to be very large (Equation 5.50). The values obtained in the equations below were 
computed after we had obtained the analytical expressions for the steady state concentration of 
each Prx2 form. We again considered kPSOH = 0.26 s-1 (Section 5.2.1.10), iH2O2 = 10-12 M 
(Section 5.2.1.3) and parameters from Table 5.6 (Section 5.2.1.9).  
 
 
PrxRed 
 
 
PSSP PSOH 
     kPSOH = 0.026 s-1                 kPSOH = 0.26 s-1 
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2 2
2 2
lim 0.28 %PrxRed
Trxtot
PrxRed PSOH
k iH OPSOH
Prxtot k iH O k
   Equation 5.50 
The limit in Equation 5.50 shows that when Trxtot increases much, PSOH tends to only depend 
on iH2O2. This happens because the availability of iH2O2 and not of TrxRed affects the rates of 
PrxRed oxidation and PSSP formation.  
In such conditions and as Equation 5.51 shows, PrxRed accumulates: 
 
lim 100 %Red PSOH
Trxtot
PrxRed 2 2 PSOH
Prx k
Prxtot k iH O k
   Equation 5.51 
On the other hand if Trxtot is very little (or if the oxidative load is much larger than the value 
supported by the Prx2/Trx cycles), practically no Prx2 is found in PSOH or PrxRed form because 
PSSP accumulates (Equation 5.52): 
 
0
lim 100 %
Trxtot
PSSP
Prxtot
  Equation 5.52 
For lower Trxtot, the availability of TrxRed limits the oxidation of PrxRed oxidation and PSSP 
formation. 
The limits obtained above are in agreement with the analysis we made in Section 5.1.2 as well as 
what was found through Figure 5.14 (Section 5.4) above. Those limits suggest that Prx2 
accumulates in PSSP form or PrxRed, depending on whether or not the Trx cycle is able to reduce 
Prx2: a very high Trxtot allows a larger rate of Prx2 reduction thus leading to PrxRed 
accumulation; on the other hand, a very low Trxtot leads to accumulation of PSSP. But the redox 
status of Prx2 depends not only on Trxtot but also on the oxidative load that the cell is facing as 
we now show. 
Take into consideration the reaction scheme in Figure 5.15, mathematically expressed through 
Model 5.5. These reactions include the antioxidant activity of Prx2 but also the contributions of 
catalase and GPx1 for iH2O2 consumption. It also includes H2O2 influx across the cellular 
membrane. 
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Figure 5.15– Reaction scheme used to address how various parameters of the system affect the redox status of Prx2. 
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The model above includes the parameters found in Table 5.10. 
Table 5.10 – Parameters used for Model 5.1. Refer to Table 5.6 (Section 5.2.1.9) for values and meaning of parameters 
here referred. 
Parameter Value Meaning/Reference 
kcatalase 218 s-1 Pseudo-first-order rate constant for H2O2 consumption by catalase, Section 5.1.1.2 
kGPx1 40 s-1 Pseudo-first order rate constant for H2O2 consumption by GPx1, Section 5.1.1.1 
kp 8 s-1 
First-order rate constant for hydrogen peroxide consumption by erythrocytes (estimated in 
Section 5.2.1.2) 
kPrxRed 108 M-1s-1 Reactivity between reduced Prx2 and H2O2 (Manta et al., 2009) 
kPSOH 0.26 s-1 First order rate constant for formation of PSSP (Section 5.2.1.10) 
kPSSP 2.1×105 M-1s-1 Reactivity between reduced Trx and PSSP (Manta et al., 2009) 
kTrxR 0.5 s-1 Pseudo-first order rate constant for Trx reduction through TrxR (Section 5.2.1.9) 
Prxtot 3.7×10-4 M Total concentration of Prx2 monomers (Section 5.1.1.3) 
Trxtot 4.8×10-6 M Total Trx concentration (from bovine erythrocytes, 5.2.1.6) 
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Using Model 5.5 we plotted the steady state fraction of PrxRed in cells facing various eH2O2, after 
taking into consideration parameters from Table 5.10: 
 
Figure 5.16 – Fraction of PrxRed in erythrocytes exposed to various eH2O2. Obtained by computing the steady state 
fraction of PrxRed through Model 5.5 and Table 5.10. The dashed line marks eH2O2 = 3×10-7 M. See text below for details. 
The figure above shows the existence of a “crossover”, from oxidative loads in which most of 
the Prx2 contents are in reduced form (“pre-crossover”) to an oxidative load that leads to PSSP 
accumulation (“post-crossover”). The dashed line marks this crossover and corresponds to 
eH2O2= 7×10-7 M. In the next section we study how this value may be obtained analytically and 
how the rate of H2O2 influx and Trxtot affect the redox status of Prx2. 
5.5.2. How H2O2 influx and Prx2 reduction affect the redox status of Prx2 
In this section we will obtain analytical expressions for the redox status of each Prx2 form and 
analyze how each parameter affects its concentration. We approached this issue in a simplified 
way by considering limit cases. 
Under low oxidative loads (eH2O2 < 3×10-12 M, Section 5.3), the contributions of catalase and 
GPx1 for iH2O2 consumption are negligible (Section 5.1.2), and H2O2 consumption by Prx2 
(vPrx2) is limited by the rate of H2O2 influx (vinflux). 
 2 2influx pv k iH O   Equation 5.53 
 2 2Prx2 PrxRed Redv k iH O Prx    Equation 5.54 
Thus, under these oxidative loads vPrx2 = vinflux. Model 5.5 (Section 5.5.1) becomes 
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Model 5.6 
Further, in order to simplify the expressions obtained, we considered vinflux « TrxRmaxv  where 
TrxR
maxv  is 
the maximal rate of Trx reduction by TrxR (= kTrxR×Trxtot). This assumption verifies in 
erythrocytes facing low sustained oxidative loads that allow Trx to remain mostly reduced, i.e. 
<2×10-8 M eH2O2 or <3×10-12 M iH2O2 as per our estimates in Section 5.3.5.3. After taking these 
considerations in mind, we computed the steady state concentrations of each redox form of Prx2: 
 
2 2
1 1( )Red p
PSOH PSSP
Prx Prxtot k eH O
k k Trxtot
      
Equation 5.55 
 
2 2p
PSOH
k eH O
PSOH
k

 
Equation 5.56 
 
2 2p
PSSP
k eH O
PSSP
k Trxtot
   
Equation 5.57 
From the equations above we see that the accumulation of the various Prx2 forms depend on the 
eH2O2 which the erythrocyte is subjected to. Most of the Prx2 contents are in PrxRed (Equation 
5.55) given that eH2O2 is very low. PSOH and PSSP are directly proportional to vinflux, whereas 
PrxRed decreases with vinflux. 
The equations above also show that the accumulation of PrxRed and PSSP depend on the balance 
between vinflux and the pseudo-first order rate constant for Prx2 reduction (=kPSSP×Trxtot given 
that Trx is in reduced form under these oxidative loads). Decreasing Trxtot leads to the 
accumulation of PSSP and decreases the concentration of PrxRed.  
On the other hand, at high eH2O2 the redox status of Prx2 is differently affected by parameters of 
the system. Under these loads the reduction of Prx2 is limited by the rate at which TrxR is 
reducing Trx, thus occurring at a rate equal to the maximum rate of TrxR activity ( max
TrxRv  = 
kTrxR×Trxtot). In addition, catalase and GPx1 have a much larger contribution that Prx2 for iH2O2 
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consumption. Therefore, iH2O2 depends on vinflux and on the rate of iH2O2 consumption by the 
three antioxidants. Model 5.5 (Section 5.5.1) then becomes 
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 Model 5.7 
When the oxidative load surpasses the capacity of the TrxR/Trx to cope with the demand for 
TrxRed (i.e. for eH2O2 » 2×10-8 M or iH2O2 » 3×10-12 M as per estimates in Section 5.3)             
vinflux » . Under these conditions, after taking Model 5.7 into consideration, the steady state 
concentrations of each Prx2 form are given by 
 
2 2
catalase GPx1 TrxR
Red
PrxRed p
k k k TrxtotPrx
k k eH O
     Equation 5.58 
 
TrxR
PSOH
k TrxtotPSOH
k

 
Equation 5.59 
 
2 2
1 catalase GPx1
TrxR
PSOH PrxRed p
k kPSSP Prxtot k Trxtot
k k k eH O
           
Equation 5.60 
Again, these equations show that a balance between vinflux and the rate of Trx reduction affects 
the concentration of each Prx2 form under high eH2O2. Whereas PSSP increases with vinflux, the 
concentration of PrxRed decreases with vinflux. The accumulation of PSSP decreases with catalase 
and/or GPx1 activity, leading to a higher PrxRed. Additionally, maxTrxRv  (=kTrxR×Trxtot) greatly affects 
the concentration of each Prx2 form. Increasing  increases PrxRed and PSOH, and decreases 
PSSP.  
Altogether, these results show that the parameters of the system affect the redox status of Prx2 
differently at low and high oxidative loads. Under low oxidative loads we found that: 1. PSSP 
and PSOH are directly proportional to vinflux, and PrxRed decreases with vinflux; 2. PrxRed increases 
with Trxtot, decreasing the fraction of Prx2 in PSSP form; 3. PSOH is only affected by vinflux and 
kPSOH. On the other hand, at high eH2O2 we have 1. a higher catalase and/or GPx1 activity allows 
max
TrxRv
max
TrxRv
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lower accumulation of PSSP and larger PrxRed concentrations; 2. PSOH is no longer dependent 
on vinflux but now depends on . 
These analyses again show that the redox status of Prx2 depends on the balance between the 
oxidative load and on the ability of the Trx/TrxR cycle to reduce Prx2. As suggested in this 
section, this balance also affects the point at which the crossover occurs. In the next section we 
analyze what variables and parameters determine the eH2O2 at which the crossover occurs. 
 What determines the eH2O2 at which the crossover occurs? 5.6.
For better framing how we obtain an analytical expression for the crossover between Prx2 
oxidation regimes let us first consider how PSOH accumulates with increasing oxidative loads. 
Using Model 5.5 and parameters from Table 5.10 (both from Section 5.5.1), we plotted the 
steady state value of PSOH by considering various eH2O2: 
 
Figure 5.17 – Steady state concentration of PSOH under various oxidative loads. Estimated by considering Model 5.5 and 
parameters from Table 5.10, both found in Section 5.5.1. The dashed line marks eH2O2 = 3×10-7 M. 
The figure above illustrates that at the low oxidative loads regime PSOH increases with 
increasing eH2O2, as evident from Equation 5.56 (Section 5.5.2). In turn, at the high oxidative 
regime PSOH does not change with eH2O2, as expressed by Equation 5.59. The crossover 
between these two regimes is defined as the eH2O2 where the regimes merge together, which can 
be found by equating Equation 5.56 to Equation 5.59: 
 
2 2p TrxR
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k eH O k Trxtot
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Equation 5.61 
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TrxRv
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2 2
TrxR
p
k TrxtoteH O
k
  Equation 5.62 
Taking into consideration the parameters from Table 5.10 (Section 5.5.1) we get                    
eH2O2 ≈ 3×10-7 M, the oxidative load that marked the crossover in Figure 5.16 (Section 5.5.1) 
and Figure 5.17. 
As Equation 5.62 shows, the eH2O2 at which the crossover occurs depends on the rate of Trx 
reduction. TrxR reduces Trx at a maximum rate of kTrxR×Trxtot. If the activity of this enzyme is 
increased, so will the eH2O2 at which the crossover occurs: larger TrxR or Trx concentrations 
allow a higher rate of Trx reduction, shifting the crossover to higher oxidative loads. 
In the analyses above we assumed that NADPH supply does not limit TrxR activity. However, 
we may still draw some conclusions about how NADPH availability affects the eH2O2 at which 
the crossover occurs. A low NADPH/NADP+ is associated with oxidative stress (Gaetani et al., 
1974). Therefore, NADPH availability TrxR activity at high eH2O2, shifting the crossover to 
lower eH2O2. 
Equation 5.62 also allows us to address how eH2O2 affects the separation of the two oxidative 
regimes: a low oxidative regime where Prx2 consumes practically all of the iH2O2; and a high 
oxidative regime where catalase becomes the main scavenger of iH2O2. In Figure 5.18 we plotted 
the relative contributions of Prx2, catalase and GPx1 for H2O2 scavenging under various eH2O2. 
This was obtained by computing the rates of H2O2 consumption by Prx2, catalase and GPx1 
through Model 5.5 (Section 5.5.1) and considering parameters from Table 5.10 (Section 5.5.1). 
 
Figure 5.18 –Relative contribution of Prx2 (green), catalase (red), and GPx1 (blue) for iH2O2 consumption under steady 
state conditions. Obtained through Model 5.5 (Section 5.5.1), considering parameters from Table 5.10 (Section 5.5.1). The 
dashed line corresponds to eH2O2 = 3×10-7 M. 
Catalase 
Prx2 
GPx1 
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Figure 5.18 shows that post-crossover eH2O2 affect the contribution of Prx2 for H2O2 
consumption. As we showed in Section 5.5.1, the contribution of Prx2 for H2O2 consumption is 
affected at high eH2O2 due to the accumulation of PSSP. When PSSP accumulates catalase 
becomes the main scavenger of H2O2. 
Overall, these results show that a balance between Trxtot and eH2O2 must occur for Prx2 to 
remain mostly reduced. Under pre-crossover eH2O2, Prx2 remains the main H2O2 scavenger 
because the Trx/TrxR cycle maintains Prx2 mostly reduced. When the crossover occurs, Prx2’s 
contribution for H2O2 consumption is affected. A higher Trxtot shifts the crossover to higher 
eH2O2 (Equation 5.62), allowing Prx2 to remain the main scavenger for higher eH2O2. Under 
post-crossover loads catalase becomes the main H2O2 scavenger. 
 Is the sulfinylation of Prx2 physiologically relevant? 5.7.
Prx2 is inactivated through sulfinylation of its peroxidatic cysteines. In this process PSOH is 
oxidized by H2O2. If very prevalent, the inactivation of Prx2 may influence the antioxidant 
activity of Prx2. 
In this Section we studied the sulfinylation of Prx2 because 1. it consumes H2O2, thus 
contributing for antioxidant protection; 2. it inactivates Prx2, leading to a state in which this 
protein cannot scavenge H2O2. 
In order to understand if sulfinylation of Prx2 may potentially compete with the formation of 
PSSP for PSOH we need the value of the rate constant for the sulfinylation of Prx2 (kPSO2H). The 
pseudo-first order rate constant for the sulfinylation of Prx2 (=kPSO2H×iH2O2) may then be 
compared with kPSOH. We now explain the considerations we made in order to analyze the 
kinetics of inactivation of Prx2. 
The experiments of (Manta et al., 2009) were previously used to determine kPSOH (Section 
5.2.1.10). We used these again to estimate kPSO2H. As discussed in Section 5.2.1.10, the majority 
of Trx is in reduced form in the conditions considered by the authors. In the same section we also 
showed that the rate of PrxRed oxidation is extremely fast. The limiting step in those conditions is 
the formation of PSOH. Because we want to estimate the rate constant for the sulfinylation of 
Prx2 we used the data from the plot in which the authors initially had considered H2O2=2 mM 
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(Figure 5.9, Section 5.2.1.10). This plot shows a slower NADPH oxidation towards the end of 
the experiment, indicative of sulfinylation of Prx2. Yet, this slowing down is not very 
pronounced, meaning that Trx is still mostly reduced. With this in mind we used the reaction 
scheme in Figure 5.19 and corresponding Model 5.8 for analyzing this experiment. 
 
Figure 5.19 – Reaction scheme used to estimate kPSO2H from the data of (Manta et al., 2009), using Model 5.8. 
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The parameters of this system of equations are the following: 
Table 5.11 – Parameters and initial values considered to estimate kPSO2H from the experiments of (Manta et al., 2009) 
Parameter Value Meaning/Reference 
kR = kPSSP×TrxOx ≈ 1.7 s-1 Rate constant for Prx2 reduction. With kPSSP=2.1×10
5 M-1 s-1 (Table 5.6) and TrxOx = 
Trxtot = 8×10-6 M [experimental conditions of (Manta et al., 2009)]. 
kPSOH 0.26 s-1 Estimated in Section 5.2.1.10. 
PSOH0 43×10-8 M Estimated in Section 5.2.1.10. 
PSSP0 66×10-9 M Estimated in Section 5.2.1.10. 
H2O2 200×10-6 M Experimental conditions of (Manta et al., 2009). 
We wanted to find a function that would follow the NADPH oxidation profile found in the 
experiment (Figure 5.9), with kPSO2H as the only free parameter of the fitting. As we saw in 
Section 5.2.1.10, the system is at a quasi-steady state and the rate of NADPH oxidation is 
approximately equal to the rate of PSSP reduction (Equation 5.64): 
 PSSP PSSP Redv k Trx PSSP    Equation 5.63 
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 PSSP PSSPv k Trxtot PSSP    Equation 5.64 
To find the expression of PSSP[t], we integrated Model 5.8. The expression found was then 
replaced into Equation 5.64, and this equation was then integrated from t=0 to t=τ giving 
NADPH[t], the function that defines the time course of NADPH oxidation. The value of NADPH 
when t=τ is the result of the difference between the initial amount of NADPH                   
(NADPH0= 200×10-6 M) and NADPH[t]. The values of all parameters in the obtained expression 
were available with exception to kPSO2H. We then sought to find the value of kPSO2H that would 
lead to the best fit of this expression to the experimental time points in the plot with the lower 
H2O2 of Figure 5.9 (Section 5.2.1.10). Similarly to what was done in Section 5.2.1.10, the time 
points were converted from absorbance units to NADPH concentration by considering Equation 
5.38 (Section 5.2.1.10). Figure 5.20 represents our fitting to the experimental data. 
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Figure 5.20 – NADPH concentration (M) as determined by (Manta et al., 2009) – dots – and fitting of NADPH[t] 
determined above (see text) – line. kPSO2H=0.23 M-1s-1, H2O2 = 200×10-6 M and parameters from Table 5.11. 
The value which led to the best fit (R2≈0.98) was approximately kPSO2H=0.23 M-1s-1. With this 
rate constant, our fitting correctly followed the kinetics of NADPH reduction by TrxR in the 
conditions of the experiment. However, using the same parameters for higher oxidative loads 
(H2O2 = 10-2 M) gives a poorer fitting: 
Experimental 
Fitting 
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Figure 5.21 – NADPH concentration (M) as determined by (Manta et al., 2009) – dots – and our fitting – line - considering 
kPSO2H=0.23 M-1s-1, H2O2 = 10-2 M and parameters from Table 5.11. 
Despite having a poorer fitting for higher oxidative loads, the lack of data related with the 
sulfinylation of Prx2 led us to use the estimated kPSO2H value. 
For the sulfinylation of Prx2 to compete with the formation of PSSP, the pseudo-first order rate 
constant for the sulfinylation of Prx2 must be similar to the first order rate constant for the 
formation of PSSP: 
 PSO2H 2 2 PSOHk iH O k   Equation 5.65 
Replacing the equation above with kPSO2H=0.23 M-1s-1 and kPSOH=0.26 s-1 (Section 5.2.1.10) 
gives iH2O2≈1.1 M, an implausibly high value which does not occur in vivo. With this estimate 
in mind we may consider that the rate of sulfinylation of Prx2 is negligible compared to the rate 
of PSSP formation. 
(Low et al., 2007) observed that Prx2 is not detectably sulfinylated in human erythrocytes even 
when exposed to higher eH2O2 boluses. Although using the estimated kPSO2H does not allow an 
exact fitting of the experimental data of (Manta et al., 2009) in all iH2O2 considered, the 
estimated rate constant is consistent with the observations of (Low et al., 2007). 
According to the observations of (Low et al., 2007) and to our estimate of kPSO2H, the 
sulfinylation of Prx2 seems to have a negligible effect on the capacity of this protein to reduce 
hydrogen peroxide in the human erythrocyte. 
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 Is Prx2 essential for plasma H2O2 scavenging by 5.8.
erythrocytes? 
Could the accumulation of PSSP affect the ability of the erythrocyte to scavenge plasma H2O2? 
Is the activity of Prx2 as an iH2O2 scavenger essential for erythrocytes to keep consuming 
plasma H2O2? 
In order to address this question we considered the reaction scheme represented in Figure 5.22. 
 
Figure 5.22– Reaction scheme for the analysis of plasma H2O2 consumption by erythrocytes and iH2O2 consumption by 
GPx1, catalase and Prx2. 
The formation and consumption of iH2O2 may be expressed through Equation 5.66 
 2 2
 ( )influx GPx1 catalase Prx2 efflux
id
t
H O
v
d
v v v v     Equation 5.66 
Where the rate of H2O2 influx (vinflux) and the rates of iH2O2 consumption by each process are 
expressed as 
 influx p 2 2v k eH O   Equation 5.67 
 GPx1 GPx1 2 2v k iH O   Equation 5.68 
 catalase catalase 2 2v k iH O   Equation 5.69 
 efflux efflux 2 2v k iH O  , Equation 5.70 
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And the total rate of iH2O2 consumption is given by 
 consumption GPx1 catalase Prx2 effluxv v v v v   
 
Equation 5.71 
In Section 5.3 we found that an eH2O2 «10-7 M (or iH2O2 < 10-11 M) allows most of the Prx2 
contents to remain reduced. If an erythrocyte is facing an oxidative load much higher than this 
value, most of the Prx2 is converted to PSSP form and Prx2 has a negligible contribution for 
H2O2 consumption. Under these conditions Equation 5.71 becomes 
 
2 2 ( )consumption GPx1 catalase effluxv iH O k k k    Equation 5.72 
Considering Equation 5.72, we computed the steady state iH2O2 after solving Equation 5.66 in 
order to iH2O2. This gives 
 p 2 2
2 2
catalase GPx1 efflux
k eH O
iH O
k k k
    Equation 5.73 
What is the relative contribution of each process for H2O2 consumption in erythrocytes facing 
very high oxidative loads? We estimated their relative rate of iH2O2 consumption by computing 
the ratio between its rate of iH2O2 consumption (Equation 5.68 to Equation 5.70) and the total 
rate of iH2O2 consumption (Equation 5.71). Values in Table 5.12 were considered for these 
estimates.  
Table 5.12 – Parameters used for comparison of rates of iH2O2 consumption by catalase and Prx2, at high eH2O2. 
Parameter Value Meaning/Reference 
kp 8 s-1 First-order rate constant for hydrogen peroxide consumption by erythrocytes (estimated in 
Section 5.2.1.2) 
kcatalase 218 s-1 Pseudo-first-order rate constant for H2O2 consumption by catalase (Section 5.1.1.2) 
kGPx1 40 s-1 Pseudo-first-order rate constant for H2O2 consumption by GPx1 (Section 5.1.1.1) 
kefflux 12 s-1 Pseudo-first order rate constant for H2O2 efflux (Estimated in Section 5.2.1.4) 
Considering 10-5 M eH2O2 (which corresponds ≈ 2×10-7 iH2O2), we find that catalase consumes 
practically all of the iH2O2 (Figure 5.23). 
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Figure 5.23 – Relative iH2O2 consumption by catalase, GPx1 and membrane efflux of H2O2 for an eH2O2 = 10-5 M. See the 
text below for details on the estimates. 
The figure above shows that catalase consumes about 80% of the iH2O2, followed by GPx1. The 
efflux of H2O2 has a negligible contribution for the consumption of H2O2,                       
because kefflux « kcatalase+kGPx1. 
Bear in mind that by considering the reaction scheme represented in Figure 5.22 we are assuming 
that H2O2 consumption by catalase and GPx1 are first-order reactions with respect to iH2O2. This 
may be different under high oxidative loads, when poor NADPH availability limits GPx1 activity 
or leads to accumulation of inactive catalase (as discussed in Sections 5.2.1.1 and 5.2.1.2). Under 
these conditions the relative contribution of catalase and GPx1 for iH2O2 consumption would be 
lower than shown in Figure 5.23. However, catalase likely exhibits pseudo-first order kinetics 
with respect to iH2O2: as discussed in Section 5.2.1.1, catalase-associated NADPH oxidation 
occurs at rates much slower than the rate of H2O2 consumption by catalase. 
Could plasma H2O2 scavenging by erythrocytes be impaired when Prx2’s contribution for iH2O2 
consumption is affected? To answer this question we will consider the situation where a limited 
NADPH supply limits Prx2’s and GPx1’s contribution for H2O2 scavenging. Under these 
conditions, only catalase and H2O2 efflux consume iH2O2. The rate of H2O2 consumption 
Equation 5.72 then becomes  
 
2 2 ( )consumption catalase effluxv iH O k k   Equation 5.74 
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For the erythrocyte’s plasma H2O2 consumption to be affected, the rates of H2O2 influx 
(Equation 5.67) and efflux (Equation 5.70) equal each other. This would occur if a limited 
NADPH supply lead to accumulation of inactive catalase, giving kcatalase « kefflux.  
It is very unlikely that catalase inactivation allows kcatalase « kefflux, as we now show. To attain           
kcatalase = 1.2 s-1, a rate constant ten-fold smaller than kefflux (Table 5.12), the concentration of 
catalase would have to be ≈7.5×10-8 M (with kCompoundI = 1.6×107 M-1s-1 as per Table 5.3, Section 
5.2.1.1). This corresponds to ≈98% of inactive catalase if we consider 3.4×10-6 M catalase [as 
determined by (Hartz et al., 1973) in the human erythrocyte]. However, such an extensive 
catalase inactivation is not likely to occur as suggested by the in vitro experiments of (Kirkman 
et al., 1999) with bovine catalase. The authors observed that even in the absence of NADPH, 
>65% of the total catalase contents (=3×10-6 M catalase) were in Ferricatalase or Compound I 
forms even after one hour of incubation with a system generating ≈2.5×10-7 M H2O2/s. Although 
a substantial (<35%) of the catalase contents had been inactivated, this evidence suggests that 
catalase inactivation occurs very slowly, even under high oxidative loads and no added NADPH. 
In the human erythrocyte, this slow rate of catalase inactivation would allow most of the catalase 
to remain active. Also, even if NADPH production by PPP is slow, it may still large enough to 
prevent inactivation of catalase under strong oxidative loads,                       
thus maintaining kcatalase » kefflux. 
If catalase remains mostly active, its activity is limited by the rate of H2O2 influx. Under these 
conditions, H2O2 consumption by catalase surpasses the rate of H2O2 efflux. Thus, erythrocytes 
remain plasma H2O2 sinks even when Prx2’s (and GPx1’s) contribution for H2O2 consumption is 
limited. 
Another possibility for Prx2 to affect plasma H2O2 scavenging by erythrocytes would be if Prx2 
oxidation would affect H2O2 permeation. There is few evidence of membrane association of Prx2 
[<3 % of Prxtot (Moore et al., 1991; Rocha et al., 2009)], but we found no reports of effects of 
Prx2 on the permeability of cellular membranes to H2O2. Possibly, the membrane association of 
Prx2 is related with the relevance of Prx2 for acting as an activator of the Gardos channel, a 
potassium channel (Moore et al., 1991; Moore et al., 1990). 
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Altogether these results show that Prx2 does not affect plasma H2O2 consumption by 
erythrocytes. This process is limited by membrane permeability even when Prx2 is completely 
oxidized. 
 Could Prx2 be replaced by catalase or GPx1? 5.9.
Could erythrocytes rely only on catalase and GPx1 for their protection against H2O2? What 
would have to be the increase in concentration of each of these defenses if they were to replace 
the antioxidant activity of Prx2? And would it be possible to replace catalase or GPx1 by Prx2? 
In this section we analyze these questions and show why the erythrocyte needs Prx2 in spite of 
its high demand for reducing equivalents in comparison to catalase. 
To do so we have considered the reactions represented in Figure 5.24. In it we have iH2O2 being 
consumed by GPx1, catalase and Prx2 (Figure 5.24, left) and being formed at rate φ. If Prx2 was 
not present the only H2O2 defenses would be GPx1 and catalase (Figure 5.24, right). 
                        
Figure 5.24 – Reactions producing and consuming iH2O2 in the normal erythrocyte (left) or in erythrocytes in which Prx2 
is not present (right). k - pseudo-first order rate constants of consumption of iH2O2 by the three antioxidants.                       
k' – pseudo-first order rate constant for iH2O2 consumption by catalase in order to compensate for the absence of Prx2. 
If catalase or GPx1 were to compensate for the absence of Prx2 what would have to be the 
increase in the concentration of each defense in order to maintain the same iH2O2 and response 
time as normal cells? We now analyze this issue by considering that the concentration of 
antioxidant i would have to increase by a factor of εi to compensate for the absence of another 
antioxidant. 
Hemoglobin is the most abundant protein in the human erythrocyte. Because erythrocytes use 
this protein to carry out their main role in the body (transport of oxygen and carbon dioxide) we 
compared the concentrations of antioxidant proteins with that of hemoglobin. With this in mind 
we considered the data in Table 5.13 in order to do the following analyses. 
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Table 5.13 –Pseudo-first order rate constants, molecular weight and concentrations of Prx2, catalase, GPx1 and 
Hemoglobin. All values are per erythrocyte except where stated otherwise.  
Protein Parameter Value Source 
Prx2 
kPrx2 (s-1) 37 000 Estimated in Section 5.1.1.3 
MWPrx2 (Da) 22 000 
Per monomer (Moore and Shriver, 1994; Schroder et al., 
2000) 
Concentration (M) 3.7×10-4 Estimated in Section5.2.1.5 
Catalase 
kcatalase (s-1) 218 Estimated in Section 5.1.1.2 
MWcatalase (Da) 64 000  Per monomer (Bonaventura et al., 1972) 
Concentration (M) 3.4×10-6 (Hartz et al., 1973), with an heme occupancy of 0.4 
GPx1 
kGPx1 (s-1) 40 Estimated in Section 5.1.1.1 
MWGPx1 (Da) 23 000 Per monomer (Awasthi et al., 1975) 
Concentration (M) 9.7×10-7 Estimated in Section 5.1.1.1 
Hemoglobin 
Concentration (g/l packed cells) 340 (Beutler, 1984) 
Concentration (g/l erythrocyte 
water) 486 
Estimated from the concentration determined by (Beutler, 
1984) and 0.7 L erythrocyte water/L erythrocytes (Savitz et 
al., 1964) 
Molecular weight (Da) 64 450 Tetramer weight (Guidotti, 1967) 
Total mass (g) 34×10-12 Estimated using 486 g Hemoglobin/L erythrocyte water and Vew = 7×10-14 L (Table 5.6, Section 5.2.1.9) 
At steady state, the rates of production and consumption of iH2O2 are equal. Considering Figure 
5.24 left gives 
  2 2 GPx1 catalase Prx2iH O k +k +k    Equation 5.75 
 
2 2
GPx1 catalase Prx2
iH O
k + k + k
  Equation 5.76 
If Prx2 was not present we would obtain from Equation 5.75: 
 
' '2 2
GPx1 catalase
iH O
k +k
  Equation 5.77 
Where 'ik  represents the pseudo-first order rate constant for iH2O2 consumption by antioxidant i 
if one of the antioxidants is not present. 
In order for iH2O2 to have the same value with and without Prx2, Equation 5.76 must equal 
Equation 5.77, giving  
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 ' 'GPx1 catalase Prx2 GPx1 catalasek + k + k k + k Equation 5.78 
First we want to assess what would have to be the increase in catalase activity. With this in mind 
consider 'GPx1 GPx1k k , and 'catalasek (= catalase catalasek  ) as the rate constant for catalase activity 
adapted to compensate for the absence of Prx2. catalase  represents the increase in catalase 
concentration required to make catalase to compensate for the absence of Prx2. Taking these 
values into consideration we get from Equation 5.78 that 
 '
catalase catalase Prx2
catalase Prx2
catalase
catalase
k k +k
k +k
k


 
 
 
 
Equation 5.79 
Using the values from Table 5.13 we obtain 171catalase  . Thus the catalase concentration would 
have to increase to ≈6×10-4 M [considering the catalase concentration in normal erythrocytes as 
3.4×10-6 M (Hartz et al., 1973)]. Such a concentration would totalize ≈11×10-12 g catalase 
(considering the molecular mass of tetrameric catalase = 2.56×105 g/mol, Table 5.13; and        
Vew = 7×10-14 L/cell, Table 5.6, Section 5.2.1.9), which represents ≈32 % of the hemoglobin 
contents in the erythrocyte (considering 34×10-12 g of hemoglobin in the cell, as estimated in 
Table 5.13). 
Using a similar reasoning we determined εi for GPx1. This was also done by considering that 
catalase or GPx1 could also be absent (Table 5.14). A 926 fold increase in GPx1 is required to 
compensate Prx2 absence, corresponding to ≈6×10-12 g GPx1 if we consider the values in Table 
5.13 for tetrameric GPx1. 
Table 5.14 – Fold increase ( i ) in the concentration of protein i and % of Hemoglobin concentration after such increase, 
required to maintain the same iH2O2 concentration as in normal erythrocytes. 
 Normal erythrocytes Prx2 absent Catalase absent GPx1 absent 
 % Hemoglobin i  % Hemoglobin i  % Hemoglobin i  % Hemoglobin 
Prx2 1.7 – – 1.006 1.7 1.001 1.7 
Catalase 0.18 171 32 – – 1.2 0.21 
GPx1 0.02 926 18 6.5 0.12 – – 
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The table above shows that much higher εcatalase and εGPx1 would be required to compensate for 
the absence of Prx2, than εPrx2 if any of the two other defenses were absent. Having such increase 
in the concentrations of catalase or GPx1 could impair the main role of the erythrocyte in 
performing gaseous exchanges. A big part of the hemoglobin contents would have to be replaced 
by these enzymes, thus reducing the ability of the cell to transport oxygen or carbon dioxide. The 
erythrocyte could also increase in size in order to have a larger amount of these antioxidants. But 
this could also reduce its mobility within capillaries, whose diameter is approximately that of an 
erythrocyte. 
Although only very small increases in Prx2 concentration would be required to compensate the 
absence of catalase or GPx1, such increase could alter the behavior of the Prx2/Trx cycles when 
erythrocytes face oxidative stress. Increasing Prx2 concentration may lead to a higher rate of 
NADPH oxidation by TrxR. However, the rate of NADPH oxidation would only increase 1.006-
fold at most, considering the values presented in Table 5.14. Also, there would only be a larger 
rate of NADPH oxidation if the concentration of Trx is not limiting the TrxR-mediated 
consumption of NADPH. 
But why is there such a difference in the values of εi of the three proteins? We reason that this is 
due to the specific activity of each antioxidant. This may be computed by the ratio in Equation 
5.80: 
 
specific activity i
i
k
MW
  Equation 5.80 
In which ki and MWi are respectively the pseudo-first order rate constant and molecular weight of 
protein i. Considering the values in Table 5.13 we obtain the following specific activities. 
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Figure 5.25 – Specific activities of Prx2, GPx1 and catalase in human erythrocytes. Estimated through Equation 5.80 and 
Table 5.13. 
The figure above shows that Prx2 has a much higher specific activity than GPx1 or catalase, 
which explains why a much larger amount of catalase or GPx1 would be needed to replace Prx2 
than the amount of Prx2 needed to replace catalase or GPx1. 
Due to the higher specific activity of Prx2 cells can achieve a suitably low iH2O2 with much less 
protein than would be necessary should it have to rely solely on catalase or GPx1. By using Prx2, 
the cell therefore saves on the biosynthetic costs of defense against H2O2, and on the fraction of 
its cytoplasmic contents devoted to defense against H2O2. 
These reasons would explain why the human erythrocyte needs Prx2 in spite of having catalase, 
a defense with much smaller requirement for reducing equivalents. However, the analyses in this 
section did not take into consideration what happens when Prx2 becomes oxidized, 
concomitantly affecting its antioxidant activity. Also, they do not explain why human 
erythrocytes have such a high amount of Prx2, nor why do these cells still need catalase or GPx1 
if they have a defense with such a high specific activity. We will address the issues in the next 
sections of this work.  
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Results Part II                                                                                                                 
Analysis of defenses against H2O2 in erythrocytes 
crossing inflammation sites 
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Some situations such as systemic inflammation of the organism lead to sustained exposure of 
erythrocytes to H2O2, as we studied in the first part of the results. We showed that Prx2 is the 
main defense of the human erythrocyte against H2O2 provided that the oxidative load does not 
surpass the erythrocyte’s capacity to reduce Prx2. However, under less severe pathological 
conditions and under physiological situations, erythrocytes are exposed to pulses of H2O2. In this 
part of the results we focus on what occurs under those circumstances. 
During their flow across the vasculature, erythrocytes may face brief exposure to H2O2. These 
may occur by interaction with monocytes or atherosclerotic lesions for instance. The frequency 
and duration of the exposure to H2O2 depends on the location of the inflammation and type of 
interaction. For large vessels, the exposure to H2O2 from atherosclerotic lesions is likely to be 
very brief due to the large diameter and blood flow rate of the vessels. However, this may not be 
the case while erythrocytes cross smaller blood vessels. Most of the gaseous exchanges are done 
at the capillary level, the blood vessels that have the slowest blood flow rate and smallest 
diameter - practically of the diameter of an erythrocyte (Marieb and Hoehn, 2007). While 
crossing a capillary, erythrocytes are thus very prone to oxidation by nearby inflammation sites.  
Could an erythrocyte be exposed to several inflammation foci in a time period shorter than the 
time scale of Prx2 reduction? If so, PSSP might accumulate over time, decreasing the 
contribution of Prx2 for the defense against H2O2. Below we investigate how these localized 
inflammation sites influence the antioxidant activity of Prx2. But before addressing these issues 
we will review the relevant physiological aspects of the human circulatory system. This will 
allow us to then analyze the properties of the Prx2/Trx cycles in physiological context. 
 Physiological aspects of human circulatory system and 5.10.
estimates for erythrocytes facing pulses of H2O2 
5.10.1. Human blood contents and blood flow velocities 
The average volume of human blood is about 5.5 dm3 in a person weighing about 70 Kg 
(Widmaier et al., 2008). The volume and cellular contents of human blood vary greatly with the 
organism and physiology of the individual. In the analyses below we considered the average 
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cellular contents of human blood (Table 5.15), and hematocrit of 45% (Marieb and Hoehn, 
2007). 
Table 5.15 – Average volume occupied by different cell types in human blood. Adapted from (Widmaier et al., 2008). * 
Consider the erythrocyte volume of 10-13 dm3 (Evans and Fung, 1972), meaning that human blood                               
has about 2.25×1013 erythrocytes. 
 Volume occupiedby each fraction (dm3) 
Erythrocytes 2.25* 
Leukocytes and Platelets 0.05 
Plasma 2.7 
The human heart is responsible for pumping an average 5 dm3 blood per minute in a resting 
individual. Yet, the blood flow is distributed between a very large number of blood vessels. In 
capillaries the blood flow is very slow [≈47×10-5 m/s (Stucker et al., 1996)] which facilitates 
gaseous exchanges in these blood vessels. If we consider the average length of a capillary           
as 1 mm (Marieb and Hoehn, 2007) erythrocytes thus take about 2 seconds to cross a capillary. 
This value is in the range of the erythrocytes’ residence time as determined by various studies. In 
lung capillaries, the transit time is <1 s (Roughton, 1964). In rat muscle, the capillary transit time 
is ≈4 s (Honig et al., 1977) while in hamster muscle it is ≈3 to 4 s (Sarelius, 1986). In our 
analyses below we will consider 2 s as the residence time of an erythrocyte in a capillary. 
Because inflammation induces vasodilation the blood flow rate within a capillary is increased 
[this was first showed in rats through an imaging assay by (Shinkarenko, 1983)] and the 
residence time thus become shorter. Although we have not found values of the transit time in 
inflamed capillaries, a couple determinations done in inflamed venules may give us some insight 
onto the effects of inflammation on the capillary transit time. (Lindner et al., 2000) determined 
the blood flow rates in control (1906×10-6 m/s) and inflamed (1778×10-6 m/s) venules from mice. 
Later they again determined these blood flows in mice and found 2055×10-6 m/s in control 
conditions, as opposed to 2442×10-6 m/s found in inflamed venules (Lindner et al., 2001). These 
blood velocities correspond to ≈7 – 19% increase in the blood flow velocity in inflamed venules. 
If we consider a similar increase in blood flow in capillaries we obtain 50×10-5 to 56×10-5 m/s, 
after considering the blood flow 47×10-5 m/s (Stucker et al., 1996). Under these conditions, 
erythrocytes would take about 1.7 s to cross a 1 mm length capillary. 
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In the subsequent analyses we will consider that an erythrocyte may be exposed to H2O2 while 
crossing a capillary. We believe that this location, rather than other blood vessels, is where this 
cell is potentially more prone to suffer strong oxidative stress for the following two reasons. First, 
the average blood flow rate in arterioles [≈100 mm/s (Marieb and Hoehn, 2007)], venules [≈60 
mm/s (Marieb and Hoehn, 2007)] and larger blood vessels is much higher than the one observed 
in capillaries. In those vessels blood flows across atherosclerotic lesions or other inflammatory 
focus much faster than in the case of capillaries. This makes the duration of exposure to H2O2 
while crossing such foci practically negligible when compared to the exposure when crossing 
capillaries. Second, it is in the capillary that the closest contact between erythrocytes and the 
endothelium occurs. This makes erythrocytes more prone to interact with inflammation focus 
that may exist nearby the endothelium. 
With this in mind, consider that an erythrocyte faces exposure to an extracellular source of H2O2 
(from an inflammation focus) while it is crossing capillaries (≈2 s) in inflammation foci. In the 
next section we estimate the frequency with which erythrocytes cross two consecutive 
inflammation sites. 
5.10.2. Frequency of crossing inflammation sites 
In order to address what happens when erythrocytes face consecutive exposures to H2O2 we need 
a rough estimate of the frequency of such exposure. To do so we estimated the average time 
between successive crossings of inflamed capillaries. 
The number of inflammatory foci as well as their distribution is highly dependent on various 
factors such as type of inflammation foci, immune response, age, and other physiological aspects 
of the individual. For instance, the number of atherosclerotic plaques was shown to vary with age 
and gender (Ben-Haim et al., 2004; Wasselius et al., 2009). So the estimate we show below 
should be taken only as a rough approximation of the frequency of crossing an inflammation site. 
To do such estimate we started by computing the average volume of the human body that is 
occupied by blood. As a rough simplifying assumption we considered that human blood bathes 
all tissues equally. Discarding the total volume occupied by the human skeleton and extracellular 
fluids (such as interstitial fluids and blood plasma) from the total body volume we get the 
approximate volume of tissue bathed by blood. Table 5.16 presents some volumes related with 
this issue and how they were estimated. 
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Table 5.16 – Relevant volumes of the human body. Values for an average body weight of 70 kg and body density of 1 
kg/dm3 (Roche et al., 1996). 
Parameter Meaning Volume (dm3) Notes 
Vtotal Total body volume 70  
Vskeleton Skeleton volume 5.5 
The human skeleton accounts for ≈15 % of the body 
weight (Flindt, 2006). The value of Vskeleton was 
obtained by considering a bone density of 1.9 kg/dm3 
(Cameron et al., 1999). 
Vinterstitial Volume of interstitial fluids 14 
The extracellular cavities are mainly filled with fluids. 
These extracellular fluids represent 14 dm3 of the body 
volume (Guyton, 1984) from which 2.7 dm3 are blood 
plasma [(Widmaier et al., 2008)].  
Vblood cells Total volume of human blood cells 2.3 
Computed from the approximate volume of 
erythrocytes and leukocytes in Table 5.15, Section 
5.10.1 
Vbathed 
Volume of human body that is 
bathed with blood To estimate 
 
Using the data above we get the volume of tissues bathed by blood Vbathed 
 3 48 dmbathed total skeleton interstitial blood cellsV V V V V     Equation 5.81 
This value was then used to compute the average time it takes for the same erythrocyte to pass by 
capillaries in inflamed regions. Consider that a portion of inflamed tissue with volume Vinflammation 
is located in a random part of the body where it is irrigated by blood vessels. Such volume 
exposes the capillaries around it to H2O2. Using this volume and the value of Vbathed estimated 
above, we compute the period T of crossing an inflammation site as 
 h
inflammation
bathed
fT
V
V
  Equation 5.82 
 
 hfT
i
   Equation 5.83 
where fh is the average time taken by the same erythrocyte to pass by the heart twice, Vinflammation 
is the volume of inflamed tissue, Vbathed is the volume of body tissue bathed by blood and i is the 
fraction of the body occupied by inflamed tissue. The following table shows the values 
considered for each of these parameters. 
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Table 5.17 – Parameters used to compute the frequency in which an erythrocyte crosses the same inflamed site. 
Parameter Value Meaning 
fh 60 s Average time taken by the same erythrocyte to pass by the heart twice, in resting conditions 
(Widmaier et al., 2008) 
i  Fraction of body volume occupied by inflamed tissue. 
Vinflammation  Volume of inflamed tissue. 
Vbathed 48 dm3 Volume of body tissue bathed by blood (computed through Equation 5.81) 
Using these values we estimated the time taken to cross an inflammatory site by considering that 
inflamed tissue occupies various fractions of the body volume (i).  
Table 5.18 – Average time (T) it takes for the same erythrocyte to pass by two consecutive inflammatory focus. i is the 
fraction of total body volume occupied by inflamed tissue (%). 
i (%) T 
0.001 1667 h 
0.1 17 h 
1 1.7 h 
10 10 min 
20 5 min 
30 3 min 
50 2 min 
The table above shows that crossing of two consecutive inflammation sites takes many days if 
one considers low volumes of inflamed tissue. An i = 0.001% (that would pertain to inflamed 
tissue with volume 48×10-5 dm3, such as a wound for instance) would require about 1667 hours 
(≈70 days) to be crossed twice by the same erythrocyte. Only when a significant volume of the 
body is occupied by inflamed tissue does T decrease to the minute range. 
Although this is not an exact determination, because of the large branching of the vasculature it 
is very likely that it takes an erythrocyte at least several hours to pass by two consecutive 
inflammatory foci under most plausible conditions. 
5.10.3. Basal intracellular and extracellular values of H2O2 
In Section 5.2.1.3 we discussed the determinations of (Giulivi et al., 1994; Kirkman et al., 1999) 
of the iH2O2 under basal oxidative loads. Again we will consider 10-12 M iH2O2 as the basal 
oxidative load in the erythrocyte, as per our analyses in Sections 5.2.1.3 and 5.3. 
Regarding the basal plasma H2O2 we considered a eH2O2 = 10-8 M. A few lines of evidence 
support this value: 1. The basal oxidative contents of the blood plasma should not be very high or 
 115 
may lead to several hazardous effects on endothelial cells and circulating cells, among other 
processes. 2. Blood plasma also possesses antioxidant defenses (Avissar et al., 1989; Frei et al., 
1988; Jones et al., 1995; Jones et al., 2002; Maddipati et al., 1987; Maddipati and Marnett, 1987; 
Schwertassek et al., 2007). These likely prevent the accumulation of reactive oxygen species to 
levels that may be toxic to cells interacting with the vasculature. 3. As per our estimates (Section 
5.3) values up to ≈10-7 M eH2O2 allow the Prx2/Trx cycles to remain mostly reduced. We 
considered 10-8 M eH2O2 because it allows Prx2/Trx to remain in reduced form and is not very 
far from the values estimated above. 
Although the results that will follow in the next Sections are highly dependent on the oxidative 
load we believe that the same results will occur even if other basal iH2O2 or eH2O2 are 
considered. Even if such loads found in vivo are different from the values we are considering, we 
will still get the same redox response of the Prx2/Trx cycles, given that these proteins should 
remain mostly reduced under basal oxidative conditions [as was showed by (Low et al., 2007), 
human erythrocytes assessed under atmospheric pressure have most of their Prx2 contents in 
reduced form]. 
5.10.4. H2O2 production in pathological conditions and cell tolerance to H2O2 
Much effort has been done in order to determine accurate levels of H2O2 levels in various 
pathological conditions. Leukocytes are one of the sources of H2O2 during inflammation. These 
cells are recruited to inflammatory sites, become activated and produce H2O2 at rates which 
depend on the conditions. Table 5.19 presents some of these values as well as approximated rates 
by single leukocytes (vprod). 
Table 5.19 – H2O2 production by opsonized leukocytes and estimates of H2O2 production per cell. 
Observed production Production            (×10-12 mol/min/cell) Source cell and reference 
0.8×10-9 mol/min/106 cells 8×10-4 Maximal rate by monocytes (Reiss and Roos, 1978)Maximal rate by monocytes (Reiss and Roos, 1978) 
4×10-9 mol/min/106 cells 4×10-3 Maximal rate by neutrophils (Reiss and Roos, 1978)Maximal rate by neutrophils (Reiss and Roos, 1978) 
0.2×10-9 mol/min/2.6×106 cells 8×10-5 Neutrophils and eosinophils, respectively (Kazura et al., 1981)Neutrophils and eosinophils, respectively (Kazura et al., 1981) 
1001×10-9 mol/60 min/107 cells 2×10-3 Maximal rate by monocytes (Nakagawara et al., 1981)Maximal rate by monocytes (Nakagawara et al., 1981) 
15×10-9 mol/30 min/106 cells 5×10-4 Neutrophils (Minczykowski et al., 2001)Neutrophils (Minczykowski et al., 2001) 
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The reports above used different techniques and molecules to stimulate the production of H2O2 
by leukocytes. The values present in Table 5.19 represent reference values and depend on many 
conditions: the degree of leukocyte stimulation with antigen, leukocyte cell volume, type of 
antigen, and so on. 
Leukocytes are also recruited by tumors, remaining in the periphery of the cancerous mass 
(Dvorak, 1986). The production of H2O2 nearby tumors depends on the number of leukocytes 
recruited (Szatrowski and Nathan, 1991). The rate of production of H2O2 by different tumors can 
reach up to 5×10-8 mol/104 cells/hour, comparable to rates by polymorphonuclear neutrophils 
(Szatrowski and Nathan, 1991). 
But could we use such rates by tumors or leukocytes to estimate the H2O2 which erythrocytes are 
exposed to? A few issues prevent a precise estimate.  Leukocyte recruitment in inflammation 
sites depends on a large number of chemokines, cytokines and other molecules (Springer, 1994; 
Worthylake and Burridge, 2001) which also depend on the pathological conditions. This affects 
the number of leukocytes present in those locations and the H2O2 produced by those cells. 
Further, the timeframe considered for the determination of some of the rates in Table 5.19 range 
up to an hour, which does not allow a very precise estimate for lower timescales. 
Other issues preventing this relate with the pathology of the inflammatory focus. For instance, it 
is known that during inflammation many leukocytes interact with (Cohnheim, 1877) and cross 
(Marchesi and Florey, 1960) the endothelium. Therefore, the endothelium may represent a 
barrier between the H2O2 produced within the inflammation focus and the bloodstream, given 
that activated leukocytes do not interact directly with blood plasma. Further, even if the H2O2 
produced by leukocyte would directly flow to the plasma, one would also have to account with 
its dilution in the bloodstream. 
With the above in mind, we chose to focus on the H2O2 production in an inflammatory location 
such as a wound rather than having a precise value for the H2O2 produced by leukocytes alone. A 
study by (Niethammer et al., 2009) used fluorescent methods in order to determine the H2O2 
levels in wound-inflicted zebrafish. The authors report values between 5×10-7 and 5×10-5 M 
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extracellular H2O2 in wound margin cells. These values, although not assessed in mammals, may 
be used as reference H2O2 levels in inflammatory locations. 
But are these loads tolerated by endothelial cells neighboring inflammatory sites? The 
cytotoxicity of H2O2 to endothelial cells was assessed in several in vitro studies. For instance, 
(Ager and Gordon, 1984) observed that a 3×10-4 M , but not 1×10-4 M H2O2 bolus was sufficient 
to induce lysis of pig aortic endothelial cells in cultures (106 cells per well). The authors also 
observed that cell culture (≈104 cells/well) with xanthine oxidase generating 5×10-6 M H2O2/s for 
1 hour did not induce cell lysis. (Harlan et al., 1984) also assessed the lysis of endothelial cells 
using bovine aorta (2-3×106 cells). These authors observed that cell culture did not significantly 
increase cell lysis as assessed 4 hours after cells had been exposed to a 10-5 M H2O2 bolus. These 
reports indicate that endothelial cells in culture can survive exposure to a 10-5 M H2O2 bolus. 
This value is not very far from the H2O2 concentrations determined by (Niethammer et al., 2009) 
in zebra fish, although the latter H2O2 are probably sustained because are being measured close 
to inflammation sites. 
As a comparison we may look at similar analyses done in human erythrocytes. (Masuoka et al., 
2006) observed that erythrocytes (2% hematocrit) exposed to a 10-4 M H2O2 bolus would not 
present significant hemolysis, 5 and 30 minutes after cells had been exposed to H2O2. 
(Nascimento et al., 2010) also addressed this issue and found that erythrocytes (2% hematocrit) 
would not undergo hemolysis even when incubated with a 10-3 M H2O2 bolus, as assessed 4 
hours after incubation with H2O2. These values are 10 to 100 fold smaller than the values 
obtained by (Ager and Gordon, 1984) and (Harlan et al., 1984).  
The studies above suggest that erythrocytes and endothelial cells survive oxidative loads in the 
range of the strongest determined near inflammation sites of other organisms (Niethammer et al., 
2009). However, the conditions which the endothelium and erythrocytes are subject in vivo 
differs greatly from the well-controlled conditions in which cells are grown or assessed, nutrient- 
and physiologically-wise. Such differences may be crucial for cell survival upon oxidative stress. 
Due to these uncertainties and to the unclear conditions in which the experiments performed 
above were done, we considered several orders of magnitude for the H2O2 that erythrocytes face                       
up to 10-5 M eH2O2. 
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 How do different eH2O2 pulses affect the redox state of 5.11.
Prx2? 
We estimated in Section 5.10.1 that the exposure of erythrocytes to H2O2 lasts about 2 s if such 
exposure happens while crossing capillaries. In this section we study how different eH2O2 affect 
the redox state of Prx2 when erythrocytes pass by such inflammatory sites. 
We used Model 5.9 (represented in Figure 5.26 and based on Model 5.4, Section 5.3) to analyze 
the redox state of Prx2 when erythrocytes face H2O2 pulses with various intensities.  
 
Figure 5.26– Reaction scheme considered to analyze how different eH2O2 affect the redox state of Prx2 at the end of a 
pulse. 
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The model above includes the parameters found in Table 5.20. 
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Table 5.20 – Parameters used for Model 5.9.  
Parameter Value Meaning/Reference 
kp 8 s-1 
First-order rate constant for hydrogen peroxide consumption by erythrocytes (estimated in 
Section 5.2.1.2) 
kcatalase 218 s-1 Pseudo-first order rate constant for H2O2 consumption by catalase (Section 5.1.1.2)   
kGPx1 40 s-1  Pseudo-first order rate constant for H2O2 consumption by GPx1 (Section 5.1.1.1) 
kPrxRed 108 M-1s-1 Reactivity between reduced Prx2 and H2O2 (Manta et al., 2009) 
kPSOH 0.26 s-1 First order rate constant for formation of PSSP (Section 5.2.1.10) 
kPSSP 2.1×105 M-1s-1 Reactivity between reduced Trx and PSSP (Manta et al., 2009) 
kTrxR 0.5 s-1 Pseudo-first order rate constant for Trx reduction through TrxR (Section 5.2.1.9) 
Prxtot 3.7×10-4 M Total concentration of Prx2 monomers (Section 5.1.1.3) 
Trxtot 4.8×10-6 M Total Trx concentration (from bovine erythrocytes, 5.2.1.6) 
We considered that both Prx2 and Trx are fully reduced before crossing a capillary that passes by 
an inflammatory focus. This approaches what happens when erythrocytes are facing basal 
oxidative conditions (Sections 5.3 and 5.5). We also considered that the contributions of catalase 
and GPx1 for H2O2 scavenging have first order kinetics with respect to H2O2, an assumption 
discussed in Sections 5.2.1.1 and 5.2.1.2. The initial value of iH2O2 was 10-12 M as per our 
analysis in Sections 5.2.1.3 and 5.3. 
Bearing these considerations in mind we evaluated what is the minimum fraction of PrxRed at the 
end of a 2 s eH2O2 pulse. This was done through numerical integration of Model 5.9 and 
determination of the fraction of reduced Prx2 when t = 2 s, considering parameters from Table 
5.20. Figure 5.27 represents the minimum fraction of PrxRed obtained for various eH2O2 pulses. 
 
Figure 5.27 – Minimum fraction of PrxRed obtained after an eH2O2 pulse (2 s), for H2O2 pulses with various eH2O2. The 
dashed line represents the load in which less than 1% of the Prx2 contents are in PrxRed form (eH2O2 = 2.5×10-5 M). 
Obtained by computing the fraction of PrxRed after an eH2O2 pulse of 2 s, through Model 5.9 and Table 5.20. 
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The figure above shows that only pulses stronger than ≈2.5×10-5 M eH2O2 lead to full PrxRed 
depletion (the dashed line in Figure 5.27 shows the eH2O2 in which < 1% of Prx2 in PrxRed form). 
This eH2O2 would correspond to ≈7×10-6 M iH2O2 at the end of the pulse. 
Such high eH2O2 is conceivable in inflammatory foci such as wounds, but likely approach the 
maximum oxidative conditions tolerated by nearby cells (see Section 5.10.4 for values of H2O2 
nearby wounds and a values tolerated by endothelial cells). This suggests that the high Prx2 
concentration in the cell is sufficient to protect erythrocytes against high oxidative loads found 
nearby inflammation sites during the estimated 2 s residence time. 
 What is the role of catalase in defense against                 5.12.
eH2O2 pulses? 
In the section above we saw that only very high eH2O2 pulses lead to full Prx2 oxidation. As we 
showed in the first part of our results, when Prx2 accumulates in PSSP form catalase becomes 
the main H2O2 defense (Section 5.6). In this section we further explore the role of catalase in the 
defense against H2O2 by addressing its contribution for H2O2 consumption when erythrocytes 
face eH2O2 pulses. 
Using Model 5.9 and parameters from Table 5.20 (Section 5.11) we computed the relative 
contribution of Prx2 and catalase for H2O2 consumption: 
 relative Prx2 contribution Prx2
H2O2
v=
v
 Equation 5.84 
 relative catalase contribution catalase
H2O2
v=
v Equation 5.85 
Where vPrx2 and vcatalase are the rates of iH2O2 consumption by Prx2 and catalase and vH2O2 is the 
total rate of iH2O2 consumption: 
 Prx2 PrxRed 2 2 Redv k iH O Prx    Equation 5.86 
 catalase catalase 2 2v k iH O   Equation 5.87 
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  H2O2 2 2 PrxRed Red catalase GPx1v iH O k Prx k k     Equation 5.88 
Considering 10-8 M eH2O2 before and after the pulse, and 10-12 M iH2O2 before the pulse, we 
estimated the relative contribution of Prx2 and catalase for iH2O2 consumption through the 
equations above.  
During a 3×10-5 M eH2O2 pulse the contribution of Prx2 for H2O2 consumption becomes 
practically null due to complete Prx2 oxidation (Section 5.11). When this occurs catalase 
becomes the main H2O2 scavenger (Figure 5.28): 
 
Figure 5.28 - Relative contribution of Prx2 and catalase for H2O2 consumption during a 2 s pulse (gray area) of 3×10-5 M 
eH2O2. Estimated using Model 5.9 and parameters from Table 5.20 (Section 5.11). 
Prx2 becomes again the main H2O2 scavenger after the pulse as it is regenerated (Section . But 
what is the importance of catalase for the defense against iH2O2 and under which conditions is it 
more important? 
To address this issue we estimated the iH2O2 at the end of various eH2O2 pulses, in the presence 
and absence of catalase, by considering again Model 5.9 and parameters from Table 5.20 
(Section 5.11): 
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Figure 5.29 – iH2O2 found at the end of a 2 s pulse of various eH2O2 concentrations, in the presence (black) and absence 
(red) of catalase.Estimated considering Model 5.9 and the parameter values in Table 5.20 (Section 5.11). The dashed line 
refers to eH2O2 = 2.5×10-5, a eH2O2 pulse that at the end of which <1 % of the Prx2 is in reduced form. 
The figure above shows that a low iH2O2 is maintained at the end of a pulse for <2.5×10-5 M 
eH2O2 pulses, regardless of catalase presence. This occurs because Prx2 consumes most of the 
iH2O2 under such oxidative loads. 
However, the situation is different when the erythrocyte is subjected to higher eH2O2 pulses. 
There is a much higher accumulation of iH2O2 in the absence of catalase than in its presence for 
pulses >2.5×10-5 M eH2O2. Under such loads most of the Prx2 contents are in PSSP form 
(Section 5.11). This makes catalase essential to maintain a low iH2O2 under those conditions. 
These results show that catalase becomes the main antioxidant defense against H2O2 when the 
cell crosses inflammation sites that lead to full Prx2 oxidation. Under such conditions, catalase is 
important to maintain a low iH2O2. 
 Could there be accumulation of PSSP due to consecutive 5.13.
crossing of inflammatory sites? 
How long would it take for Prx2 to be reduced back after facing such intense oxidative stress? Is 
it plausible that an erythrocyte may cross consecutive oxidative pulses before there is time for 
Prx2 to be fully reduced? If so, this could impair the antioxidant ability of Prx2. To answer these 
questions we used Model 5.9 and Table 5.20 (both from Section 5.11) and considered that the 
antioxidant activity of catalase and GPx1 is not impaired by the oxidative insult (we addressed 
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under which conditions this is plausible in Section 5.2.1.1 and 5.2.1.2). Because we want to 
analyze how long it takes for Prx2 to be fully reduced we considered that initially all Prx2 and 
Trx are oxidized. This was done because Trx reduction limits Prx2 reduction when erythrocytes 
face high oxidative loads, as discussed in Section 5.2.2. As for the oxidative conditions, we 
considered that the cell is facing basal eH2O2 (10-8 M, Section 5.10.3). This simulates what 
occurs right after an erythrocyte crosses an inflammation site. 
The iH2O2 at the end of such a pulse is expected to be higher than the basal concentration (which 
was considered as 10-12 M iH2O2). However, the value of iH2O2 at the end of a pulse also 
depends on the eH2O2 the erythrocyte is subjected to while crossing an inflammation site. For 
this reason we considered that iH2O2 is initially 7×10-7 M, which would correspond to a              
25×10-6 M eH2O2 pulse, as estimated in Section 5.11. Although lower iH2O2 may be found in 
vivo, considering other initial iH2O2 does not change greatly the time taken to reduce Prx2: even 
if we only consider the antioxidant activities of catalase and GPx1 (Section 5.1.2), the half-life of 
iH2O2 is 
 
1/2 2 2
ln(2)( ) 3 ms
GPx1 catalase
t H O
k +k
  Equation 5.89 
Were GPx1 activity impaired due to a low NADPH availability and catalase the only active 
antioxidant we would still get a similar t1/2(H2O2). Due to such small t1/2(H2O2), changing the 
initial value of iH2O2 practically does not affect our estimate of the time taken to reduce Prx2. 
After taking the above into consideration, we numerically integrated Model 5.9 and solved it in 
order to every dependent variable. Figure 5.30 represents the fraction of Prxred over time. 
 
Figure 5.30 – Fraction of Prxred over time (s) using Model 5.9 and the parameter values in Table 5.20 (Section 5.11). See 
the text above for assumptions. The dashed line marks 3 minutes. 
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The figure above shows that it takes less than 3 minutes for Prx2 to be fully reduced back to 
PrxRed. This represents a limit situation for the oxidative conditions considered. The initial eH2O2 
and iH2O2 considered (taken from our analysis in Section 5.11) represent oxidative loads close to 
maximum values found in vivo in pathological conditions (see Section 5.10.4 for a discussion of 
these values). Because of this, an inflammatory focus that does not lead to full oxidation of Prx2 
also allows Prx2 to be fully reduced back to PrxRed even faster than above. However, we 
acknowledge that the time taken to fully reduce Prx2 may differ from the above estimate. Prx2 
reduction depends on other factors besides the intensity of the pulse. It is mostly limited by Trx 
reduction as discussed in Sections 5.2.2 and 5.3. Different Trxtot values or limiting NADPH 
levels would affect the rate of Prx2 reduction. In this analysis we are still considering that 
NADPH availability is not limiting TrxR activity, which may not be the case in erythrocytes 
facing higher oxidative loads. 
Could an erythrocyte cross more than one inflammatory focus in less than 3 minutes, hence 
leading to the cumulative oxidation of Prx2? We addressed the time taken to interact with two 
consecutive inflammatory foci in Section 5.10.2. Taking into consideration our estimates of the 
time required for Prx2 to be fully reduced back (<3 minutes), what would the volume fraction of 
inflammed tissue (i) (Table 5.17, Section 5.10.2) have to be so that the mean period between 
consecutive crossings of inflammation sites became less than 3 minutes? As per our estimates 
(Table 5.17, Section 5.10.2), i would have to be at least 30%. 
The number and size of inflammatory foci in the body is highly dependent on the individual and 
the pathological conditions found in the body. Various diseases may lead to extensive 
inflammation in the body, such as bacterial infection, vasculitis, and metastatic cancer. Under 
severe cases of these pathologies, it is possible that the total volume of inflamed permits for 
frequent crossing of multiple inflamed foci: (Wasselius et al., 2009) observed that a few hundred 
atherosclerotic plaques are present in the aorta of asymptomatic individuals over 60 years old. 
Nevertheless, values of i as high as 30% are only plausible under severe cases of bacterial 
infection like cellulitis or erysipelas for instance. On the other hand, localized inflammatory sites 
may occur in less pathological conditions. It is the case of wound healing or localized pathogen 
infection. These occur constantly throughout the body and are fought by our immune system. 
Because these are usually very localized inflammatory regions, the frequency of crossing such 
sites is very low.   
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To this extent, it very likely that in between crossing two inflammatory foci there is enough time 
for the complete reduction of Prx2. Taken together, these results show that the erythrocyte is 
likely able to fully reduce Prx2 between two consecutive oxidative pulses, in most physiological 
conditions. 
 Why is Prx2 so abundant in the human erythrocyte? 5.14.
As we saw above, Prx2 has the highest contribution for H2O2 consumption among the main H2O2 
scavengers in the human erythrocyte. The results in Section 5.11 show that only very strong 
oxidative pulses lead to full Prx2 oxidation. When Prx2 accumulates in PSSP form its 
contribution for defense against H2O2 decreases. Under these conditions catalase becomes the 
main H2O2 scavenger, maintaining a low iH2O2. But then why is Prx2 one of the most abundant 
proteins in the human erythrocyte? 
The results in Section 5.11 indicate that Prx2 is present in human erythrocytes at approximately 
the concentration that is necessary to protect them during the residence time in capillaries against 
pulses <2.5×10-5 M eH2O2, in the range of the strongest oxidative loads (5×10-5 M H2O2) found 
by (Niethammer et al., 2009) in inflammation foci in other organisms. This result suggests that 
the selective pressure that mediates the evolutionary maintenance of such high Prx2 
concentrations is the need to avoid a large iH2O2 accumulation as erythrocytes cross capillaries 
that are located within inflammation foci. 
To further investigate the extent of protection conferred by Prx2 in these circumstances we 
proceeded as follows. Assuming that H2O2-induced damage (D) accumulates over time and is 
proportional to iH2O2 we can write: 
 D 2 2
dD k iH O
dt
 
,
 Equation 5.90 
where kD is a proportionality constant for the damaging effects of iH2O2 to the cell. This constant 
must be much lower than 1 or D would accumulate greatly overtime. During eH2O2 pulses there 
is higher iH2O2, which leads to higher damage (Dp). In order to estimate the Dp that would be 
accumulated at the end of an eH2O2 pulse in presence or absence of Prx2 we added Equation 
 126 
5.90 to Model 5.9 (Section 5.11), and integrated this extended model using the parameter values 
from Table 5.20 (Section 5.11). Because we are only interested in addressing the influence of 
Prx2 on the value of D, not on the physiological accurate value of D, we assumed kD = 1 
(Equation 5.90). We considered that by the beginning of a pulse, Prx2 and Trx are fully reduced. 
The initial value of iH2O2 considered was 10-12 M and the basal eH2O2 = 10-8 M. We then plotted 
Dp at the end of an eH2O2 pulse, in presence and in absence of Prx2 (Figure 5.31). 
 
Figure 5.31 – Accumulated damage at the end of 2 s eH2O2 pulses of various intensities, in the presence (black) or absence 
(red) of Prx2. The dashed line represents the eH2O2 pulse at the end of which <1 % of the total Prx2 contents is in PrxRed 
form (Section 5.11).  
The results shows that Dp accumulates much more in the absence of Prx2 than in the presence of 
physiological concentrations of this protein.  
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6. Discussion  
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In this work we analyzed the role of the main antioxidant systems of the human erythrocyte to 
defend this cell against H2O2: glutathione peroxidase 1, catalase, and peroxiredoxin 2. It was 
previously suggested that GPx1 is mainly used to protect this cell from organic peroxides 
(Gaetani et al., 1996; Johnson et al., 2002), casting out a distinct role for catalase and Prx2: 
catalase protects erythrocytes from high H2O2 concentrations (Gaetani et al., 1996; Johnson et al., 
2000; Mueller et al., 1997a) whereas Prx2 protects only against low H2O2 (Low et al., 2007). As 
hypothesized by (Low et al., 2007) this may be related with the different requirements that these 
two systems have for reducing equivalents. Whereas H2O2 scavenging by Prx2 is 
stoichiometrically coupled to NADPH oxidation, H2O2 consumption by catalase practically does 
not entail NADPH oxidation. Then why do these cells need Prx2? Why do not human 
erythrocytes rely only on catalase for their defense against H2O2? Is Prx2 redundant in the 
protection of these cells from H2O2? 
We used kinetic analyses and mathematical modeling to answer these questions. In this section 
we discuss the results that allowed us to answer these questions, addressing a few improvements 
and analyses that may further develop this work. We then discuss the relevance of this work for 
various areas of research. We will start by addressing our analyses of the redox behavior of 
Prx2/TrxR/Trx cycles when erythrocytes are under sustained exposure to basal and high eH2O2. 
This allows us to examine what occurs when the organism is under systemic inflammation. 
 Prx2 is the main scavenger of low/mild H2O2 6.1.
We started our analyses by estimating the pseudo-first order rate constants for H2O2 consumption. 
Due to the very high Prx2 concentration (≈3.7×10-4 M, Section 5.1.1.3) and reactivity with H2O2 
[≈108 M-1s-1 (Manta et al., 2009)], we estimate a kPrx2 = 37 000 s-1 as the pseudo-first order rate 
constant for Prx2-mediated H2O2 reduction (Section 5.1.1.3). This rate constant largely surpasses 
the rate constant of GPx1 (=40s-1, Section 5.1.1.1) and catalase (=218s-1, Section 5.1.1.2). Prx2 
consumes >99% when the erythrocyte faces oxidative loads up to 9.5×10-7 M H2O2/s (Sections 
5.1.2, 5.3 and 5.6). These differences suggest that Prx2 has a potentially very high contribution 
for the defense against H2O2. 
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Yet, (Low et al., 2007) observed that Prx2 is extremely sensitive to oxidation by H2O2. Based on 
the accumulation of oxidized Prx2 and low turnover of Prx2, the authors suggested that this 
protein scavenges only low H2O2 levels. In agreement with these observations, (Johnson et al., 
2010) later observed that Prx2 is important for controlling endogenously produced H2O2. These 
observations suggested that Prx2 is important for controlling iH2O2 only under basal oxidative 
loads. We will now discuss these and other observations, and their relation with our estimates.  
6.1.1. Basal concentration and production of H2O2 
To estimate the basal endogenous production of iH2O2 we considered that all Prx2 is reduced 
under basal oxidative loads, thus accounting for most of the iH2O2 consumption. This estimate 
was carried out through two approaches (Section 5.3): 1. we estimated the rate of Prx2 reduction 
(=2.3×10-7 M/s) after accumulation of PSSP from the data of (Low et al., 2007) (Figure 5.6, 
Section 5.2.1.9). From this rate we get that <1.2×10-7 M H2O2/s is sufficient for >99% of the 
Prx2 contents to remain in reduced form; 2. considering the maximal rate of NADPH production 
by the PPP and assuming that NADPH supply limits Prx2 reduction, we estimate that a load 
<9.5×10-7 M H2O2/s allows ≈99% of the Prx2 to be reduced, thus consuming most of the iH2O2. 
These two independent estimates yielded very close estimates for the basal oxidative loads, 
which further reinforces the confidence in these estimates. 
As discussed in Section 5.2.1.3, (Kirkman et al., 1999) and (Giulivi et al., 1994) determined the 
rates of H2O2 production under atmospheric O2 pressure and glucose depletion. They 
respectively determined ≈3.3×10-8 M H2O2/s and ≈4×10-10 M H2O2/s. What would be 
physiologically more plausible: to consider the fluxes determined by (Giulivi et al., 1994; 
Kirkman et al., 1999) as the basal oxidative load in vivo, or the author’s estimate of steady state 
H2O2? 
The rates of H2O2 production determined by (Kirkman et al., 1999) and (Giulivi et al., 1994) 
correspond to the rates at which NADPH is oxidized under basal loads if Prx2 is the main 
scavenger of iH2O2. These rates are >55 fold lower than the maximal rate of NADPH production 
by the PPP [ PPPmaxV =1.9×10
-6 M, (Albrecht et al., 1971)]. On the other hand, the authors’ estimate 
of 2×10-10 M and 3×10-9 M iH2O2 would correspond to a Prx2 activity of 7.4×10-6 M/s and       
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10-4 M/s, respectively. These rates are much higher than PPPmaxV , and thus are not physiologically 
plausible. 
While the experiments of (Kirkman et al., 1999) and (Giulivi et al., 1994) aimed to determine 
basal oxidative loads experimentally, others aimed to estimate the steady state iH2O2 under basal 
oxidative loads through kinetic modeling (Johnson et al., 2005; Johnson et al., 2010). Using a 
kinetic model that includes the antioxidant activities of catalase and Prx2, and endogenous 
production of iH2O2 from Hb autoxidation, (Johnson et al., 2005) and (Johnson et al., 2010) 
respectively estimated steady state iH2O2 = 5.2×10-11 and 2.6×10-10 M. These iH2O2 surpass our 
estimate of the basal iH2O2 (=10-14 M) by several orders of magnitude, which may be explained 
by the following two reasons. 
First, in their models (Johnson et al., 2005; Johnson et al., 2010) considered a pseudo-first order 
rate constant for H2O2 reduction by Prx2 of kPrx2= 24 s-1. To estimate this rate constant the 
authors considered a Prxtot = 2.4×10-4 M [≈1.5-fold lower than the 3.7×10-4 M Prxtot considered 
in this work, Section 5.1.1.3). Although their source reference for this concentration was the 
same as ours (Moore et al., 1991), it is not clear what was the molecular weight or volume of 
erythrocyte water considered to estimate a 2.4×10-3 M Prxtot. Second, to estimate kPrx2 = 24 s-1 
(Johnson et al., 2010) considered 105 M-1 s-1 as the reactivity between Prx2 and H2O2. However, 
this reactivity was determined from microbial peroxiredoxins (Hofmann et al., 2002), and more 
recent experiments found several fold higher reactivities between human peroxiredoxin 2 and 
H2O2 [=107 - 108 M-1 s-1, (Manta et al., 2009; Peskin et al., 2007)]. Thus, the kPrx2 considered in 
the experiments of (Johnson et al., 2005; Johnson et al., 2010) underestimates the contribution of 
Prx2 for iH2O2 consumption. 
As per our estimates (Section 5.2.1.3), a 3.7×10-8 M iH2O2/s is a physiologically plausible 
oxidative load because it would entail a rate of NADPH oxidation much smaller than the 
maximal rate of NADPH production by the PPP [=1.9×10-6, (Albrecht et al., 1971)]. To our 
knowledge, these basal oxidative loads are the first estimates that consider the high contribution 
that Prx2 has for H2O2 scavenging under basal oxidative loads. 
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6.1.2. Redox status of Prx2 under basal oxidative loads 
To estimate the basal oxidative loads above we considered that Prx2 is fully reduced under such 
conditions. However, the experiments of (Low et al., 2007) suggest that a substantial (40%) 
fraction of Prx2 could be in PSSP form in erythrocytes not subjected to exogenous H2O2. Could 
the 2×10-10 M iH2O2 determined by (Kirkman et al., 1999) be physiologically plausible if we 
consider 40% PSSP under basal oxidative loads? 
(Low et al., 2007) assessed the redox status of Prx2 from human erythrocytes                       
(≈0.05% hematocrit) ten minutes after incubation with 5×10-3 M glucose. Considering 60% of 
Prx2 in PrxRed form, we estimate a pseudo-first order rate constant for H2O2 consumption by 
Prx2 of 0.6×kPrx2 ≈ 22 000 s-1 (with kPrx2 = 37 000 s-1, Section 5.1.1.3). This rate constant largely 
surpasses those of catalase or GPx1 (kcatalase =218 s-1, Section 5.1.1.2; kGPx1 = 40 s-1, Section 
5.1.1.1), showing that Prx2 still consumes most of the iH2O2 under these conditions. Considering 
2×10-10 M iH2O2 (Kirkman et al., 1999) and kPrx2 = 22 000 s-1, we estimate the rate of Prx2-
mediated H2O2 reduction: 
 Prx2 Prx2 2 2v k iH O   Equation 6.1 
 64.4 10  M/sPrx2v
     
Because this rate surpasses the maximum rate of NADPH production by the PPP [=1.9×10-6, 
(Albrecht et al., 1971)], the 2×10-10 M iH2O2 estimated by (Kirkman et al., 1999) is implausibly 
high under basal oxidative loads even if one considers 40% PSSP. 
Could endogenous H2O2 production account for the large fraction of PSSP found by (Low et al., 
2007) under atmospheric partial O2 pressure (pO2 = 160 torr)? As our estimates in Section 2.1.3 
suggest, the contribution of Hb autoxidation for H2O2 production (<4.9×10-9 M H2O2/s) is lower 
than that coming from GSH autoxidation (<48×10-9 M H2O2/s), considering pO2 (=90 torr) from 
venous blood. This suggests that GSH autoxidation is the main process of endogenous 
production of H2O2. We estimated the endogenous H2O2 production from GSH autoxidation 
under atmospheric partial O2 pressure as follows. 
Glutathione reacts with O2 (Reaction 2.2, Section 2.1.1) with a kspon = 0.1 M-1s-1 (Scarpa et al., 
1996). Considering atmospheric partial O2 pressure [1 atm, 1.3×10-3 M O2/atm (Wilhelm et al., 
1977)] and total glutathione contents in the erythrocyte [GSH = GStot = 3.2×10-3 M (Thorburn 
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and Kuchel, 1987)], we get a rate of 4.2×10-7 M H2O2/s produced from glutathione oxidation. 
This endogenous production of H2O2 yields >99% of reduced Prx2 (as estimated through Model 
5.9 from Section 5.11 after considering no eH2O2, and parameters from Table 5.20, Section 5.11). 
Therefore, the large accumulation of PSSP found by (Low et al., 2007) in erythrocytes subjected 
to no exogenous H2O2 is not due to endogenous production of H2O2 from glutathione 
autoxidation even under atmospheric pO2. This is further supported by our estimates in Section 
5.2.1.8 where we estimate that endogenous production of >2×10-6 M H2O2/s would be required 
to obtain the eH2O2 = 10-7 M observed towards the end of the experiment of (Low et al., 2007) 
(Figure 5.5, Section 5.2.1.8). An endogenous production of 2×10-6 M H2O2/s is implausibly high 
because it surpasses the maximal rate of NADPH production in human erythrocytes [=1.9×10-6 
M/s (Albrecht et al., 1971)]. 
These estimates suggest that a substantial fraction of Prx2 is oxidized during sample handling in 
the experiments (Low et al., 2007), as acknowledged by the authors. Furthermore, pretreatment 
of erythrocytes with a thiol-blocking agent allowed (Low et al., 2007) to observe only a small 
fraction of PSSP in cells exposed to no H2O2. Overcoming the issue of uncontrolled oxidative 
stress during sample handling is a difficult task, given the large reactivity of Prx2 with H2O2. A 
possible way to avoid such uncontrolled oxidation would be to perform those experiments in a 
Argon-rich anaerobic atmosphere. While performing those experiments one should also take 
special care to prevent leukocyte activation. 
6.1.3. Prx2 contributes significantly for H2O2 consumption under low/mild loads 
More than ≈99% of the iH2O2 is consumed by Prx2 under oxidative loads <9.5×10-7 M H2O2/s 
that allow most of Prx2 to remain reduced (Sections 5.1.2 and 5.3). 
Other studies also assessed the relevance of Prx2 for the redox status of the cell. Based on their 
studies, (Johnson et al., 2005; Johnson et al., 2010; Low et al., 2007) refer that Prx2 is a 
scavenger of low H2O2. We will now discuss the experiments of these authors. 
(Johnson et al., 2005) determined the rate of endogenously produced H2O2 in GPx1-knockout 
mice erythrocytes (5% hematocrit) by determining catalase activity through the method of (Aebi, 
1984), as explained in Section 5.2.1.3. Using a kinetic model that included the H2O2-scavenging 
activity of catalase and GPx1, (Johnson et al., 2005) then observed that inclusion of kPrx2 = 24 s-1 
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in their model would suffice to fit the model to the experimentally determined catalase activity. 
These results led the authors to suggest that Prx2 is a scavenger of endogenously generated H2O2.  
Yet, in our estimates we considered a much higher kPrx2 of 37 000 s-1 (Section 5.1.2). Then why 
does kPrx2 = 24 s-1 suffice to obtain a good fitting of the model of (Johnson et al., 2005) to the rate 
of endogenously produced H2O2? The rate of H2O2 production was determined from the rate of 
catalase inhibition by aminotriazole in GPx1-deficient mice erythrocytes incubated with 10-2 M 
glucose. (Johnson et al., 2005) observed inhibition of ≈3.5% catalase/hour for 4 hours. However, 
aminotriazole-mediated inhibition of catalase occurs only after other iH2O2 scavengers (such as 
Prx2) have been completely oxidized and are not contributing for iH2O2 consumption (Cohen 
and Hochstein, 1964; Giulivi et al., 1994). Considering that GPx1-defficient erythrocytes were 
incubated with 10-2 M glucose to prevent depletion of the NADPH pool, Prx2’s activity is not 
limited by NADPH supply in the experiments of (Johnson et al., 2005). Under these conditions, 
Prx2 is likely accounting for most of the iH2O2 consumption in their experiments . Thus, 
aminotriazole-mediated catalase inhibition occurs very slowly and a small kPrx2 (=24 s-1) suffices 
to fit the model to the determined rate of catalase inhibition. 
Other studies went further to address the impact of each defense on the redox status of the 
erythrocyte. (Johnson et al., 2010) compared the contributions of GPx1, catalase and Prx2 for 
defending mice erythrocytes (5% hematocrit) from H2O2. They did so by generating mice strains 
where each of these defenses had been knocked-out. The erythrocytes were incubated with            
10-2 M glucose and then assessed the redox status of erythrocytes. This was done by determining 
the fraction of MetHb (an oxidized form of Hb) in catalase-knockout and wild type erythrocytes. 
They observed no accumulation of MetHb in catalase-knockout erythrocytes, as assessed 15 
minutes after incubation with 10-2 M glucose. This suggests that catalase is not contributing 
significantly for defense against iH2O2 under those conditions, in agreement with our results. 
The authors then examined the contribution of Prx2 for defense against H2O2 by following 
aminotriazole-mediated catalase inhibition for 3 hours in Prx2-knockout and wild-type 
erythrocytes. This allowed the authors to determine the rate of H2O2 accumulation due to 
endogenous production. They observed a slightly higher rate (=10-11 M/s) in the knock-outs than 
in wild-type (6×10-12 M/s) erythrocytes. This suggests that Prx2 is important for scavenging 
endogenously generated iH2O2. Yet, by using aminotriazole-associated catalase inactivation to 
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measure the rate of endogenously generated H2O2, the authors may have faced the same issues as 
(Johnson et al., 2005), as mentioned above. 
(Johnson et al., 2005) and (Johnson et al., 2010) also addressed the contribution of Prx2 for H2O2 
scavenging through kinetic modeling. However, some of the authors’ considerations in their 
model present a few issues. The authors not only underestimate Prx2’s contribution for H2O2 
consumption by considering a kPrx2 = 24 s-1 (as discussed in Section 6.1.1), but also catalase’s 
contribution for this process. (Johnson et al., 2010) considered a kcatalase ≈ 5 s-1, whereas (Johnson 
et al., 2005) considered a kcatalase = 3.5 s-1 (after considering k=107 M-1 s-1 for the reactivity 
between catalase and H2O2, and total catalase concentration ≈5×10-7 M). These rate constants are 
even lower than kGPx1 considered [≈6 s-1 (Johnson et al., 2010) and =140 s-1 (Johnson et al., 
2005)]. Taken together, these issues show that although their model fits the experimentally 
determined rate of catalase inactivation by aminotriazole, the values of some of their parameters 
need to be re-evaluated.  
The study of (Low et al., 2007) further suggests that Prx2’s contribution for defense against 
H2O2 is only important under low H2O2. (Low et al., 2007) found that ≈60% Prx2 was in PSSP 
form, as assessed ten minutes after erythrocytes (0.05% hematocrit) were exposed                       
to a 5×10-7 M H2O2 bolus. As discussed in Section 6.1.2, a substantial fraction of Prx2 may have 
been oxidized during sample handling. 
Together with our estimates, the results above show that Prx2 contributes significantly for iH2O2 
consumption in erythrocytes facing low/mild H2O2. This is further supported by the observation 
that it would be physiologically implausible to replace Prx2 with catalase: in order for catalase 
(or GPx1) to replace Prx2 and maintain the same responsiveness and iH2O2 a 171 fold (926 fold) 
increase in concentration of enzyme would be required (Section 5.9). These higher 
concentrations would then account for 32% (18%) of the total Hb concentration in the 
erythrocyte. However, such increases could impair the erythrocyte’s ability to for performing 
gaseous exchanges. A significant part of Hb would have to be replaced with antioxidant enzyme, 
affecting the cell’s ability to transport oxygen or carbon dioxide. On the other hand, an increase 
in cell’s size would allow for higher intracellular protein concentrations but could affect the 
erythrocyte’s mobility in capillaries, vessels whose diameter is about that of an erythrocyte. 
Conversely, replacing catalase or GPx1 with Prx2 would require < 1% increase in Prx2’s 
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concentration. These differences are due to the much higher specific activity of Prx2 compared 
to the specific activities of catalase or GPx1. Through Prx2, the erythrocyte is thus able to defend 
itself against low/mild H2O2 while requiring less protein to do so. 
 Catalase becomes the main scavenger of iH2O2 under high 6.2.
oxidative stress 
Our results showed that Prx2 accounts for most of the iH2O2 consumption for eH2O2 < 3×10-7 M 
(Sections 5.5.1 and 5.6). But what occurs under sustained exposure to high eH2O2 such as that 
found during systemic inflammation? As per our estimates, catalase becomes the main scavenger 
of iH2O2 when the erythrocyte is exposed to > 3×10-7 M eH2O2, consuming about 80% of the 
iH2O2, whereas GPx1 consumes <15%. 
(Johnson et al., 2010) also assessed the contribution of GPx1, catalase and Prx2 for defense 
against high H2O2. The authors assessed the fraction of MetHb in mice erythrocytes where each 
of these defenses had been knocked out. As assessed 15 minutes after exposure to                       
a 30×10-6 M and 300×10-6 M H2O2 bolus, catalase-knockouts exhibited 10% and 25% MetHb, 
respectively. On the other hand, wild type erythrocytes did not exhibit higher fractions of MetHb, 
regardless of H2O2 bolus to which they were exposed. These H2O2 boluses respectively yield 
initial rates of H2O2 influx of 2.4×10-4 M/s and 2.4×10-3 M/s, considering kp = 8 s-1                  
(Section 5.2.1.2). These fluxes largely surpass the erythrocyte’s maximum rate of NADPH 
production [1.9×10-6 M/s, (Albrecht et al., 1971)]. Therefore, PSSP accumulates and the 
erythrocyte relies mainly on catalase for defense against H2O2. Because of this, catalase-
knockout erythrocytes present a much higher MetHb accumulation than GPx1-knockouts or wild 
type erythrocytes. 
On the other hand, (Johnson et al., 2010) observed that Prx2-knockout erythrocytes exposed to a 
50 - 500×10-6 M H2O2 bolus did not exhibit higher MetHb comparatively to wild-type cells. This 
led the authors to refer that Prx2 does not contribute significantly for the defense of the 
erythrocyte against exogenous H2O2. Could these eH2O2 boluses lead to PSSP accumulation, 
explaining why Prx2-knockouts and wild-type erythrocytes have similar MetHb? To analyze this 
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question we considered the reaction scheme in Figure 6.1, Model 6.1 and parameters from Table 
6.1. 
 
Figure 6.1– Reaction scheme considered to analyze the experiments of (Johnson et al., 2010). 
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 Model 6.1 
The parameters of Model 6.1 are expressed in Table 6.1. 
Table 6.1 – Parameters used for Model 6.1.  
Parameter Value Meaning/Reference 
kp 0.42 s-1 
First-order rate constant for hydrogen peroxide consumption by erythrocytes. Estimated 
through Equation 5.32 and considering hematocrit 5%, Ve = 10-13 dm3 (Evans and Fung, 1972), 
Vo = 1 dm3 and other parameters from Table 5.5 (Section 5.2.1.10) with exception for n.  
kcatalase 218 s-1 Pseudo-first order rate constant for H2O2 consumption by catalase (Section 5.1.1.2)   
kGPx1 40 s-1  Pseudo-first order rate constant for H2O2 consumption by GPx1 (Section 5.1.1.1) 
kPrxRed 108 M-1s-1 Reactivity between reduced Prx2 and H2O2 (Manta et al., 2009) 
kPSOH 0.26 s-1 First order rate constant for formation of PSSP (Section 5.2.1.10) 
kPSSP 2.1×105 M-1s-1 Reactivity between reduced Trx and PSSP (Manta et al., 2009) 
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Parameter Value Meaning/Reference 
kTrxR 0.5 s-1 Pseudo-first order rate constant for Trx reduction through TrxR (Section 5.2.1.9) 
Prxtot 37×10-4 M Total concentration of Prx2 monomers (Section 5.1.1.3) 
Trxtot 4.8×10-6 M Total Trx concentration (from bovine erythrocytes, 5.2.1.6) 
Using Model 6.1 we estimated the fraction of Prx2 in PSSP form for 10 minutes (Figure 6.2), 
considering the following initial conditions: eH2O2 = 500×10-6 M, iH2O2 = 10-12 M, Prx2 and Trx 
fully reduced. We also considered that eH2O2 is consumed only by permeation across the 
erythrocyte membrane and no exogenous or endogenous production of iH2O2 occurs. Because 
(Johnson et al., 2010) provided 10-2 M glucose to the incubation medium, we also assumed that 
NADPH is not limiting the activity of Prx2, catalase or GPx1. 
 
Figure 6.2 – Estimated fraction of PSSP in erythrocytes subjected to a 500×10-6 M eH2O2 bolus in the experiments of 
(Johnson et al., 2010). Estimated using Model 6.1 and parameters from Table 6.1. See text above for considerations. 
Figure 6.2 shows that although PSSP initially accumulates, it is completely reduced by the time 
of assessment of MetHb (t=600 s) by (Johnson et al., 2010).  
Then why did (Johnson et al., 2010) observe similar MetHb in wild-type and Prx2-knockout 
erythrocytes, regardless of the eH2O2 to which erythrocytes were exposed? In their experiments 
MetHb reduction may have completely regenerated hemoglobin to its native state in both Prx2-
knockouts and wild-type erythrocytes. Another possible explanation is that PSSP may have 
accumulated due to uncontrolled oxidation of the erythrocytes during sample preparation. 
To clarify this issue the authors could have assessed iH2O2 instead of MetHb. This would allow 
understanding if Prx2-knock outs exhibit higher iH2O2 when erythrocytes are exposed to eH2O2 
of various concentrations. Such analysis could then be related with the MetHb found by (Johnson 
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et al., 2010).These points show that further analyses of the iH2O2 and NADPH contents in Prx2-
deficient erythrocytes are required. To clarify the relevance of Prx2 for defense against iH2O2, 
(Johnson et al., 2010) could have assessed MetHb concentrations after exposure of erythrocytes 
to lower exogenous H2O2. 
 The contribution of Prx2 for H2O2 consumption is affected by 6.3.
oxidative load and NADPH supply 
Under eH2O2 higher than a certain threshold (> 3×10-7 M, Section 5.6) Prx2 accumulates in 
PSSP form. This threshold, which we referred to as crossover, marks the transition between two 
regimes: a low oxidative regime (where Prx2 accounts for most of the iH2O2 consumption); and 
a highly oxidative regime (where catalase becomes the main scavenger of iH2O2) (Sections 5.1.2 
and 5.8). But what affects the eH2O2 at which the crossover occurs? 
Because Prx2 reduction is coupled with the Trx/TrxR cycle, (Low et al., 2007) hypothesized that 
accumulation of PSSP was affected by a limited TrxR activity. This led the authors to assess 
TrxR activity. To do so, they used DTNB as a substrate (as discussed in Section 5.2.2) in 
hemolysates (0.05% dm3 hemolysate/dm3). As per our estimates from the authors’ data (Section 
5.2.2) TrxR is reducing DTNB at a rate of 7.9×10-6 M/s, corresponding to a rate of Trx reduction 
of ≈6.1×10-6 M/s. These rates surpass the maximal rate of NADPH production by the PPP 
[=1.9×10-6, (Albrecht et al., 1971)], suggesting that NADPH supply and not TrxR activity limits 
Prx2 regeneration. This is further supported by our estimate of the maximal rate of Trx reduction 
(≈2.4×10-6 M/s, Section 5.2.2), in the range of the maximal rate of NADPH produced by the PPP 
[=1.9×10-6, (Albrecht et al., 1971)]. 
Yet, determination of the limiting step in Prx2 reduction under high oxidative conditions is 
associated with some uncertainties. First, the total Trx concentration considered in our estimates 
was taken from bovine erythrocytes because we have not found reports of concentration in 
human erythrocytes. Second, our estimate of kTrxR was taken from the immunoblots of the 
experiments of (Low et al., 2007) (Figure 5.6, Section 5.2.1.9) where the fraction of reduced 
Prx2 is imprecise. Third, to estimate kTrxR we considered a kinetic model that included singly- 
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and doubly-crosslinked forms of Prx2 (Figure 5.8, Section 5.2.1.9). Yet, we assumed that 
reactions leading to Prx2 oxidation would simply occur with rate constant kPrxRed, whereas Prx2 
reduction would occur with rate constant kPSSP. However, formation/consumption of singly-
crosslinked Prx2 may exhibit different kinetics than those respectively found for the 
formation/consumption of doubly-crosslinked Prx2. 
A more exact determination of Trxtot in human erythrocytes could help clarifying the issues 
above. It could also be interesting to perform the same analyses as (Low et al., 2007) while 
controlling the rate of NADPH produced by the PPP (by the method of (Gaetani et al., 1989) for 
instance). One could then relate the rate of NADPH supplied with the redox status of Prx2. 
However, one should take particular care with uncontrolled oxidation of samples, due to the very 
high reactivity of Prx2 with H2O2. 
What would occur if lower kTrxR or Trxtot are found in human erythrocytes? In Section 5.6 we 
determined an analytical expression (Equation 5.62) that allowed us to estimate the conditions 
under which PSSP would accumulate. This analytical expression relates rate of iH2O2 influx 
(=kp×eH2O2) with rate of TrxR activity (=kTrxR×Trxtot) and allows us to draw some predictions 
of how different kTrxR and Trxtot affect the eH2O2 at which the crossover occurs. A lower kTrxR 
due to lower Trxtot would shift the crossover to lower eH2O2, saving the NADPH pool from 
depletion by the Prx2/Trx/TrxR cycles. A limited NADPH availability would also lead to lower 
kTrxR, then decreasing the eH2O2 at which the crossover occurs. However, these could also affect 
Prx2’s contribution for iH2O2 consumption. 
 Prx2’s high concentration allows the human erythrocyte to 6.4.
remain protected against H2O2 when crossing inflammation sites 
The observation that Prx2 is one of the most abundant proteins in the human erythrocyte (Moore 
et al., 1991) does not seem plausible if Prx2 contributes only for the protection against low (Low 
et al., 2007) or endogenously generated (Johnson et al., 2010) H2O2. Yet, our analyses suggest 
that a high Prx2 concentration allows protection of human erythrocytes against H2O2 from those 
sites, even if the oxidative insults are relatively strong. 
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Under mildly pathological conditions such as localized inflammation, erythrocytes are only 
rarely and briefly exposed to oxidative loads capable of substantially oxidizing Prx2. Most of the 
gaseous exchanges involving the erythrocyte are done at the capillary level, the blood vessels 
with smallest diameter and where blood flow is the slowest. This makes capillaries as the 
locations where erythrocytes are most prone to suffer with oxidation from nearby inflammation 
sites. As per our estimates, the average residence time of an erythrocyte in a capillary is ≈2 s 
(Section 5.10.1). Crossing of a capillary may lead to complete Prx2 oxidation if plasma H2O2 
reaches >2.5×10-5 M (Section 5.11), in the range of the highest H2O2 (5×10-5 M) found close to 
wound sites (Niethammer et al., 2009) in other organisms. Therefore, only when erythrocytes 
cross highly oxidative inflammation foci does Prx2 fully accumulate in PSSP form. 
However, a stepwise accumulation of PSSP due to crossing of multiple inflammation sites is 
highly unlikely. We found that erythrocytes are able to regenerate fully oxidized Prx2 to its 
active form in <3 minutes (Section 5.13) and crossing of multiple inflammation sites takes 
several hours in between (Section 5.10.2). This allows Prx2 to be completely reduced by the time 
an erythrocyte crosses another inflammation site (Section 5.10.2). In contrast, (Low et al., 2007) 
observed that fully oxidized Prx2 takes about 20 minutes to be regenerated back. The differences 
in time taken for Prx2 reduction may be explained as follows.  
In the experiments of (Low et al., 2007) the authors exposed erythrocytes (0.05% hematocrit) to 
a 5×10-6 M H2O2 bolus. In less than 1 minute after the exposure they observe full accumulation 
of PSSP, whereas a large fraction of Prx2 was regenerated in 20 minutes. They also observed 
that extracellular H2O2 is practically fully consumed by erythrocytes in 20 minutes (Figure 5.4, 
Section 5.2.1.8). These two observations show that erythrocytes were no longer exposed to high 
oxidative loads, thus allowing Prx2 to be regenerated. The difference between our estimate        
(<3 min) and the time determined by (Low et al., 2007) for Prx2 reduction could also be due to 
substantial Prx2 oxidation during sample handling, as discussed above. This difference is also 
due to the conditions we considered in our estimates: the time taken for Prx2 to be completely 
reduced was estimated after considering that erythrocytes were exposed to low eH2O2 (=10-8 M). 
Yet, even if Prx2 regeneration takes about 20 mins, a stepwise increase in PSSP is still highly 
unlikely. 
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Altogether, these evidences suggest that a high Prx2 concentration allows crossing of 
inflammation foci while preventing accumulation of PSSP. Even where Prx2 is completely 
oxidized, plasma H2O2 consumption by erythrocytes is still limited by membrane permeation 
(Section 5.8). This further supports the claim that human erythrocytes are regarded as the main 
H2O2 sinks in the human blood (Manta et al., 2009; Winterbourn and Stern, 1987). 
 Prx2 inactivation and reaction between H2O2 and Prx2 6.5.
In our analyses we considered that sulfinylation of Prx2 may be disregarded as an important 
process that affects the contribution of Prx2 for H2O2 scavenging. This consideration was taken 
due to the very low reactivity between PSOH and H2O2 (kPSO2H = 0.23 M-1 s-1, Section 5.7) and is 
in agreement with previous observations by other authors, as we will now discuss. 
(Manta et al., 2009) used an in vitro assay (5×10-5 M Prx2; 8×10-6 M Trx; 10-6 M TrxR; 200×10-6 
M NADPH) to determine if Prx2 sulfinylation would be detected in the mixture 10 minutes after 
beginning of reaction. (Manta et al., 2009) found some sulfinylated Prx2 when a 25×10-5 M 
H2O2 bolus was added to the mixture (concentration of sulfinylated Prx2 was not specified). 
To examine why (Manta et al., 2009) found accumulation of sulfinylated Prx2 we considered the 
reaction scheme in Figure 6.3 from which we built Model 6.2. 
 
Figure 6.3 – Reaction scheme considered for the analysis of the experiments of (Manta et al., 2009). 
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Model 6.2 
The parameters of Model 6.2 are expressed in Table 6.2. 
Table 6.2 – Parameters used for Model 6.2.  
Parameter Value Meaning/Reference 
( )mK NADPH  6×10-6 M Km of TrxR for NADPH (Urig et al., 2006) 
 mK Trx  1.83×10-6 M Km of TrxR for Trx (Turanov et al., 2006) 
kPrxRed 108 M-1s-1 Reactivity between reduced Prx2 and H2O2 (Manta et al., 2009) 
kPSOH 0.26 s-1 First order rate constant for formation of PSSP (Section 5.2.1.10) 
kPSSP 2.1×105 M-1s-1 Reactivity between reduced Trx and PSSP (Manta et al., 2009) 
Prxtot 5×10-5 M Total concentration of Prx2 monomers (Section 5.1.1.3) 
Trxtot 8×10-6 M Total Trx concentration (from bovine erythrocytes, 5.2.1.6) 
TrxR
maxV  2.58×10
-6 M/s Estimated from the product of TrxR considered in the experiments of (Manta et al., 2009) (=10-6 M) with the catalytic constant kcat = 25.8 s-1 (Turanov et al., 2006) 
With the aim of understanding the results of (Manta et al., 2009) we aimed to simulate what the 
authors did through Model 6.2. Using this model we assessed the redox status of Prx2 ten 
minutes after an initial bolus of 25×10-5 M H2O2. We considered that H2O2 is consumed by Prx2, 
and that NADPH is consumed by TrxR (according to the rate expression in Equation 5.35, 
Section 5.2.1.9). As per the initial conditions of (Manta et al., 2009) we considered: Prx2 and Trx 
fully reduced; NADPH = 200×10-6 M; H2O2 = 25×10-5 M. 
Bearing these considerations in mind, we estimate a iH2O2 ≈1.3×10-4 M and a                      
NADPH ≈ 1.8×10-4 M when t = 600 s [which corresponds to the time at which (Manta et al., 
2009) assessed their mixture for presence of sulfinylated Prx2]. We also found that Prx2 
accumulates in PSOH form:  
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Figure 6.4 – Estimated fraction of PSOH in the experiments of (Manta et al., 2009). Estimated through Model 6.2, 
parameters from Table 6.2. See text above for more considerations. 
As the figure above shows, PSOH quickly accumulates and remains practically constant until the 
end of the simulation time. The accumulation of PSOH occurs because the pseudo-first order rate 
constant for PrxRed oxidation, in order to PrxRed (=kPrxRed×H2O2 ≈ 23 830 s-1) largely surpasses 
the rate constant for the formation of PSSP (=kPSOH = 0.26 s-1, Section 25.2.1.10). Under these 
conditions, and because there is still plenty NADPH and H2O2 available, the limiting step in Prx2 
activity is the formation of PSSP. Because PSOH accumulates, Prx2 is also prone to accumulate 
in sulfinylated form. However, iH2O2 as high as 25×10-5 M largely surpass the physiologically 
plausible iH2O2. 
Similarly, (Cho et al., 2010) also addressed whether erythrocytes (50% hematocrit) exposed to        
7.5 - 75×10-8 M H2O2/s would accumulate sulfinylated forms of 2-Cysteine peroxiredoxins, as 
assessed 3 hours after incubation. The authors found no sulfinylated peroxiredoxin when no 
exogenous H2O2 was provided, which they attributed to sulfiredoxin activity able to regenerate 
sulfinylated peroxiredoxin under basal oxidative conditions. On the other hand, they found 
sulfinylated peroxiredoxin when erythrocytes were subjected to 7.5×10-8 M H2O2/s. However, as 
acknowledged by the authors, the antibodies used for detecting sulfinylated forms of 2-Cysteine 
peroxiredoxins do not allow distinction between peroxiredoxins 1 and 2 given their similar 
catalytic site sequence and size. Because human erythrocytes also possess peroxiredoxin 1 
(Marzocchi et al., 2005), the sulfinylated 2-cysteine peroxiredoxin detected may pertain to 
sulfinylated peroxiredoxin 1, not Prx2. 
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On the other hand, (Low et al., 2007) found no sulfinylated Prx2 as assessed 10 minutes after 
human erythrocytes (≈0.05 % hematocrit) were exposed up to <200×10-6 M H2O2 bolus. As per 
the conditions of the experiment, Prx2 does not accumulate in sulfinylated form because 1. 
≈100% of Prx2 was in PSSP form as determined by the authors and 2. because even if Prx2 is in 
PSSP form, catalase likely prevents accumulation of iH2O2 beyond physiologically plausible 
concentrations that may lead to kPrxRed×H2O2 > kPSOH. 
Taken together, this evidence suggests that Prx2 sulfinylation is not physiologically relevant for 
Prx2-mediated H2O2 reduction given the very slow rates at which sulfinylated Prx2 accumulates. 
 Improvements and experiments needed 6.6.
Throughout this report we already discussed some of the constraints of our results. We now 
proceed to further explore some of them and refer some of the studies that could be done to 
improve our results and answer other questions. 
6.6.1. Basal and pathological oxidative loads 
As discussed throughout Sections 5.2.1.3, 5.3, 5.10.3 and 5.10.4, the determination of the basal 
and pathological H2O2 loads which erythrocytes face is an experimentally difficult task. Such 
difficulties come from the sensitivity of the methods used, of the short half-life of H2O2, and 
samples prone to suffer oxidative stress during preparation. 
Current methodologies for quantifying H2O2 are not sensitive to concentrations much lower than 
nanomolar. However, our analyses suggest that iH2O2 under basal loads should be < 2×10-11 M, 
allowing most of the Prx2 contents to remain in reduced form. Those methodologies usually rely 
on coupled reactions to determine the intracellular H2O2 loads. It is the case of the catalase 
inhibition assays employed by (Giulivi et al., 1994) or catalase fluorescence in the work of 
(Kirkman et al., 1999). If the kinetics of reaction between catalase and inhibitor or between 
catalase and H2O2 are not fast enough, the determination of H2O2 concentration is limited by the 
reactivity between the reactants. Further, if the oxygen which the erythrocytes are exposed to 
during sample handling is not well controlled, the oxidative stress which these cells may be 
facing may potentially affect the iH2O2 concentration. 
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A possible way to overcome part of these issues would be to directly quantify H2O2 levels from 
hemolysates in an Argon anaerobic atmosphere, taking special care to minimize leukocyte 
activation during blood collection. The quantification could be done through H2O2 probes that 
directly quantify H2O2 in cells. But these probes are either oxidizable by other substrates 
(Corbett, 1989; Crow, 1997; Foppoli et al., 2000; Gomes et al., 2005; Wang and Joseph, 1999) or 
their detection limit does not allow detecting H2O2 below the nanomolar range (Zhou et al., 
1997). This makes it unfeasible to directly quantify H2O2 in erythrocytes. 
(Niethammer et al., 2009) developed an H2O2 sensor for quantifying H2O2. This sensor is 
introduced onto the embryo of the target organism through mRNA injection, inducing global 
cytoplasmic expression of the sensor. Later on, the tissue is assessed for the fluorescent 
excitation of the sensor, whose emission spectra increases upon oxidation by H2O2. (Niethammer 
et al., 2009) used this method in zebrafish to measure the plasma H2O2 near wounds and detected 
≈0.5 – 50×10-6 M H2O2 in those locations. This sensor was previously used in mammalian cells 
and was found to be sensitive down to 5×10-6 M H2O2. Again, despite its potential as an H2O2 
probe, a couple of problems may arise for using this method to quantify H2O2 in mice. First, the 
ability to use this sensor in mammalian cells was shown in HeLa cells (Belousov et al., 2006). 
However, this does not guarantee that its insertion in mice embryos is possible, or that the sensor 
would even be expressed in the erythrocytes’ cytoplasm. Second, in order to determine the H2O2 
levels, blood would have to be collected. This may subject erythrocytes to oxidative stress during 
handling, due to immune reactions nearby the blood collection site. Thirdly, a higher oxidative 
stress could result from sample handling (uncontrolled oxygen conditions during handling). 
The issues above further show the difficulty in quantification of intracellular and extracellular 
H2O2 levels in blood. Better and more sensitive methods for assaying H2O2 concentration are 
needed in order to obtain more precise determinations of the redox behavior of Prx2/Trx cycles 
under various conditions. 
6.6.2. Catalytic cycle of catalase 
In our work we considered that catalase-mediated H2O2 consumption is a first order process with 
respect to H2O2. As discussed in Section 5.2.1.1, the accumulation of Intermediate and 
Compound II forms of catalase is likely not very prevalent, provided that NADPH availability 
does not lead to accumulation of Compound II. 
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However, the kinetics of formation and consumption of Intermediate are not completely 
characterized and further experiments are required to assess them. This is an experimental 
complicated issue, given the instability of the Intermediate. So instead of assessing the kinetics 
of formation and consumption of Intermediate, one could analyze the formation of Compound II 
and kinetics of NADPH consumption by catalase. This could be done in vitro with purified 
enzyme and under controlled NADPH and H2O2 conditions. 
The rate of NADPH consumption by catalase could be studied under various NADPH and H2O2 
concentrations. This would allow not only studying the kinetics of NADPH oxidation by catalase 
but also under which H2O2 concentration is NADPH consumption limited by H2O2 availability. 
The concentrations of different catalase forms and NADPH could be determined through 
spectrophotometric assays as previously described (Hillar et al., 1994; Kirkman et al., 1999). The 
levels of H2O2 could be determined through H2O2 probes. However, the probes’ sensitivity to 
H2O2 would have to allow measuring H2O2 <10-10 M (in Section 5.2.1.1 we estimated that 
catalase-mediated NADPH oxidation is limited by H2O2 availability if H2O2 is below this 
concentration). Yet, this H2O2 may be too low for quantification by any probe so special care in 
choosing the H2O2 quantification method would have to be taken. 
In future studies we intend on including the full catalytic cycle of catalase, considering also 
catalase inactivation. By doing so we would be able to obtain the conditions in which the 
dismutase activity is a first-order process with respect to H2O2, and address if catalase 
inactivation may occur in vivo. 
6.6.3. Frequency of crossing inflammation sites and H2O2 induced by crossing 
inflammation sites 
In Section 5.10.2 we estimated the frequency taken by an erythrocyte to cross two consecutive 
inflammation sites. The value estimated represents a rough approximation and depends on 
various factors such as number, location and volume of the inflammation foci; capillary density 
nearby the inflammation foci; heart beat rate; body volume; etc. Yet, could any experiment be 
designed to determine a more accurate frequency of crossing a localized inflammation site? 
If a single erythrocyte could be labeled and exhibit different signal-intensity levels of the label 
upon exposure to H2O2, this could potentially be assessed. Yet, this would require that a whole 
body analysis method would detect even the small signal intensity emitted by that single cell. 
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However, this is technically not possible because whole body assays do not permit such a high 
degree of sensitivity. 
Another issue that could help understanding the behavior of Prx2/Trx cycles in human would be 
to determine the oxidative load which an erythrocyte is subjected to when crossing an 
inflammation site. A possible way to assess this issue would be to first induce the expression of 
an H2O2 sensor such as the one used by (Belousov et al., 2006) in the cytoplasm of mice 
erythrocytes. Afterwards, one could induce a wound in the tail of the mouse and inject the 
modified erythrocytes very close to the wound. By collecting the modified erythrocytes after 
these have passed by the wound and quantifying the fluorescence of the H2O2 sensor, we would 
be able to measure the H2O2 which an erythrocyte is exposed to. However, the mere injection 
and blood collection could induce an inflammatory response. Thus we would also have to 
perform the same assay without inducing the wound. The difference in fluorescence in the 
cytoplasm of the erythrocytes that had crossed the wound versus the erythrocytes that were 
injected but had no wound would give the H2O2 which erythrocytes would be subjected to. 
However, a fundamental issue associated with this method is that the mere injection and blood 
collection could lead to a very high oxidative stress. If the oxidative load was high enough to 
lead to full oxidation of Prx2, the iH2O2 would be much higher than what would be gotten by 
mere crossing of inflammation sites. 
6.6.4. Peroxidase activity and relevance of Prx2 for H2O2 defense 
In ouranalyses we considered a simplified redox cycle of Prx2. However, a few experiments 
could improve our estimates and allowa more accurate description of the behavior of the 
Prx2/Trx cycles. 
The rate constant for PSSP formation could be better determined. We estimated this rate constant 
from the NADPH oxidation assays of (Manta et al., 2009). However, if it was possible to 
determine the redox state of Prx2 through a spectrometric assay, one could follow the formation 
and consumption of PSSP and obtain the rate constant for PSSP formation. (Monteiro et al., 
2007) used spectrometric assays to determine the redox status of cysteines of the yeast 
peroxiredoxin 1. Possibly the same method may be done with Prx2 isolated from human 
erythrocytes to further determine the kinetics of PSSP formation. 
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Another issue that needs to be further analyzed is what limits the peroxidase activity of Prx2 at 
high oxidative loads. Our analyses suggest that NADPH (not Trx) concentration, limit Prx2 
activity and the maximum rate of H2O2 reduction achieved by Prx2. But because the Trx 
concentration we considered was taken from bovine erythrocytes, this protein also needs to be 
quantified in human erythrocytes in order to verify if the total Trx concentration may limit the 
peroxidase activity of Prx2. 
Another issue that potentially may affect the peroxidase activity of Prx2 is the kinetics of Trx 
reduction by TrxR. In our study we considered that TrxR exhibits first-order kinetics with 
respect to Trx. However, it would be interesting to express the full ping-pong kinetics of TrxR in 
our models to address how the kinetic parameters of this enzyme relate with oxidative load and 
NADPH availability. The issue of NADPH availability and how it potentially affects the activity 
of each enzyme is discussed further below.  
In our results we also found that Prx2 has a very high specific activity, comparatively to catalase 
and GPx1. Because of this, the erythrocyte requires less protein to remain protected against low 
H2O2 than if it was using catalase for instance. However, high oxidative loads limit Prx2 activity, 
which is when catalase becomes the main defense against H2O2. Given that catalases and 
peroxiredoxins are widely distributed in nature, could the properties of H2O2 defense found in 
the human erythrocyte be shared in other organisms? This will be the case if such organisms 
possess a peroxidase with very high specific activity and an H2O2 dismutase with lower specific 
activity but that requires less reducing equivalents. 
Indeed a few similarities between the main H2O2 defense systems found in the human 
erythrocyte are shared with other organisms. First, studies done in Saccharomyces cerevisiae 
(Munhoz and Netto, 2004), Escherichia coli (Seaver and Imlay, 2001) and other bacteria 
(Cosgrove et al., 2007; Hebrard et al., 2009; LeBlanc et al., 2006) showed that the main defenses 
of these cells against H2O2 complement each other: peroxiredoxins protect the cell against low 
hydrogen peroxide levels whereas catalases are required to protect the cell against stronger 
oxidative stress. Second, peroxiredoxins are much more abundant than catalases in E. coli (Link 
et al., 1997; Lopez-Campistrous et al., 2005; Taoka et al., 2004) and S. cerevisiae 
(Ghaemmaghami et al., 2003). Third, in E. coli the reactivity of one of the peroxiredoxins with 
H2O2 (Niimura et al., 1995) is much larger than the reactivity of catalases (Hillar et al., 2000) 
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with the same substrate. Fourth, the specific activity of that peroxiredoxin is more than tenfold 
higher than the reactivity of catalase with the same substrate5. Taken together, these evidences 
suggest that the principles found in human erythrocytes in terms of redox behavior of its H2O2 
defenses could be found in other cells. If that is the case, the utilization of peroxiredoxins thus 
allows cells to minimize the biosynthetic and space costs of H2O2 defense, while the utilization 
of catalases minimizes the cost of H2O2 defense in terms of utilization of reducing equivalents. 
It could be interesting to address if these features would be observed in E. coli and S. cerevisiae, 
explaining why those organisms also possess two types of defenses against H2O2. This could be 
addressed through a similar approach to the one used in this work. A few more issues could also 
be analyzed: the relevance of each system for H2O2 defense; their competition for reducing 
equivalents when these are scarce; the costs of replacing one of the antioxidants by the other (in 
terms of consumption of reducing equivalents and concentration of protein required). 
6.6.5. Effects of NADPH supply on H2O2 defense 
It could be very useful to understand the effects of a limited NADPH supply for the contribution 
of each antioxidant for defense against H2O2. Although we expect catalase to not be greatly 
affected by a low NADPH supply given its low NADPH requirement, NADPH availability may 
limit the antioxidant activities of Prx2 and GPx1. This would occur when the NADPH supply 
cannot keep up with the demand for reducing equivalents. The reduction of Prx2 and GSH would 
then be limited, affecting the contribution of Prx2 and GPx1 for antioxidant protection. 
Indeed, in work done after this study we already addressed some of the effects of limited 
NADPH availability on the activities of Prx2 and GPx1. We already considered full 
GPx1/GSH/GSR cycles; NADPH consumption by TrxR and GSR; and a saturable NADPH 
supply by the PPP. We found that the kinetic parameters of TrxR and GSR permit that GSR 
outcompetes TrxR for NADPH when the demand for reducing equivalents exceeds the supply. 
This allows the reduction of oxidized glutathione to be privileged over Prx2 regeneration, 
suggesting that it is more important for the erythrocyte to maintain glutathione in reduced form 
                                                 
 
5 The peroxiredoxin AHPC has higher specific activity (≈3×10-3 mol H2O2/s/g, estimated considering kcat = 76 s-1 (Baker 
and Poole, 2003) and MW = 20 762 Da (Kwon et al., 2008)) than the catalase [≈0.1×10-3 mol/s/g (Visick and Clarke, 1997)]. 
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than maintaining the peroxidase activity of Prx2. This may be because glutathione reduction 
enables GPx1-mediated scavenging of organic peroxides and prevents accumulation of oxidized 
glutathione, a compound toxic for the cell. 
Together with the results presented in this report, the work done afterwards shows the 
complementarity of these antioxidant systems. The utilization of Prx2 allows the cell to keep a 
low iH2O2 and fast response time while minimizing the protein committed to H2O2 defense under 
low oxidative loads. On the other hand, catalase’s low NADPH requirements makes its 
contribution for H2O2 defense particularly important under conditions in which NADPH supply 
limits Prx2 reduction. GPx1 contributes little for H2O2 elimination it is important for the 
elimination of organic peroxides that also accumulate under oxidative stress. Lastly, the kinetic 
parameters of TrxR and GSR are orchestrated in such way that the GPx1/GSR system has 
priority over the Prx2/TrxR system in its access to NADPH when NADPH becomes scarce, 
likely due to GPx1’s role in defense against organic peroxides.  
 Relevance of the study 6.7.
Our results bring important insight onto the possible roles of catalase, Prx2 and GPx1 for 
antioxidant defense in erythrocytes. It was previously thought that catalase was the main defense 
against H2O2 in human erythrocytes. Our results showed that Prx2 is the main defense of the 
human erythrocyte against H2O2 under most physiological conditions. 
Peroxiredoxin deficiency and inactivation has been implicated in many diseases such as 
development of various cancer types (Neumann et al., 2003), anemia (Johnson et al., 2010; 
Neumann et al., 2003), senescence (Han et al., 2005), Parkinson’s disease (Przedborski, 2007), 
and many other pathologies. Yet, because peroxiredoxins were previously thought to protect only 
against low H2O2 concentrations, the study of those proteins was not an important issue. Our 
results potentially change this, shedding new light onto the potential role that peroxiredoxins 
may have for preventing the development of those diseases. By demonstrating that 
peroxiredoxins are one of the most important proteins in the protection of human erythrocytes 
from H2O2, new studies are required to determine how Prx2 activity is related with the 
development of those pathologies. Prx2 is a widely distributed protein and development of those 
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diseases may be associated with the inability to maintain active Prx2 and the H2O2-associated 
progression of those pathologies.  
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7. Conclusion 
Peroxiredoxin 2 is the main defense of human erythrocytes against hydrogen peroxide under 
most physiological circumstances. It protects this cell upon sustained exposure to low/mild 
hydrogen peroxide loads. Under strong oxidative conditions its antioxidant activity is impaired 
and the erythrocyte mainly relies on catalase for the defense against hydrogen peroxide. Even 
when peroxiredoxin 2 is inactivated, plasma hydrogen peroxide consumption by erythrocytes is 
limited by membrane permeation. 
Due to the much higher specific activity of peroxiredoxin 2, replacement of this protein by 
catalase or glutathione peroxidase is physiologically not plausible. Also, the very large 
abundance of peroxiredoxin 2 in the human erythrocyte allows the protection against hydrogen 
peroxide when the erythrocyte crosses inflammation sites. 
Our results have important implications for the study of antioxidant protection and reactive 
oxygen species-associated diseases in mammalian cells. 
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9. Appendix 
The following abstracts refer to poster and oral communications of this work. 
 Poster presentations 9.1.
Benfeitas R., Antunes F., Salvador A. (2010). The role of peroxiredoxin 2 in the protection of 
human erythrocytes against hydrogen peroxide: a kinetic analysis. 
XVII Congresso Nacional de Bioquímica, Porto, Portugal, 15-17 December. 
Peroxiredoxin 2 (Prx2) is a hydrogen peroxide (H2O2) reducing protein abundant in human 
erythrocytes (~0.37 mM). Its high reactivity with H2O2 (k~108 M-1 s-1) makes it potentially very 
relevant for antioxidant protection of these cells. However, erythrocytes’ limited capacity for 
reducing Prx2 to its active form once this protein is oxidized by H2O2 raises questions about that 
relevance in vivo. Seeking to clarify this issue we set up a kinetic model that encompasses the 
main processes protecting human erythrocytes against H2O2. Namely, the glutathione peroxidase 
(GPx1), catalase and Prx2 systems. We then used the model to examine the dynamic behavior of 
these processes under various conditions. 
Analysis of the relevant concentration and time scales highlights the following. (i) Under basal 
conditions, assuming a sustained extracellular H2O2 (eH2O2) concentration <30 nM and <25 
nM/s intracellular H2O2 (iH2O2) production, Prx2 is expected to be fully reduced. Prx2, catalase 
and GPx1 would then eliminate 99%, 0.6% and 0.1% of the H2O2, respectively. (ii) Doses >0.4 
mM H2O2 entering the erythrocyte over a period of <1 min, or sustained eH2O2 concentrations 
>200 nM fully oxidize Prx2 to its disulfide form. Catalase then becomes the main defense 
against H2O2. (iii) eH2O2 consumption by erythrocytes is limited by membrane permeation even 
when Prx2 is fully oxidized. Thus, although erythrocytes are quite likely the main sink of plasma 
H2O2, Prx2 is dispensable for this role. (iv) Once all Prx2 is oxidized, erythrocytes can 
regenerate the reduced form in minutes if eH2O2 concentrations and iH2O2 production return to 
basal values. The points above have the following implications. (a) Mere crossing of 
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inflammation sites is insufficient to cause extensive Prx2 oxidation, as the following reasoning 
shows. The residence time of a circulating erythrocyte in an inflammation site is determined by 
the time (~2 s) to cross the capillaries, where these cells are in most intimate contact with the 
vasculature walls and circulate most slowly. For a dose of 0.4 mM H2O2 to enter the erythrocyte 
in such a short time, the local eH2O2 concentration would have to be ~20 µM, sufficient to 
extensively damage the surrounding endothelial cells. (b) A stepwise increase in Prx2 oxidation 
through repeated crossing of inflammation sites is very unlikely. This because such crossings are 
expected to occur many hours in between; time enough for Prx2 to be fully reduced. (c) Short-
term eH2O2 doses sufficient to fully oxidize Prx2 are only conceivably attained through direct 
contact of the erythrocytes with activated phagocytes, for instance in immune clearance. (d) 
However, high enough sustained eH2O2 concentrations are conceivable in systemic 
inflammation. Altogether, our results indicate that Prx2 is the main defense of human 
erythrocytes against H2O2 under most physiological circumstances. 
This work was supported by grant PTDC/QUI/70523/2006 from “Fundação para a Ciência e Tecnologia” 
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Benfeitas R., Antunes F., Salvador A. (2011). The role of peroxiredoxin 2 in protecting 
human erythrocytes against hydrogen peroxide: a kinetic analysis.  
XII International Congress on Molecular Systems Biology, Lleida, Spain, 8 – 12 May. 
Peroxiredoxin 2 (Prx2) is a hydrogen peroxide (H2O2) reducing protein abundant in human 
erythrocytes (~0.37 mM). Its high reactivity with H2O2 (k~108 M-1 s-1 ) makes it potentially very  
relevant for antioxidant protection of these cells. However, erythrocytes’ limited capacity for  
reducing Prx2 to its active form once this protein is oxidized by H2O2 raises questions about that 
relevance in vivo. Seeking to clarify this issue we set up a kinetic model that encompasses the 
main processes protecting human erythrocytes against H2O2. Namely, the glutathione peroxidase  
(GPx1), catalase and Prx2 systems. We then used the model to examine the dynamic behavior of  
these processes under various conditions.  
Analysis of the relevant concentration and time scales highlights the following. (i) Under basal 
conditions, assuming a sustained extracellular H2O2 (eH2O2) concentration <30 nM and <25 
nM/s intracellular H2O2 (iH2O2) production, Prx2 is expected to be fully reduced. Prx2, catalase  
and GPx1 would then eliminate 99%, 0.6% and 0.1% of the H2O2, respectively. (ii) Doses >0.4  
mM H2O2 entering the erythrocyte over a period of <1 min, or sustained eH2O2 concentrations  
>200 nM fully oxidize Prx2 to its disulfide form. Catalase then becomes the main defense 
against H2O2. (iii) Once all Prx2 is oxidized, erythrocytes can regenerate the reduced form in 
minutes if eH2O2 concentrations and iH2O2 production return to basal values. (iv) eH2O2  
consumption by erythrocytes is limited by membrane permeation even when Prx2 is fully 
oxidized: under these conditions the log gain of eH2O2 consumption by the  erythrocyte with 
respect to  changes in the permeability constant is ~0.96, whereas those  with respect to  changes 
in catalase and GPx1 concentrations are <0.04 and <0.01, respectively. Thus, although 
erythrocytes are quite likely the main sink of plasma H2O2, Prx2 is dispensable for this role.  
The points above have the following implications. (a) Crossing of inflammation sites may 
plausibly cause substantial but transient Prx2 oxidation, as the following reasoning shows. The 
residence time of a circulating erythrocyte in an inflammation site is determined by the time (~2 
s) to cross the capillaries, where these cells are in most intimate contact with the vasculature 
walls and circulate most slowly. A dose >0.4 mM H2O2 will enter the erythrocyte during this 
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time if the local eH2O2 concentration is >16 µM, which is in the scale of experimentally 
determined values for inflammatory foci in other organisms. (b) A stepwise increase in Prx2 
oxidation through repeated crossing of inflammation sites is very unlikely. This because such 
crossings are expected to occur many hours in between; time enough for Prx2 to be fully reduced. 
(c) High enough sustained eH2O2 concentrations sufficient to fully oxidize Prx2 are only 
conceivable in systemic inflammation. 
Altogether, our results show that Prx2 is the main defense of these cells against H2O2 under  
most physiological circumstances. However, Prx2 inactivation does not impair the erythrocytes’ 
ability to scavenge eH2O2 because the activity of catalase is sufficiently high to eliminate 
virtually all the incoming H2O2.  
Work supported by grant PTDC/QUI/70523/2006 from FCT-Portugal. 
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 Oral communications 9.2.
Benfeitas R., Antunes F., Salvador A. (2011). Are the defenses of human erythrocytes against 
hydrogen peroxide functionally redundant? 
XII International Congress on Molecular Systems Biology, Lleida, Spain, 8 – 12 May. 
Human erythrocytes contain three enzymes — peroxiredoxin 2 (Prx2), glutathione peroxidase 
(GPx1) and catalase — that decompose hydrogen peroxide (H2O2). Whereas GPx1 reduces also 
fatty acid hydroperoxides, and thus has a distinct specificity from Prx2, the specificity of catalase 
is largely overlapped by Prx2. Further, whereas H2O2 reduction via the first two enzymes is 
stoichiometrically coupled to NADPH consumption, H2O2 dismutation via catalase entails 
minimal NADPH consumption. Why do then erythrocytes rely mainly on Prx2 for protection 
against H2O2? Why is catalase still required despite the extremely large (37000 s-1) pseudo-first-
order rate constant of Prx2 for H2O2 reduction? And how is access to NADPH prioritized among 
the Prx2 and the GPx1 redox systems at oxidative loads where that resource becomes limiting?  
Using a kinetic model that encompasses these three antioxidant systems we found the following. 
(1) In order to fully replace Prx2 such that the same H2O2 concentration and response time as in 
normal erythrocytes would be retained ~10 pg catalase (60 pg GPx1) would be required. This 
amounts to 32% (176%) of the hemoglobin in human erythrocytes. Such a solution could thus 
impair oxygen transport either by making erythrocytes bigger, and thus less able to cross 
capillaries, or by reducing the space available for hemoglobin. (2) On the other hand, a mere 
0.6% increase in Prx2 concentration would suffice to compensate for the effect of catalase 
elimination on H2O2 concentration and response time at basal oxidative loads. However, as 
erythrocytes cross inflammatory  foci Prx2 can become substantially oxidized, and thus inactive. 
In such conditions the absence of catalase leads to much higher H2O2 concentrations being 
transiently attained. (3) The kinetic parameters of thioredoxin reductase and glutathione 
reductase — enzymes that mediate the transfer of reducing equivalents to the Prx2 and the GPx1 
systems, respectively  — are orchestrated in such way that the latter enzyme outcompetes the 
former for NADPH when the demand for reducing equivalents exceeds the supply. This has the 
effect of privileging the reduction of oxidized glutathione (GSSG) at the cost of delaying Prx2 
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recovery, consistent with biochemical evidence that GSSG accumulation is deleterious. Under 
these circumstances, catalase activity becomes very important to avoid strong H2O2 
accumulation and further glutathione oxidation.  
Altogether, our results illuminate the functional complementarily among apparently overlapping 
erythrocyte defenses against H2O2.  Namely, although Prx2 is the main defense at low to 
moderate H2O2 concentrations, at the high H2O2 concentrations that may be attained in 
inflammation sites catalase becomes the main defense. Further, the kinetic parameters of the 
Prx2 and the GPx1 system are orchestrated in such way as to prioritize GSSG reduction over 
Prx2 reduction. 
Work supported by grant PTDC/QUI/70523/2006 from FCT-Portugal. 
